Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008401	s-pujoe	— (—)	4936	5127	100.00%	Distribution not available
3008401	s-pujoe	kU/l (u/ml)	4289	4698	0.02%
3008401	pujo	— (—)	625	649	100.00%	Distribution not available
3008401	pujo	kU/l (u/ml)	117	120	0.00%
3008401	s-pujoe	kU/l______ (u/ml)	115	116	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Conjunctivitis

2350

6921

2.82

307.65

1.1

1.35

0.93

u/ml

2.08

1382

2877

Asthma (diagnoses ohter than nonallergic)

3076

6514

3.98

307.65

1.1

1.01

1.10

u/ml

0.27

1826

2545

Disorders of conjunctiva

2399

7109

2.69

307.65

1.1

1.34

0.92

u/ml

2.14

1401

2947

Nasal polyp

560

869

6.79

307.65

1.2

1.0

0.48

1.29

u/ml

1.67

346

320

Asthma (only as main-diagnosis)

2716

2807

5.67

307.65

1.1

1.0

1.04

1.20

u/ml

0.39

1544

925

Other diseases of upper respiratory tract

2410

4527

2.83

307.65

1.1

1.0

1.09

1.01

u/ml

0.20

1291

1660

Asthma, excluding more controls

2702

2774

5.23

307.65

1.1

1.0

1.04

1.22

u/ml

0.45

1509

909

Dermatitis and eczema

2663

6590

2.44

307.65

1.1

1.59

0.73

u/ml

6.31

1404

2696

Desensitization to allergens

544

807

8.37

307.65

1.2

1.1

1.61

1.06

u/ml

1.02

407

364

Asthma (only as main-diagnosis), excluding more controls

2700

2774

5.65

307.65

1.1

1.0

1.05

1.22

u/ml

0.43

1536

909

Asthma, unspecified (mode)

1334

2544

3.89

307.65

1.1

1.0

0.91

1.25

u/ml

0.80

650

820

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1970

5928

3.32

307.65

1.1

1.39

0.91

u/ml

2.33

1191

2372

Chronic lower respiratory diseases

3764

5778

3.55

307.65

1.1

1.04

1.08

u/ml

0.14

2011

2287

Vasomotor and allergic rhinitis

2352

3490

7.25

307.65

1.2

1.0

1.34

1.03

u/ml

1.07

1524

1306

Asthma

2731

2807

5.24

307.65

1.1

1.0

1.03

1.20

u/ml

0.43

1525

925

Obesity related asthma

929

2325

4.16

307.65

1.1

1.0

0.84

0.93

u/ml

0.17

468

842

Atopic dermatitis, strict definition with reimbursement

1349

3825

3.59

307.65

1.2

1.1

2.27

0.83

u/ml

6.89

895

1627

Allergic asthma (mode), excluding more controls

1459

1836

8.55

307.65

1.2

1.0

1.18

1.31

u/ml

0.22

1000

626

Atopic dermatitis

2146

5787

3.07

307.65

1.1

1.90

0.74

u/ml

7.54

1225

2376

Asthma-related infections

1897

4878

3.95

307.65

1.2

1.1

1.02

1.13

u/ml

0.31

1149

1943

Asthma and allergy

1076

1136

10.78

307.65

1.2

1.0

1.36

1.55

u/ml

0.23

771

395

Asthma, unspecified (mode), excluding more controls

1326

2515

3.89

307.65

1.1

1.0

0.91

1.27

u/ml

0.85

646

806

1658

4100

4.21

307.65

1.2

1.1

0.98

1.14

u/ml

0.46

1008

1663

Allergic asthma (mode)

1459

1827

8.59

307.65

1.2

1.0

1.18

1.31

u/ml

0.22

1000

624

Allergic rhinitis

2252

3505

7.15

307.65

1.2

1.1

1.33

1.11

u/ml

0.58

1498

1340

Chronic sinusitis

1163

2982

4.04

307.65

1.1

1.0

0.91

1.05

u/ml

0.25

614

1027

Chronic rhinitis, nasopharyngitis and pharyngitis

1032

2336

4.63

307.65

1.1

1.0

0.81

1.04

u/ml

0.65

562

845

Asthma/COPD (KELA code 203)

3071

5757

3.69

307.65

1.1

1.06

1.09

u/ml

0.07

1663

2281

Asthma, including avohilmo

4107

5313

4.43

307.65

1.1

1.04

1.09

u/ml

0.14

2138

2106

Asthma and allergy, excluding more controls

1077

1159

10.58

307.65

1.2

1.0

1.36

1.50

u/ml

0.17

772

411

Asthma, hospital admission 2, infections

1897

4878

3.95

307.65

1.2

1.1

1.02

1.13

u/ml

0.31

1149

1943

Allergic conjunctivitis

2036

6264

3.26

307.65

1.1

1.37

0.92

u/ml

2.16

1231

2528

Asthma (mode)

2746

2819

5.35

307.65

1.1

1.0

1.02

1.20

u/ml

0.45

1543

928

Asthma, hospital admissions , main diagnosis only

2957

6673

4.03

307.65

1.1

1.04

1.06

u/ml

0.06

1739

2643

Pollen allergy

1791

2500

8.41

307.65

1.2

1.1

1.30

1.08

u/ml

0.60

1226

1030

Suggestive for eosinophilic asthma

364

399

9.93

304.83

1.3

1.0

0.47

1.60

u/ml

1.40

253

150

Atopic dermatitis, strict definition

1272

4282

3.07

275.81

1.2

1.1

2.35

0.88

u/ml

6.65

854

1891

Cough

1079

3178

3.27

265.12

1.1

0.80

1.29

u/ml

1.92

554

1379

Other pulmonary diagnosis

1590

2851

2.85

260.10

1.1

1.0

1.12

1.20

u/ml

0.14

784

945

COPD differential diagnosis

1564

2820

2.83

253.39

1.1

1.0

1.12

1.20

u/ml

0.14

773

928

ILD differential diagnosis

1563

2819

2.83

253.06

1.1

1.0

1.12

1.20

u/ml

0.14

772

928

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1092

3459

3.12

251.91

1.1

1.0

0.67

1.00

u/ml

1.64

527

1218

Excluding asthma or asthma-COPD overlap

1570

2851

2.81

251.17

1.1

1.0

1.13

1.20

u/ml

0.11

774

945

Childhood asthma (age<16)

658

1208

4.54

237.57

1.1

1.0

1.77

1.51

u/ml

0.27

412

444

Childhood asthma (age<16), excluding more controls

657

1210

4.53

236.22

1.1

1.0

1.77

1.51

u/ml

0.27

411

443

Oral corticosteroids

2286

6278

2.17

224.50

1.1

1.22

0.97

u/ml

0.81

1193

2575

ILD medications: prednisolone, methylprednisolone, prednisone

2365

6362

2.10

210.88

1.1

1.31

0.93

u/ml

1.53

1227

2675

Undetermined asthma

372

632

6.16

209.60

1.2

1.0

0.84

1.38

u/ml

0.61

212

203

Asthma-related pneumonia

736

2146

3.51

207.33

1.2

1.1

1.14

1.01

u/ml

0.22

445

845

Asthma, hospital admissions 3, pneumonia

738

2156

3.50

207.25

1.2

1.1

1.13

1.01

u/ml

0.22

446

852

Asthma-related pneumonia or sepsis

738

2156

3.50

207.25

1.2

1.1

1.13

1.01

u/ml

0.22

446

852

Undetermined asthma, excluding more controls

372

640

6.08

206.90

1.2

1.0

0.84

1.39

u/ml

0.65

212

206

Diseases of the respiratory system

1179

2128

2.83

190.82

1.1

1.0

1.20

1.16

u/ml

0.06

551

724

Abnormalities of breathing

2029

5603

2.11

183.76

1.1

0.93

1.15

u/ml

0.77

994

2412

Biological medicines for asthma

199

198

12.65

183.49

1.3

1.1

1.55

0.72

u/ml

0.90

134

Childhood allergy (age < 16)

816

2344

3.08

168.39

1.2

1.1

1.68

1.28

u/ml

0.70

578

1068

ILD medications

2372

6708

1.93

167.99

1.1

1.29

0.96

u/ml

1.28

1224

2880

Inflammatory bowel disease treatment related agents

2355

6927

1.91

162.83

1.1

1.22

1.00

u/ml

0.67

1199

2966

Deviated nasal septum

579

1736

3.41

156.79

1.1

1.0

0.76

1.17

u/ml

0.89

275

619

Conjunctivitis (acute, non atopic), including avohilmo

1909

5878

1.99

150.93

1.1

1.33

0.92

u/ml

1.41

915

2374

Adverse effects, not elsewhere classified

669

2264

3.10

150.21

1.2

1.1

1.21

1.04

u/ml

0.31

453

1022

First line medication for Crohn's disease

2270

6625

1.87

145.40

1.1

1.24

0.99

u/ml

0.81

1165

2837

Symptoms and signs involving the circulatory and respiratory systems

2124

5624

1.92

144.75

1.1

0.94

1.15

u/ml

0.75

1037

2422

FESS (DNB20)

400

1020

4.14

139.95

1.2

1.1

0.57

0.96

u/ml

0.79

222

420

Ethmoidectomy

404

1062

4.01

135.40

1.2

1.1

0.56

0.98

u/ml

0.92

225

439

Chronic diseases of tonsils and adenoids

1442

4402

2.10

132.94

1.1

1.0

1.05

1.03

u/ml

0.04

669

1616

Urticaria

842

3563

2.44

120.43

1.1

1.47

1.11

u/ml

0.60

482

1614

Dermatitis due to ingested food

294

656

5.02

118.48

1.3

1.1

1.86

1.10

u/ml

0.97

234

359

Urticaria and erythema

929

4174

2.29

115.18

1.1

1.42

1.11

u/ml

0.54

530

1887

Other and unspecified effects of external causes

791

3370

2.42

111.58

1.2

1.1

1.30

1.12

u/ml

0.30

509

1528

Non-allergic asthma (mode), excluding more controls

355

969

3.72

109.73

1.1

1.0

0.31

1.53

u/ml

3.28

152

336

Non-allergic asthma (mode)

355

971

3.72

109.39

1.1

1.0

0.31

1.51

u/ml

3.21

152

336

Dyspnoea

1563

6379

1.79

93.63

1.1

0.91

1.06

u/ml

0.45

770

2763

Acute upper respiratory infections

1834

6450

1.72

92.82

1.1

1.03

1.08

u/ml

0.13

861

2804

Diseases of the skin and subcutaneous tissue

1735

4973

1.77

92.51

1.1

1.41

0.72

u/ml

3.45

896

1988

Personal history of allergy to analgesic agent

21.19

90.23

1.6

1.0

0.44

0.77

u/ml

0.46

Acute sinusitis

1150

5530

1.92

89.62

1.1

0.83

1.13

u/ml

0.92

554

2379

Acute upper respiratory infections of multiple and unspecified sites

1483

6228

1.76

83.92

1.1

1.05

1.09

u/ml

0.07

722

2709

Polypectomy (DHB20)

175

349

5.29

83.51

1.3

1.1

0.48

1.62

u/ml

1.39

114

142

Dermatitis

1006

5205

1.91

79.04

1.1

1.02

0.74

u/ml

1.04

484

2081

Personal history of allergy to drugs, medicaments and biological substances

103

10.84

77.55

1.5

1.1

0.43

0.90

u/ml

0.85

Insomnia

1680

7125

1.66

76.31

1.1

0.90

1.11

u/ml

0.69

697

3167

Diseases of the eye and adnexa

1685

5065

1.69

75.93

1.1

1.28

0.98

u/ml

0.86

881

2127

Any reimbursement code in KELA

1412

4046

1.78

75.75

1.1

1.36

1.01

u/ml

0.89

726

1648

Sleep apnoea, including avohilmo

1609

5881

1.67

73.25

1.1

0.78

1.02

u/ml

0.92

662

2564

Sleep disorders

1671

7094

1.64

72.49

1.1

0.92

1.12

u/ml

0.67

701

3169

D07AA Corticosteroids, weak (group I)

482

2022

2.47

70.75

1.2

1.1

2.65

1.08

u/ml

2.69

340

984

Other and unspecified dermatitis

841

4371

1.95

70.16

1.1

0.99

0.74

u/ml

0.92

409

1757

Asthma mixed form (mode)

125

223

5.85

67.27

1.1

1.0

0.47

2.14

u/ml

1.06

Bronchitis

1894

7299

1.57

67.17

1.1

1.00

1.07

u/ml

0.17

929

3141

1850

5940

1.59

67.17

1.1

1.02

1.07

u/ml

0.11

865

2504

Asthma mixed form (mode), excluding more controls

125

224

5.82

66.94

1.1

1.0

0.47

2.15

u/ml

1.07

Behavioural syndromes associated with physiological disturbances and physical factors

1706

7334

1.59

65.14

1.1

0.91

1.12

u/ml

0.71

725

3338

Allergic contact dermatitis

324

1169

2.86

64.70

1.1

1.84

0.84

u/ml

0.92

168

454

Migraine

1183

5402

1.73

63.86

1.1

0.76

1.18

u/ml

2.24

545

2427

Other and unspecified urticaria

497

2218

2.31

63.22

1.1

1.44

1.06

u/ml

0.51

282

1008

Sleep disorders (combined)

1850

6225

1.57

63.03

1.1

0.99

1.15

u/ml

0.44

784

2866

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1775

7338

1.57

62.95

1.1

0.98

1.06

u/ml

0.18

792

3333

Pain in joint

1085

3787

1.78

62.27

1.1

1.19

1.04

u/ml

0.23

516

1727

Medical observation and evaluation for suspected diseases and conditions

1145

3346

1.77

61.51

1.1

0.92

1.12

u/ml

0.51

604

1350

Early onset COPD, excluding more controls

215

646

3.37

58.26

1.1

1.0

0.76

1.24

u/ml

0.56

102

203

Other medical care

680

2911

1.98

58.12

1.1

1.58

1.03

u/ml

1.53

465

1265

Chronic laryngitis and laryngotracheitis

210

642

3.35

55.70

1.1

1.0

0.53

1.16

u/ml

1.03

228

Voice disturbances

452

2043

2.26

55.39

1.1

0.70

0.91

u/ml

0.59

214

864

Headache

1309

6326

1.62

54.93

1.1

0.92

1.13

u/ml

0.48

585

2816

Asthma and opportunity respiratory infection

115

7.32

54.48

1.1

0.63

1.72

u/ml

0.48

Sleep apnoea

1402

5612

1.59

52.97

1.1

0.82

0.99

u/ml

0.49

585

2412

Special screening examination for infectious and parasitic diseases

648

2442

1.97

52.51

1.1

1.0

1.19

1.21

u/ml

0.02

351

923

Dentofacial anomalies [including malocclusion]

1411

7115

1.57

52.32

1.1

0.82

1.09

u/ml

1.21

637

3155

Other acute lower respiratory infections

933

5221

1.72

51.71

1.2

1.1

0.90

1.15

u/ml

1.02

519

2416

Recurrent or chronic depression

760

2932

1.82

48.36

1.1

1.18

1.13

u/ml

0.07

343

1296

Bronchiectasis

179

5.38

47.00

1.1

0.45

1.75

u/ml

0.94

Examination and observation for other reasons

984

3338

1.68

45.43

1.1

0.86

1.12

u/ml

0.85

490

1346

Symptoms and signs involving speech and voice

492

2480

2.01

45.25

1.1

0.71

0.91

u/ml

0.63

229

1063

Dermatographic urticaria

200

680

3.08

45.05

1.1

1.53

0.93

u/ml

0.35

107

283

Idiopathic urticaria

103

225

5.03

44.99

1.1

0.63

0.75

u/ml

0.15

100

Any death

119

2846

0.29

44.07

1.0

1.1

0.72

0.92

u/ml

0.37

1246

Episodal and paroxysmal disorders

1871

6641

1.44

42.66

1.1

0.93

1.13

u/ml

0.73

845

3068

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

726

2036

1.81

42.19

1.1

1.15

1.29

u/ml

0.18

319

902

Other special examinations and investigations of persons without complaint or reported diagnosis

1056

3346

1.61

40.78

1.1

0.96

1.12

u/ml

0.41

505

1350

Neurotic, stress-related and somatoform disorders

1569

7475

1.46

40.51

1.1

1.12

1.04

u/ml

0.15

757

3263

Migraine, single triptan purchase ok & required. ICD-code if available is included

1445

6669

1.48

40.31

1.1

1.02

1.14

u/ml

0.28

611

2986

Triptan medication for migraine, single purchase ok

1445

6669

1.48

40.31

1.1

1.02

1.14

u/ml

0.28

611

2986

Anxiety disorders

1573

7475

1.46

40.24

1.1

1.12

1.04

u/ml

0.16

757

3266

COPD/asthma related infections

1624

5633

1.45

39.10

1.1

1.10

1.09

u/ml

0.01

763

2390

COPD/asthma/ILD related infections

1624

5633

1.45

39.10

1.1

1.10

1.09

u/ml

0.01

763

2390

Intestinal infectious diseases, including avohilmo, including avohilmo

1811

7192

1.41

37.91

1.1

0.98

1.09

u/ml

0.24

785

3265

Pain in throat and chest

1333

5326

1.49

37.87

1.1

0.81

1.17

u/ml

2.04

615

2263

Acute bronchitis

631

3568

1.75

37.84

1.1

0.86

1.20

u/ml

1.23

329

1642

Exposure to unspecified factor

1694

8182

1.42

37.72

1.1

1.19

1.01

u/ml

0.46

885

3607

Gastro-oesophageal reflux disease

992

5404

1.56

36.93

1.1

0.74

1.03

u/ml

1.10

413

2367

Other inflammation of eyelid, including avohilmo

890

5677

1.59

36.22

1.1

1.21

1.06

u/ml

0.32

421

2514

Irritable bowel syndrome

504

2765

1.85

36.10

1.1

0.94

1.04

u/ml

0.10

221

1171

All anxiety disorders

1267

6742

1.47

35.16

1.1

1.33

1.09

u/ml

0.45

640

2969

COPD

305

1131

2.20

34.88

1.1

1.0

0.71

1.07

u/ml

0.74

140

426

Temporomandibular joint disorders, including avohilmo

942

5980

1.55

33.85

1.1

0.74

1.16

u/ml

2.38

426

2592

Depression or dysthymia

950

3326

1.57

33.76

1.1

1.12

1.08

u/ml

0.06

433

1506

Pain (limb, back, neck, head abdominally)

1167

3908

1.51

33.72

1.1

1.28

1.02

u/ml

0.46

551

1829

Mycoses, including avohilmo

1501

8153

1.41

33.24

1.1

0.87

1.09

u/ml

0.97

657

3664

Anxiety (asthma-related co-morbidities)

1221

6403

1.46

32.77

1.1

1.22

1.07

u/ml

0.26

617

2790

Other chronic obstructive pulmonary disease

285

1064

2.21

32.76

1.0

0.71

1.09

u/ml

0.73

133

392

Exposure to other specified factors

1380

8381

1.42

32.74

1.1

1.18

1.03

u/ml

0.33

701

3744

Abnormalities of heart beat

497

2720

1.79

32.11

1.1

1.27

1.19

u/ml

0.05

219

1137

Triptan medication for migraine, min. 3 purchases

1187

6112

1.47

32.09

1.1

0.81

1.09

u/ml

0.77

505

2643

Persons encountering health services for examination and investigation

1011

3346

1.53

31.07

1.1

0.95

1.12

u/ml

0.39

491

1350

Coxibs

407

1104

1.95

30.47

1.1

1.99

0.91

u/ml

0.91

172

552

Other headache syndromes

686

4272

1.62

30.47

1.1

0.88

1.11

u/ml

0.33

318

1804

Atopic conjunctivitis

134

461

3.04

29.79

1.2

1.1

0.98

1.48

u/ml

0.44

212

Codes for special purposes

845

5530

1.53

29.39

1.1

0.72

1.05

u/ml

1.00

388

2505

Provisional assignment of new diseases of uncertain etiology

844

5528

1.53

29.26

1.1

0.72

1.05

u/ml

0.99

388

2504

Acetic acid derivatives and related substances

385

1028

1.96

28.82

1.1

0.95

0.94

u/ml

0.01

162

500

Anxiety disorders, excluding more controls

1357

6211

1.41

28.65

1.1

1.07

1.00

u/ml

0.15

652

2711

Other specific joint derangements/joint disorders

1377

6170

1.40

28.41

1.1

1.08

1.13

u/ml

0.08

634

2818

Covid-19 suspected case

466

2693

1.76

28.29

1.1

0.85

1.18

u/ml

0.48

217

1205

Depression

1537

7542

1.37

28.22

1.1

1.13

1.05

u/ml

0.15

726

3286

Low back pain

1248

5982

1.42

28.00

1.1

0.91

1.06

u/ml

0.35

548

2639

Other disorders of lacrimal gland

505

3016

1.69

26.94

1.1

1.14

0.99

u/ml

0.28

224

1256

Malignant neoplasm

639

5838

0.64

26.71

1.1

0.79

1.03

u/ml

0.59

281

2510

Tonsillectomy and adenotomy

1276

6411

1.40

26.42

1.1

1.09

1.10

u/ml

0.03

603

2993

Dorsalgia

1596

6272

1.36

26.30

1.1

1.10

1.09

u/ml

0.02

725

2816

Disorders of lacrimal system

597

3682

1.61

26.14

1.1

1.04

0.97

u/ml

0.14

263

1541

Other soft tissue disorders, not elsewhere classified

1534

6457

1.36

26.02

1.1

1.08

1.07

u/ml

0.01

690

2998

Other dorsopathies, not elsewhere classified

1632

6323

1.35

25.82

1.1

1.07

1.08

u/ml

0.02

739

2847

Caries of enamel

1532

7456

1.35

25.75

1.1

0.87

1.06

u/ml

0.80

729

3276

Malignant neoplasm

645

5826

0.64

25.59

1.1

0.78

1.03

u/ml

0.62

283

2503

Other anxiety disorders

970

5752

1.45

25.32

1.1

1.53

1.05

u/ml

0.81

500

2534

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1445

8357

1.35

25.20

1.1

1.29

1.01

u/ml

0.62

660

3793

Soft tissue disorders

1702

6572

1.33

25.01

1.1

1.13

1.07

u/ml

0.10

780

3069

Eosinophilic disease (BM)

7.84

24.85

1.4

1.0

0.42

4.80

u/ml

0.45

Bronchitis, not specified as acute or chronic

120

428

2.86

24.69

1.1

1.0

1.04

1.25

u/ml

0.15

157

Speech therapy

327

1773

1.87

24.48

1.1

0.51

0.96

u/ml

1.57

131

784

Solid cancers

609

5516

0.64

24.40

1.1

0.85

0.98

u/ml

0.26

267

2338

Pain and other conditions associated with female genital organs and menstrual cycle

479

2412

1.69

24.33

1.1

0.88

1.17

u/ml

0.59

198

1089

Migraine without aura

498

3056

1.66

24.25

1.1

0.79

1.18

u/ml

1.00

246

1368

Myalgia

408

2371

1.74

24.24

1.1

0.63

1.06

u/ml

1.76

181

1028

Mood [affective] disorders

1571

7589

1.33

24.00

1.1

1.08

1.06

u/ml

0.03

736

3312

Candidiasis, including avohilmo

510

3159

1.63

23.75

1.1

0.66

1.10

u/ml

2.00

229

1401

Functional dyspepsia

386

2220

1.76

23.75

1.1

0.80

1.09

u/ml

0.69

173

956

Mood disorders

1570

7589

1.33

23.60

1.1

1.08

1.06

u/ml

0.03

736

3311

Diseases of the musculoskeletal system and connective tissue

1091

3889

1.42

23.24

1.1

1.43

1.13

u/ml

0.53

518

1894

Opioids

1578

6155

1.33

23.00

1.1

1.00

1.08

u/ml

0.19

723

2667

Malignant neoplasm, wide definition

705

6080

0.67

22.97

1.1

0.75

1.02

u/ml

0.78

313

2630

Conjunctivitis (acute, non atopic)

480

2945

1.64

22.83

1.1

1.49

0.96

u/ml

1.13

254

1304

Codeine

1467

5943

1.34

22.73

1.1

0.86

1.06

u/ml

0.72

652

2549

Lower back pain or/and sciatica

1603

7591

1.32

22.70

1.1

0.91

1.06

u/ml

0.40

701

3297

Certain infectious and parasitic diseases, including avohilmo

1100

3938

1.41

22.63

1.1

1.29

0.99

u/ml

0.67

493

1778

Abnormal findings on diagnostic imaging of lung

418

2350

1.70

22.60

1.1

1.29

0.99

u/ml

0.29

189

997

Malignant neoplasm, including Hilmo

712

6094

0.68

22.25

1.1

0.75

1.02

u/ml

0.82

317

2639

Any event in cancer register

811

6793

0.69

22.20

1.1

0.99

1.02

u/ml

0.05

361

2975

Diseases of middle ear and mastoid

1084

6447

1.38

21.86

1.1

1.25

1.09

u/ml

0.24

542

2971

Dorsopathies

1666

6469

1.31

21.76

1.1

1.05

1.07

u/ml

0.04

764

2963

Solid cancers, including Hilmo

675

5811

0.67

21.71

1.1

0.77

1.00

u/ml

0.60

295

2472

Selective serotonin reuptake inhibitors

1465

5743

1.33

21.65

1.1

1.08

1.02

u/ml

0.14

663

2564

Codeine or tramadol medication

1644

6853

1.31

21.59

1.1

0.84

1.04

u/ml

0.84

717

2927

Lichen simplex chronicus and prurigo

325

2.99

21.21

1.1

0.61

1.08

u/ml

0.55

131

Nonsuppurative otitis media, including avohilmo

699

4123

1.48

20.69

1.1

1.41

1.23

u/ml

0.19

365

1948

Migraine with aura

519

3349

1.57

20.43

1.1

0.54

1.11

u/ml

3.38

251

1460

Parasetamol

1263

4757

1.35

20.23

1.1

1.23

1.13

u/ml

0.14

576

2183

Other joint disorders

1572

6311

1.31

20.15

1.1

1.10

1.12

u/ml

0.04

715

2909

Pruritus

178

842

2.15

19.90

1.1

0.80

u/ml

0.00

330

Migraine without aura and triptan purchases

390

2372

1.67

19.84

1.1

0.61

1.17

u/ml

1.57

177

1055

Cystitis

1223

5445

1.34

19.57

1.1

1.22

0.97

u/ml

0.58

524

2426

Abdominal and pelvic pain

1503

5791

1.31

19.56

1.1

0.94

1.11

u/ml

0.66

695

2694

Herpesviral [herpes simplex] infections, including avohilmo

476

3046

1.58

19.50

1.1

1.79

1.10

u/ml

0.68

229

1324

Gastrointestinal diseases

1147

4247

1.36

19.48

1.1

1.19

1.18

u/ml

0.02

534

1977

Neurological diseases

1472

5663

1.31

19.43

1.1

1.03

1.20

u/ml

0.49

677

2662

Propionic acid derivatives

445

1368

1.65

19.25

1.1

1.32

0.99

u/ml

0.34

195

746

Depression medications

729

2510

1.48

19.22

1.1

1.76

1.11

u/ml

0.88

343

1165

Other antidepressants

1436

5607

1.31

19.18

1.1

1.32

0.99

u/ml

0.69

635

2452

Neurological diseases, wide definition

676

2292

1.50

19.09

1.1

0.84

1.23

u/ml

1.35

331

1173

Diseases of oesophagus, stomach and duodenum

1538

7042

1.30

19.04

1.1

0.80

1.04

u/ml

1.24

678

3120

Persons encountering health services for specific procedures and health care

1699

7887

1.28

18.83

1.1

1.09

1.05

u/ml

0.10

928

3438

Hyperkinetic disorders, excluding more controls

415

2425

1.63

18.73

1.2

1.1

1.60

1.10

u/ml

0.49

231

1219

Allergic urticaria

183

902

2.08

18.55

1.1

2.41

1.06

u/ml

0.85

108

429

Mood disorders, excluding more controls

1375

6199

1.31

18.50

1.1

1.02

1.01

u/ml

0.03

640

2686

Renal tubulo-interstitial diseases

685

7133

0.70

18.31

1.1

0.92

1.08

u/ml

0.34

310

3177

Symptoms and signs involving the digestive system and abdomen

1494

5793

1.30

18.31

1.1

0.90

1.11

u/ml

0.91

697

2696

COPD (mode)

170

629

2.12

17.82

1.0

0.62

1.38

u/ml

0.88

206

Soft tissue disorders related to use, overuse and pressure

323

1921

1.70

17.72

1.1

1.00

0.92

u/ml

0.07

130

784

Other viral diseases, including avohilmo

771

5495

1.40

17.39

1.1

0.85

1.16

u/ml

1.41

378

2607

Fenamates

191

647

2.03

17.29

1.1

0.76

0.89

u/ml

0.18

318

Diseases of the ear and mastoid process

1787

7148

1.26

17.07

1.1

1.17

1.03

u/ml

0.29

817

3172

Migraine with aura and triptan purchases

361

2242

1.64

16.98

1.1

0.55

1.15

u/ml

2.41

183

993

Other nutritional deficiencies

1047

7249

1.33

16.55

1.1

0.87

1.05

u/ml

0.39

477

3168

Mouth breathing

528

3602

1.48

15.88

1.1

0.91

1.03

u/ml

0.22

245

1741

All kidney diseases

925

8213

0.75

15.75

1.1

1.11

1.04

u/ml

0.10

426

3676

Diabetes, insulin treatment (Kela reimbursement)

827

6636

0.74

15.65

1.1

0.69

1.01

u/ml

1.53

348

2957

Acute bronchiolitis

225

1141

1.85

15.48

1.3

1.1

1.01

1.60

u/ml

1.10

167

662

Suppurative and unspecified otitis media

772

5010

1.38

15.46

1.1

1.16

u/ml

0.00

390

2365

Early onset COPD

215

1186

1.83

15.43

1.1

0.76

1.14

u/ml

0.66

102

501

Inflammatory diseases of female pelvic organs

1033

5375

1.32

15.43

1.1

0.93

1.00

u/ml

0.14

459

2229

Haemorrhage from respiratory passages

304

1628

1.66

15.34

1.1

0.84

1.26

u/ml

0.75

136

701

Other menopausal disorders

339

1153

1.65

15.27

1.1

0.79

0.78

u/ml

0.01

145

461

Other chronic obstructive pulmonary disease, including avohilmo

407

2172

1.55

15.04

1.0

1.1

0.61

1.03

u/ml

1.39

192

910

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

676

4230

1.40

14.94

1.1

1.01

0.92

u/ml

0.11

292

1823

Disturbance of activity and attention

424

2754

1.53

14.88

1.2

1.1

1.48

1.20

u/ml

0.24

245

1432

Hyperkinetic disorders

440

2883

1.52

14.73

1.2

1.1

1.49

1.19

u/ml

0.28

255

1496

Schizophrenia

1642

0.37

14.72

1.0

1.1

0.71

1.08

u/ml

0.36

740

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

801

6374

0.74

14.67

1.1

0.70

0.98

u/ml

1.23

342

2849

Disorders of eyelid, lacrimal system and orbit

1133

6452

1.29

14.46

1.1

1.17

1.05

u/ml

0.21

498

2813

Follow-up examination after treatment for conditions other than malignant neoplasms

598

2802

1.43

14.45

1.1

1.20

1.09

u/ml

0.14

272

1104

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

369

2394

1.56

14.44

1.1

0.92

0.95

u/ml

0.03

158

1021

Injuries to the ankle and foot

1226

8248

1.28

14.42

1.1

1.05

1.07

u/ml

0.04

604

3713

Acne, including avohilmo

610

3525

1.42

14.28

1.1

1.35

1.24

u/ml

0.12

286

1740

Injuries to the wrist and hand

1531

8176

1.25

14.27

1.1

0.90

1.07

u/ml

0.49

715

3694

Accidents

1215

4746

1.29

14.22

1.1

1.34

0.94

u/ml

0.91

570

2002

Non-allergic asthma

103

449

2.33

14.17

1.0

0.24

0.92

u/ml

1.26

152

Transport accidents

736

4508

1.37

14.15

1.1

1.34

0.95

u/ml

0.72

337

1896

General symptoms and signs

1636

6622

1.24

14.14

1.1

0.99

1.12

u/ml

0.33

761

2952

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1608

6900

1.24

14.09

1.1

0.78

1.10

u/ml

1.91

810

3039

Dermatophytosis, including avohilmo

925

6923

1.32

14.06

1.1

0.84

1.11

u/ml

1.22

403

3050

External causes of morbidity and mortality

1042

3997

1.31

14.05

1.1

1.31

0.94

u/ml

0.77

483

1707

Anti-inflammatory and antirheumatic products, non-steroids

418

1370

1.55

14.04

1.1

1.31

0.99

u/ml

0.33

196

748

Chronic conjunctivitis

229

2.94

14.03

1.1

3.11

2.07

u/ml

0.28

112

Other external causes of accidental injury

1212

4746

1.29

13.93

1.1

1.30

0.94

u/ml

0.79

578

2002

Allergic colitis

115

541

2.28

13.80

1.2

1.53

1.18

u/ml

0.30

329

Eosinophilia

4.31

13.39

1.4

1.1

0.42

0.70

u/ml

0.40

Schizophrenia or delusion

204

3481

0.58

13.37

1.1

0.98

1.09

u/ml

0.15

1544

Pain in limb

1237

6226

1.27

13.32

1.1

1.15

1.07

u/ml

0.14

561

2876

Arthropathies

1560

6386

1.24

13.27

1.1

0.98

1.11

u/ml

0.31

712

2973

Other viral diseases, not elsewhere classified, including avohilmo

533

3762

1.42

13.19

1.1

0.74

1.22

u/ml

2.13

258

1831

Other inflammation of eyelid

195

1100

1.80

13.15

1.1

1.25

1.10

u/ml

0.16

494

Paracetamol or NSAID medication

299

923

1.65

13.12

1.1

1.56

1.21

u/ml

0.25

148

527

Somatoform disorder

259

1584

1.66

13.02

1.1

0.57

1.11

u/ml

1.58

105

645

Oxicams

222

718

1.77

12.92

1.1

1.31

0.89

u/ml

0.31

350

Schizophrenia, schizotypal and delusional disorders

207

3484

0.59

12.88

1.1

0.97

1.09

u/ml

0.16

1547

Symptoms and signs involving the skin and subcutaneous tissue

975

7176

1.29

12.70

1.1

1.09

1.04

u/ml

0.09

476

3113

Later onset COPD, excluding more controls

195

2.71

12.51

1.0

0.52

1.83

u/ml

0.79

Unspecified threat to breathing

100

3.99

12.43

1.3

1.1

0.92

0.79

u/ml

0.11

Injuries to the knee and lower leg

1756

7845

1.21

12.42

1.1

1.01

1.07

u/ml

0.12

780

3551

Kela-code for severe mental illness

242

3884

0.62

12.38

1.1

0.93

1.09

u/ml

0.25

111

1724

Heartburn

162

881

1.86

12.36

1.1

0.54

1.06

u/ml

1.15

381

Other bacterial diseases

780

6769

0.76

12.33

1.1

1.64

0.96

u/ml

1.49

392

3014

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

613

3929

1.38

12.27

1.1

1.84

1.14

u/ml

0.86

331

1963

Emphysema

133

3.34

12.17

1.1

1.0

1.39

1.10

u/ml

0.15

Acute pharyngitis

327

2128

1.54

12.15

1.1

1.87

1.43

u/ml

0.31

165

1049

Acute suppurative otitis media

613

4211

1.37

12.11

1.2

1.1

0.86

1.17

u/ml

1.38

313

2019

Simple and mucopurulent chronic bronchitis

139

3.29

12.07

1.1

0.27

2.05

u/ml

1.01

Diabetes medication

1023

7559

0.79

12.05

1.1

0.86

1.06

u/ml

0.60

443

3365

Disease of hard tissues of teeth, NOS

625

2379

1.38

12.02

1.1

1.44

1.17

u/ml

0.31

281

982

Obesity

957

7062

1.28

11.99

1.1

0.64

1.10

u/ml

2.47

433

3063

Obesity and other hyperalimentation

959

7068

1.28

11.99

1.1

0.63

1.10

u/ml

2.50

435

3065

Other diseases of intestines

1674

7706

1.21

11.96

1.1

1.05

1.06

u/ml

0.01

750

3546

Intestinal infectious diseases

1378

8349

1.23

11.83

1.1

0.89

1.08

u/ml

0.59

649

3779

Other and unspecified tonsillitis

674

4192

1.35

11.81

1.1

1.17

1.21

u/ml

0.05

299

1950

Other enthesopathies

377

2563

1.48

11.77

1.2

1.1

0.97

0.95

u/ml

0.01

163

1056

Dysphagia

241

1493

1.63

11.48

1.1

1.02

1.15

u/ml

0.17

119

640

Persons encountering health services in other circumstances, wide

1624

6901

1.21

11.41

1.1

0.85

1.10

u/ml

1.24

800

3039

Subjective visual disturbances

338

2266

1.50

11.39

1.1

1.13

1.05

u/ml

0.05

165

999

Other diseases of lip and oral mucosa

530

3861

1.38

11.29

1.1

0.79

1.12

u/ml

1.23

243

1680

Enthesopathies of lower limb, excluding foot

312

2061

1.53

11.29

1.1

1.67

1.05

u/ml

0.49

137

866

Oedema, not elsewhere classified

352

2325

1.49

11.26

1.1

0.86

0.98

u/ml

0.22

172

1003

Benign neoplasm: Colon

408

2666

1.44

11.10

1.1

0.72

0.98

u/ml

0.75

166

1100

ILD, hospital admissions 1, main diag only

473

2.11

10.96

1.1

0.71

1.25

u/ml

0.61

208

Visual disturbances

617

4626

1.34

10.92

1.1

1.02

1.12

u/ml

0.11

291

2087

Female infertility, cervical, vaginal, other or unspecified origin

453

2048

1.43

10.85

1.1

1.18

1.14

u/ml

0.05

182

887

Disorders of synovium and tendon

720

4673

1.31

10.76

1.1

0.45

1.00

u/ml

6.42

273

2014

Dislocation, sprain and strain of joints and ligaments of knee

963

6920

1.26

10.76

1.1

1.08

1.06

u/ml

0.03

414

3012

Malignant neoplasm of breast

257

2557

0.64

10.72

1.1

1.14

0.78

u/ml

0.30

101

998

Rotator cuff syndrome

636

3281

1.34

10.67

1.1

0.90

0.96

u/ml

0.08

256

1350

Malignant neoplasm of breast, HER2-negative

257

2554

0.64

10.66

1.1

1.14

0.78

u/ml

0.30

101

997

Lichen simplex chronicus

178

2.88

10.62

1.1

0.52

1.64

u/ml

0.83

Malignant neoplasm of digestive organs, including Hilmo

135

1783

0.55

10.56

1.1

1.23

1.07

u/ml

0.16

737

Genitourinary diseases

919

3611

1.28

10.56

1.1

1.19

1.10

u/ml

0.14

436

1832

Other noninfective gastroenteritis and colitis

358

2470

1.46

10.44

1.2

1.1

1.11

1.32

u/ml

0.35

192

1206

Other diseases of hard tissues of teeth

628

2423

1.35

10.43

1.1

1.00

1.14

u/ml

0.18

283

1017

Prurigo nodularis

3.60

10.39

1.0

0.24

2.30

u/ml

0.82

Restless leg syndrome

182

1080

1.70

10.37

1.1

1.14

0.98

u/ml

0.15

456

Excessive attrition of teeth

948

7488

1.26

10.37

1.1

1.06

1.07

u/ml

0.01

433

3320

Diaphragmatic hernia

299

1993

1.51

10.34

1.1

0.73

0.88

u/ml

0.34

147

814

Generalized anxiety disorder

357

2472

1.46

10.28

1.1

1.03

1.12

u/ml

0.15

192

1083

Disturbances of skin sensation

420

2995

1.41

10.27

1.1

1.30

1.00

u/ml

0.30

216

1272

Nummular dermatitis

408

2.16

10.18

1.1

1.27

1.07

u/ml

0.08

153

Other and unspecified nonorganic psychotic disorders

145

2502

0.57

10.13

1.1

1.18

1.19

u/ml

0.01

1140

COPD, hospital admissions

284

1576

1.52

10.11

1.0

1.1

0.71

1.05

u/ml

0.79

133

662

Injury, poisoning and certain other consequences of external causes

844

3299

1.29

10.09

1.1

1.16

0.97

u/ml

0.33

389

1437

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1073

7925

1.24

10.09

1.1

1.29

1.05

u/ml

0.49

497

3599

Sciatica+with lumbago

644

4343

1.32

10.05

1.1

0.74

1.06

u/ml

0.86

283

1830

Acute laryngitis and tracheitis

277

1807

1.53

10.03

1.2

1.1

0.88

1.45

u/ml

1.29

138

917

Cervicobrachial syndrome

281

1864

1.52

10.03

1.2

1.1

0.48

1.09

u/ml

2.43

119

753

Disorders of skin appendages

800

6255

1.28

10.02

1.1

0.94

1.14

u/ml

0.57

362

2817

Unspecified privation

151

860

1.78

10.01

1.1

1.14

u/ml

0.00

366

Irregular menses

878

5227

1.27

9.91

1.1

0.77

1.04

u/ml

0.96

382

2207

Schizophrenia or delusion, excluding more controls

204

3182

0.63

9.86

1.1

0.98

u/ml

0.01

1397

Female infertility

488

2129

1.39

9.80

1.1

1.19

1.11

u/ml

0.09

189

929

COPD, hospital admissions 1, only main diagnosis

201

1059

1.64

9.80

1.0

1.1

0.62

0.98

u/ml

0.79

457

COPD, early/later onset

285

1588

1.51

9.79

1.0

1.1

0.71

1.06

u/ml

0.83

133

667

Peritonsillar abscess

259

1698

1.54

9.77

1.1

1.0

0.53

1.23

u/ml

2.31

118

625

Visual disturbances and blindness

640

4898

1.31

9.77

1.1

1.00

1.10

u/ml

0.12

304

2223

Insulin medication

409

4699

0.72

9.75

1.1

0.68

1.07

u/ml

1.37

176

2193

Other respiratory diseases principally affecting the interstitium

122

658

1.87

9.60

1.1

0.67

1.02

u/ml

0.49

300

Internal derangement of knee

472

3434

1.37

9.58

1.1

0.87

1.15

u/ml

0.48

210

1468

Ganglion

304

2072

1.48

9.54

1.1

0.40

1.11

u/ml

4.28

126

868

Malignant neoplasm of breast, including Hilmo

276

2619

0.67

9.48

1.1

1.03

0.78

u/ml

0.22

114

1021

Malignant neoplasm of breast, HER2-negative, including Hilmo

276

2619

0.67

9.47

1.1

1.03

0.78

u/ml

0.22

114

1021

All chronic kidney diseases

322

3684

0.69

9.47

1.1

1.41

1.10

u/ml

0.36

142

1743

Diabetes, varying definitions

1053

7487

0.81

9.45

1.1

1.07

1.06

u/ml

0.02

462

3342

Diabetes mellitus

1062

7511

0.81

9.41

1.1

1.06

u/ml

0.01

465

3354

Psychiatric diseases

1313

5438

1.21

9.29

1.1

1.13

1.05

u/ml

0.13

600

2473

1175

5633

1.22

9.27

1.1

1.07

1.09

u/ml

0.04

597

2390

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1175

5633

1.22

9.27

1.1

1.07

1.09

u/ml

0.04

597

2390

ILD, hospital admissions

105

546

1.94

9.26

1.1

0.69

1.08

u/ml

0.44

248

Other interstitial pulmonary diseases

105

547

1.93

9.21

1.1

0.69

1.07

u/ml

0.44

249

Other general symptoms and signs

126

694

1.84

9.19

1.2

1.1

0.49

0.97

u/ml

1.25

384

Benign neoplasm: Colon, unspecified

175

1061

1.66

9.19

1.1

0.91

1.05

u/ml

0.17

447

Interstitial lung disease endpoints

105

548

1.93

9.17

1.1

0.69

1.07

u/ml

0.44

249

Interstitial lung disease

105

548

1.93

9.17

1.1

0.69

1.07

u/ml

0.44

249

Cervicocranial syndrome

138

787

1.77

9.13

1.1

1.25

1.24

u/ml

0.00

328

Excessive, frequent and irregular menstruation

625

2543

1.32

9.09

1.1

1.05

1.15

u/ml

0.14

266

1159

Renal failure

157

2204

0.60

9.01

1.1

0.87

1.03

u/ml

0.21

1021

Dermatitis due to substances taken internally

396

2.11

9.00

1.1

2.31

0.99

u/ml

0.90

163

Unspecified mental disorder

321

4548

0.70

8.99

1.1

1.05

u/ml

0.00

143

2015

Fibromyalgia

150

882

1.73

8.96

1.1

0.71

1.03

u/ml

0.49

356

ILD, hospital admission 2, with pulmonary infections

298

2.27

8.94

1.1

0.86

1.05

u/ml

0.12

118

Viral warts, including avohilmo

384

2768

1.40

8.93

1.1

0.97

1.27

u/ml

0.67

150

1321

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

130

737

1.79

8.83

1.2

1.1

0.68

0.94

u/ml

0.37

324

Other diseases of oesophagus

432

2.03

8.80

1.1

0.60

1.21

u/ml

0.91

187

Shoulder lesions

852

4073

1.26

8.76

1.1

0.78

1.01

u/ml

0.57

344

1707

Dislocation, sprain and strain of joints and ligaments at neck level

281

1924

1.48

8.73

1.1

1.55

1.19

u/ml

0.25

130

857

Disorders of other endocrine glands

622

4755

1.29

8.62

1.1

1.08

1.11

u/ml

0.04

276

2279

Trochanteric bursitis

152

905

1.69

8.62

1.1

0.36

0.96

u/ml

2.06

377

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1150

0.44

8.61

1.0

1.1

0.17

0.77

u/ml

4.35

466

Rosacea

180

1124

1.62

8.52

1.1

1.13

1.24

u/ml

0.10

463

Vocal cord dysfunction

211

1198

1.56

8.50

1.2

1.1

0.52

1.09

u/ml

1.59

519

Panic disorder

296

2059

1.45

8.48

1.1

0.77

1.16

u/ml

1.47

153

881

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

102

372

1.94

8.44

1.1

0.73

1.15

u/ml

0.44

182

Exfoliative dermatitis

4.81

8.43

1.2

1.0

14.39

1.18

u/ml

1.02

Alcohol dependence

114

1995

0.57

8.42

1.1

0.99

1.03

u/ml

0.03

879

Malignant neoplasm of digestive organs

119

1581

0.57

8.39

1.1

1.27

1.14

u/ml

0.11

657

Diseases of external ear

435

3232

1.35

8.34

1.1

2.09

1.13

u/ml

0.83

209

1503

Inflammatory diseases of prostate (prostatitis)

109

596

1.84

8.31

1.1

0.66

1.38

u/ml

0.94

274

Pain in thoracic spine

210

1369

1.55

8.25

1.1

0.85

1.28

u/ml

0.77

585

Other intervertebral disc disorders

1014

4950

1.22

8.24

1.1

1.07

1.04

u/ml

0.03

440

2107

Biguanides

802

6009

0.80

8.19

1.1

0.90

0.99

u/ml

0.17

337

2541

Organic, including symptomatic, mental disorders

130

1544

0.59

8.16

1.0

1.1

0.91

0.79

u/ml

0.13

667

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

476

3599

1.33

8.15

1.1

0.80

1.16

u/ml

1.06

235

1648

Diarrhoea and gastroenteritis of presumed infectious origin

1033

7631

1.21

8.03

1.1

0.86

1.10

u/ml

0.67

507

3480

Allergic contact dermatitis due to drugs in contact with skin

137

2.86

8.00

1.1

0.54

0.81

u/ml

0.39

Other disorders of breast

199

1302

1.55

7.75

1.1

1.22

0.92

u/ml

0.24

549

Other and unspecified vaccines and biological substances

4.06

7.71

1.2

1.1

0.35

0.82

u/ml

0.51

Other disorders of urethra and urinary system

886

5028

1.23

7.70

1.1

1.26

0.90

u/ml

0.63

369

2178

Hypertrophy of breast in women and men

277

1938

1.44

7.70

1.1

1.06

0.96

u/ml

0.14

111

790

Tramadol

982

4857

1.22

7.67

1.1

0.84

1.06

u/ml

0.58

453

2065

Other and unspecified rosacea

126

739

1.73

7.66

1.1

1.46

1.22

u/ml

0.17

305

Oesophagitis

267

2.24

7.66

1.2

1.1

0.54

0.93

u/ml

0.94

120

Lumbar disc prolapse

770

4593

1.25

7.62

1.1

1.01

1.04

u/ml

0.04

342

1953

Other disorders of patella

251

1728

1.47

7.61

1.1

0.48

1.15

u/ml

3.06

725

Fall on same level involving ice and snow

712

5710

1.25

7.60

1.1

1.14

1.06

u/ml

0.12

326

2511

Other (not insulin) diabetes medications

865

6200

0.82

7.58

1.1

0.86

1.01

u/ml

0.35

365

2639

Heart failure, not strict

416

3718

0.75

7.56

1.0

1.1

0.76

0.98

u/ml

0.62

174

1643

Superficial injury of lower leg

382

2830

1.36

7.55

1.1

1.01

1.24

u/ml

0.19

171

1304

Urinary track infection

975

4015

1.22

7.50

1.1

1.24

0.87

u/ml

0.78

415

1745

Liquid cancers, including Hilmo

147

2068

0.62

7.49

1.1

0.56

1.07

u/ml

1.40

902

Other diseases of urinary system

1303

6185

1.19

7.47

1.1

1.28

1.00

u/ml

0.66

564

2797

Mental and behavioural disorders due to alcohol, excluding acute intoxication

277

3858

0.71

7.46

1.1

1.25

1.08

u/ml

0.18

140

1696

Diseases of oral cavity, salivary glands and jaws

604

2424

1.29

7.45

1.1

1.10

1.14

u/ml

0.04

273

1017

Type 2 diabetes

939

6575

0.82

7.45

1.1

0.95

1.01

u/ml

0.11

398

2813

Other extrapyramidal and movement disorders in other diseases

243

1668

1.47

7.45

1.1

0.92

1.06

u/ml

0.17

721

Tinnitus

250

1726

1.46

7.44

1.1

0.66

1.09

u/ml

1.18

111

741

Other contact dermatitis

104

582

1.81

7.44

1.1

0.30

0.94

u/ml

1.64

225

COPD related to multimorbidity

213

1196

1.51

7.44

1.1

0.70

0.95

u/ml

0.45

503

Other bacterial diseases, including avohilmo

1032

7709

0.83

7.38

1.1

1.63

0.93

u/ml

1.85

511

3439

3.99

7.19

1.1

1.0

0.22

1.47

u/ml

—

Dental pulpitis, including avohilmo

1400

7670

1.17

7.17

1.1

0.95

1.07

u/ml

0.31

616

3365

Infections with a predominantly sexual mode of transmission, including avohilmo

771

5746

1.23

7.17

1.1

1.30

1.12

u/ml

0.27

359

2543

Nonorganic sleeping disorders, excluding more controls

345

2539

1.37

7.16

1.1

1.11

0.99

u/ml

0.19

158

1120

464

5228

0.77

7.16

1.1

1.01

1.03

u/ml

0.03

224

2302

Cerebrovascular diseases

368

3423

0.74

7.16

1.1

0.59

0.90

u/ml

0.98

143

1459

Infective dermatitis

117

686

1.72

7.12

1.1

0.72

0.80

u/ml

0.09

261

Oter anti-inflammatory and antirheumatic agents, non-steroids

147

488

1.66

7.11

1.1

0.16

1.02

u/ml

2.63

225

Malignant neoplasm of breast, ER-positive, including Hilmo

175

1980

0.65

7.11

1.1

1.07

0.73

u/ml

0.20

761

Disorders of tooth development and eruption

268

1533

1.43

7.09

1.1

0.56

1.31

u/ml

2.58

128

691

Chronic gastritis

181

1182

1.54

7.07

1.1

0.39

0.81

u/ml

1.52

487

Postviral fatigue syndrome

114

2.99

7.06

1.2

1.1

0.77

0.62

u/ml

0.09

Noninfective enteritis and colitis

633

5055

1.26

7.03

1.1

1.27

1.10

u/ml

0.20

304

2355

Vasomotor rhinitis (mode)

484

1.86

7.02

1.1

1.17

1.34

u/ml

0.08

210

Disorders of breast

687

4872

1.25

7.01

1.1

1.05

0.93

u/ml

0.24

291

1976

Factors influencing health status and contact with health services

377

1391

1.37

6.99

1.1

1.37

1.14

u/ml

0.19

176

543

Substance abuse

462

5536

0.77

6.95

1.1

1.06

1.03

u/ml

0.05

231

2432

Cervicalgia

229

1577

1.46

6.95

1.1

0.65

1.14

u/ml

1.36

664

Malignant neoplasm of breast, HER-positive

175

1972

0.66

6.94

1.1

1.07

0.73

u/ml

0.19

755

Any gastric operation

1339

5724

1.18

6.94

1.1

1.13

1.12

u/ml

0.03

624

2650

GASTRO-related operations

1339

5724

1.18

6.94

1.1

1.13

1.12

u/ml

0.03

624

2650

Fissure and fistula of anal and rectal regions

279

1993

1.41

6.92

1.1

0.60

1.00

u/ml

1.32

111

874

Dementia, including avohilmo

975

0.54

6.90

1.0

1.1

0.41

0.75

u/ml

0.95

424

Insulin, combination of fast acting with intermediate-acting or long-acting

409

4858

0.76

6.90

1.1

0.68

1.05

u/ml

1.29

176

2254

Any dementia

729

0.46

6.89

1.0

0.36

0.88

u/ml

1.16

315

Anomalies of dental arch relationship, including avohilmo

398

2722

1.33

6.85

1.1

1.19

1.22

u/ml

0.04

203

1339

Alcohol use disorder, ICD-based

257

3601

0.71

6.85

1.1

1.29

1.05

u/ml

0.24

127

1582

Cervical disc disorders

331

2436

1.37

6.83

1.1

0.72

1.07

u/ml

0.73

141

988

Ovarian cyst

507

2244

1.30

6.82

1.1

0.82

1.09

u/ml

0.48

213

982

Striking against or struck by other objects

536

4216

1.28

6.81

1.1

1.18

1.19

u/ml

0.01

282

2045

Falls/tendency to fall

1617

7015

1.16

6.79

1.1

1.03

1.05

u/ml

0.06

771

3120

Other symptoms and signs involving the circulatory and respiratory systems

404

1.93

6.78

1.1

1.0

0.18

1.49

u/ml

2.21

173

Type 2 diabetes, strict (exclude DM1)

860

6042

0.83

6.76

1.1

0.95

1.00

u/ml

0.11

366

2567

Other specified disorders of external ear

150

2.57

6.72

1.0

1.1

5.96

1.00

u/ml

0.64

Disorders of the thyroid gland

1231

6800

1.18

6.69

1.1

0.75

1.09

u/ml

1.80

497

3013

Noninflammatory disorders of female genital tract

645

2582

1.26

6.65

1.1

1.10

1.13

u/ml

0.04

269

1188

Disorders of thyroid, IBD co-morbidities

272

1322

1.42

6.64

1.1

0.53

1.23

u/ml

2.40

118

606

Otitis externa

314

2306

1.37

6.63

1.1

1.98

1.26

u/ml

0.47

146

1064

Periodontitis

886

6775

0.83

6.60

1.1

1.19

0.96

u/ml

0.37

419

2837

Hypertrophy of breast

250

1771

1.42

6.58

1.1

1.12

0.91

u/ml

0.31

715

Other disorders of eyelid

319

2212

1.36

6.58

1.1

1.71

0.80

u/ml

0.63

128

904

Unspecified chronic bronchitis

3.20

6.58

1.1

1.0

0.74

2.54

u/ml

—

Chronic periodontitis, including avohilmo

884

6766

0.83

6.57

1.1

1.19

0.96

u/ml

0.37

418

2831

432

4981

0.77

6.56

1.1

1.04

1.05

u/ml

0.00

212

2199

Other respiratory disorders and diseases

143

902

1.59

6.55

1.1

0.54

1.06

u/ml

1.33

422

Other diseases of the respiratory system

143

902

1.59

6.55

1.1

0.54

1.06

u/ml

1.33

422

Type 2 diabetes, definitions combined

861

6029

0.83

6.55

1.1

0.96

0.97

u/ml

0.04

366

2564

Benign neoplasm of colon, rectum, anus and anal canal

480

3160

1.29

6.49

1.1

0.64

0.96

u/ml

1.23

197

1289

Mental and behavioural disorders due to psychoactive substance use

487

5663

0.78

6.47

1.1

1.04

1.03

u/ml

0.02

240

2489

Any dementia, excluding more controls

695

0.47

6.42

1.0

1.1

0.36

0.73

u/ml

0.87

298

Seborrhoeic dermatitis

104

609

1.72

6.41

1.1

0.75

0.74

u/ml

0.02

248

Alcohol use disorder, Swedish definition

379

4503

0.76

6.35

1.1

1.02

1.06

u/ml

0.05

184

1959

Other and unspecified drugs and medicaments

110

657

1.69

6.34

1.2

1.1

0.74

1.20

u/ml

0.57

283

Other degenerative diseases of the nervous system

102

1243

0.60

6.31

1.0

0.34

1.16

u/ml

3.18

521

Herpesviral [herpes simplex] infections

160

1049

1.54

6.27

1.1

2.26

1.05

u/ml

0.64

460

Hypothyroidism, other/unspecified

1149

6440

1.18

6.22

1.1

0.79

1.09

u/ml

1.29

463

2850

Adenomyosis (Endometriosis of uterus)

145

929

1.57

6.22

1.1

0.43

0.91

u/ml

1.14

378

Blepharochalasis

196

1340

1.47

6.20

1.1

0.66

0.86

u/ml

0.31

538

Unspecific neurodegenerative disorder

720

0.49

6.17

1.0

1.1

0.58

0.80

u/ml

0.32

324

Other and unspecified nerve root and plexus disorders, also in other diseases

247

1770

1.41

6.09

1.1

0.61

1.13

u/ml

1.86

104

753

Ocular pain

133

843

1.60

6.09

1.1

0.63

1.04

u/ml

0.69

383

Other diseases of intestine

125

779

1.61

6.07

1.1

0.82

0.94

u/ml

0.11

338

Continuous positive airway pressure

220

1283

1.44

6.03

1.1

0.66

0.99

u/ml

0.65

101

652

COPD, hospital admission 2, with asthma infections

180

1043

1.49

6.03

1.1

0.87

1.05

u/ml

0.24

450

Epiphora

2.90

5.98

1.0

0.67

2.07

u/ml

0.52

Degenerative diseases of the nervous system

669

0.47

5.97

1.0

1.1

0.60

0.89

u/ml

0.45

287

All influenza

317

2371

1.34

5.97

1.1

0.88

1.01

u/ml

0.24

153

1139

Other infestations, including avohilmo

3.01

5.90

1.1

0.82

1.08

u/ml

0.21

Infections of the skin and subcutaneous tissue

824

6787

1.20

5.89

1.1

1.43

1.05

u/ml

0.55

430

3119

Candidiasis

186

1275

1.47

5.89

1.1

0.56

1.11

u/ml

1.43

557

Congenital malformations, deformations and chromosomal abnormalities

956

7684

1.18

5.88

1.1

1.15

1.07

u/ml

0.16

437

3541

Viral and other specified intestinal infections, including avohilmo

554

4295

1.25

5.87

1.1

0.81

1.21

u/ml

1.37

253

2120

Obesity, other/unspecified

494

3931

1.26

5.85

1.1

0.50

1.02

u/ml

3.71

240

1676

Mental and behavioural disorders due to alcohol

379

4660

0.77

5.84

1.1

1.15

1.07

u/ml

0.10

187

2047

Endometriosis of pelvic peritoneum

237

1543

1.41

5.84

1.1

0.83

0.94

u/ml

0.15

660

Other disorders of eye and adnexa

208

1460

1.44

5.82

1.1

0.69

1.00

u/ml

0.76

670

Xerosis cutis

3.21

5.79

1.0

2.13

0.89

u/ml

—

Haemorrhoids and perianal venous thrombosis

309

2298

1.34

5.75

1.1

0.72

0.95

u/ml

0.69

110

979

Unspecified acute lower respiratory infection

193

1339

1.45

5.74

1.2

1.1

0.98

1.27

u/ml

0.42

106

596

Hypothyreosis and Thyroxine purchase for inclusion criteria

1182

6662

1.16

5.73

1.1

0.78

1.03

u/ml

1.08

474

2943

Acute tubulo-interstitial nephritis

505

5305

0.80

5.67

1.1

0.92

1.06

u/ml

0.24

234

2364

Other arthrosis

522

2791

1.26

5.67

1.1

0.67

1.00

u/ml

0.66

219

1143

Spondylolisthesis/Spondylolysis

180

1235

1.47

5.66

1.1

0.43

1.17

u/ml

2.16

517

Other septicaemia, including avohilmo

186

2496

0.70

5.65

1.1

1.50

0.93

u/ml

0.68

101

1178

Benign neoplasm of other and ill-defined parts of digestive system

147

969

1.53

5.63

1.1

0.50

0.90

u/ml

1.22

401

Stroke, including SAH

266

2583

0.74

5.63

1.0

1.1

0.50

0.93

u/ml

1.78

103

1127

Type 2 diabetes, wide definition

540

4217

0.80

5.61

1.1

0.78

0.96

u/ml

0.42

224

1758

Other/unspecified dorsalgia

431

3349

1.28

5.59

1.1

1.23

1.14

u/ml

0.08

215

1444

Obsessive-compulsive disorder

164

1112

1.50

5.59

1.1

0.50

1.29

u/ml

3.08

520

Selective deficiency of immunoglobulin G [IgG] subclasses

3.80

5.58

1.1

0.48

0.97

u/ml

—

Appendicitis, broad definition

973

7446

1.18

5.54

1.1

1.38

0.97

u/ml

0.66

400

3220

Pain, not elsewhere classified

367

2838

1.30

5.50

1.1

0.92

1.07

u/ml

0.34

171

1277

Type 2 diabetes, definitions combined, including avohilmo

893

6091

0.84

5.50

1.1

1.04

0.99

u/ml

0.09

382

2586

Acute and transient psychotic disorders

1141

0.55

5.49

1.0

1.1

0.73

1.24

u/ml

0.72

495

General examination and investigation of persons without complaint and reported diagnosis

775

3346

1.21

5.46

1.1

0.79

1.12

u/ml

1.22

332

1350

Otalgia

135

882

1.55

5.46

1.2

1.1

0.85

1.23

u/ml

0.70

447

Certain infectious and parasitic diseases

1423

6224

1.15

5.45

1.1

1.36

0.98

u/ml

0.93

664

2784

Erosion of teeth , including avohilmo

442

3506

1.27

5.44

1.1

0.66

1.21

u/ml

2.25

214

1608

COPD-related respiratory insufficiency

327

1.91

5.43

1.0

1.1

0.37

1.64

u/ml

1.63

138

Exposure to other and unspecified forces of nature

3.46

5.42

1.1

0.91

0.63

u/ml

0.20

Dementia

872

0.57

5.39

1.0

1.1

0.43

0.75

u/ml

0.79

378

Other enthesopathy of foot (+metatarsalgia)

131

852

1.55

5.38

1.1

0.82

1.08

u/ml

0.22

356

Care involving use of rehabilitation procedures

772

5825

1.19

5.35

1.1

0.66

1.02

u/ml

1.59

367

2547

Other reaction to severe stress, and adjustment disorders

599

4915

1.22

5.35

1.1

1.04

1.08

u/ml

0.05

290

2120

Hypothyroidism, strict autoimmune

978

5477

1.17

5.33

1.1

0.71

1.07

u/ml

1.84

377

2423

Mental retardation, wide definition

747

0.45

5.33

1.2

0.16

1.18

u/ml

4.94

473

Diseases of appendix

975

7461

1.17

5.33

1.1

1.38

0.97

u/ml

0.67

400

3226

Septicaemia

221

2769

0.72

5.32

1.1

1.40

0.94

u/ml

0.61

121

1305

Malaise and fatigue

589

3792

1.23

5.26

1.1

1.12

1.07

u/ml

0.06

277

1710

Nonsuppurative otitis media

467

3242

1.26

5.26

1.1

1.60

1.21

u/ml

0.35

263

1596

Other septicaemia

182

2425

0.70

5.21

1.1

1.51

0.93

u/ml

0.68

100

1144

Stroke, excluding SAH

236

2316

0.73

5.20

1.1

0.48

0.97

u/ml

1.88

995

Crossbite

204

1346

1.42

5.19

1.1

1.2

1.22

1.45

u/ml

0.19

135

777

Acute appendicitis

923

7325

1.17

5.15

1.1

1.41

0.97

u/ml

0.70

386

3167

Acute appendicitis, no complications

778

6529

1.19

5.14

1.1

1.23

0.98

u/ml

0.36

314

2831

Dental operations

618

2603

1.22

5.10

1.1

1.23

0.99

u/ml

0.28

273

1097

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1088

7929

0.86

5.10

1.1

0.69

1.11

u/ml

3.41

499

3588

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

813

5341

1.19

5.09

1.1

0.99

0.94

u/ml

0.10

302

2251

Pulmonary eosinophilia, not elsewhere classified

3.65

5.09

1.3

1.0

0.40

1.30

u/ml

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

931

0.52

5.09

1.1

1.34

1.31

u/ml

0.01

409

Recurrent aphthous stomatitis , including avohilmo

196

1398

1.41

5.07

1.1

0.87

1.09

u/ml

0.27

659

Mental retardation

732

0.46

5.07

1.2

0.16

1.19

u/ml

4.92

467

Benign neoplasm: Sigmoid colon

124

807

1.54

5.07

1.1

0.65

0.86

u/ml

0.37

346

ILD, hospital admissions 3, with pneumonia sepsis

258

1.99

5.07

1.1

0.96

1.47

u/ml

0.26

106

Immunodeficiencies

439

1.76

5.07

1.1

0.47

1.04

u/ml

1.04

222

Endocrine, nutritional and metabolic diseases

1354

5985

1.15

5.04

1.1

1.25

1.12

u/ml

0.21

630

2796

Extrapyramidal and movement disorders

316

2426

1.31

5.02

1.1

0.81

0.99

u/ml

0.33

128

1050

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

588

4837

1.22

5.01

1.1

0.83

0.97

u/ml

0.25

278

2037

Peripheral artery disease

104

1287

0.64

5.00

1.1

1.18

0.94

u/ml

0.19

553

Condition for Implicit Sepsis (Organ dysfunction codes)

771

6310

0.84

5.00

1.1

0.74

1.04

u/ml

1.54

352

2827

Obesity due to excess calories

677

5667

1.20

4.98

1.1

0.73

1.11

u/ml

1.16

292

2474

Inflammatory disease of uterus

225

1651

1.38

4.94

1.1

1.12

0.95

u/ml

0.15

110

682

Schizoaffective disorder

804

0.49

4.94

1.1

0.39

1.10

u/ml

2.07

356

Any operation in hilmo

206

1.83

4.94

1.1

2.25

0.97

u/ml

0.36

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

887

0.52

4.94

1.0

1.16

0.81

u/ml

0.26

356

Embedded and impacted teeth

616

4146

1.21

4.93

1.1

0.82

1.32

u/ml

2.33

297

2001

Substance abuse, excluding more controls

462

4772

0.81

4.93

1.1

1.06

1.04

u/ml

0.03

231

2055

Olecranon bursitis

289

1.92

4.93

1.1

3.46

1.39

u/ml

0.49

123

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

682

5650

1.20

4.88

1.1

1.08

1.12

u/ml

0.05

344

2604

Insulin, intermediate and long-acting

365

4457

0.79

4.87

1.0

1.1

0.69

1.07

u/ml

1.16

155

2070

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

196

1389

1.41

4.87

1.2

1.1

0.99

1.14

u/ml

0.18

102

772

Pleural plaque

143

2.32

4.84

1.0

1.1

0.70

0.79

u/ml

—

Other functional intestinal disorders

525

3901

1.23

4.83

1.1

1.21

1.03

u/ml

0.17

248

1837

Endometriosis

452

2102

1.26

4.81

1.1

0.86

1.11

u/ml

0.52

181

906

Other gastritis (incl. Duodenitis)

173

1218

1.43

4.80

1.2

1.1

0.83

0.92

u/ml

0.12

506

Diseases of male genital organs

567

2334

1.23

4.80

1.1

0.88

1.25

u/ml

0.80

286

1220

Erysipelas, including avohilmo

539

4850

0.82

4.79

1.1

1.98

0.86

u/ml

1.87

262

2038

Injury of muscle and tendon at shoulder and upper arm level

289

2209

1.31

4.77

1.1

0.42

1.02

u/ml

3.07

118

949

Cholinergic urticaria

4.56

4.75

1.1

1.0

1.06

1.08

u/ml

—

Nonorganic sleeping disorders

345

2707

1.28

4.72

1.1

1.11

1.22

u/ml

0.16

158

1193

Impacted teeth

489

3423

1.24

4.70

1.1

0.86

1.34

u/ml

1.73

230

1689

Appendectomy

887

7257

1.17

4.70

1.1

1.39

0.98

u/ml

0.73

384

3119

Other complications of surgical and medical care, not elsewhere classified

121

800

1.53

4.68

1.1

0.93

0.98

u/ml

0.04

344

Postmenopausal atrophic vaginitis

202

787

1.40

4.67

1.1

1.28

0.75

u/ml

0.50

300

Explicit Sepsis, including avohilmo

277

3271

0.76

4.67

1.1

1.98

1.04

u/ml

0.83

141

1521

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

710

3768

1.19

4.64

1.1

1.00

0.98

u/ml

0.03

331

1583

Certain disorders involving the immune mechanism

216

1593

1.36

4.60

1.1

1.12

1.02

u/ml

0.05

114

716

Redundant prepuce, phimosis and paraphimosis

244

1805

1.34

4.56

1.1

0.89

1.38

u/ml

0.96

131

903

Complications of medical and surgical care

822

6323

1.17

4.56

1.1

0.78

1.05

u/ml

0.78

378

2693

Alzheimer disease, including avohilmo

566

0.51

4.56

1.0

1.1

0.54

0.86

u/ml

0.48

252

Liquid cancers

123

1718

0.67

4.55

1.1

0.60

1.05

u/ml

0.94

757

Explicit Sepsis

268

3181

0.76

4.54

1.1

2.02

1.04

u/ml

0.85

138

1489

Disorders of choroid and retina

535

4527

0.82

4.53

1.1

1.11

0.92

u/ml

0.22

227

1913

Disorders of sclera, cornea, iris and ciliary body

655

5518

1.19

4.51

1.1

1.74

0.99

u/ml

1.03

312

2426

Immunodeficiency with predominantly antibody defects

236

1.99

4.51

1.1

0.30

0.75

u/ml

1.91

121

Polyuria

179

1284

1.40

4.50

1.1

0.90

0.97

u/ml

0.10

546

Other/unspecified soft tissue disorders related to use, overuse and pressure

222

2.02

4.50

1.1

1.0

0.58

0.82

u/ml

0.39

Keratitis

430

3480

1.24

4.49

1.1

2.39

0.99

u/ml

1.46

209

1536

Diseases of salivary glands

380

3038

1.26

4.44

1.1

0.57

1.08

u/ml

2.55

165

1322

Dialysis, with operation codes

841

0.53

4.43

1.1

0.37

1.19

u/ml

1.98

410

Hypermobility syndrome

108

708

1.55

4.43

1.1

0.23

0.99

u/ml

2.76

300

Other disorders of white blood cells

315

1.83

4.43

1.2

1.1

0.30

1.18

u/ml

1.65

147

Benign neoplasm: Liver

183

2.12

4.42

1.1

0.19

0.89

u/ml

2.60

Persistent delusional disorders

498

0.40

4.37

1.1

0.24

1.36

u/ml

—

211

Injuries to the neck

332

2620

1.27

4.36

1.1

1.52

1.29

u/ml

0.17

155

1175

Menorrhagia

417

1865

1.25

4.35

1.1

0.78

0.96

u/ml

0.27

169

818

Cervical polyps

621

1.57

4.35

1.0

1.1

1.69

0.95

u/ml

0.31

250

Benign neoplasm: Transverse colon

420

1.70

4.35

1.1

1.0

0.60

1.09

u/ml

0.79

181

Metatarsalgia

116

774

1.51

4.33

1.1

0.83

1.11

u/ml

0.22

321

Impingement syndrome of shoulder

194

1421

1.37

4.32

1.0

0.30

1.05

u/ml

3.42

584

Myotonic disorders

3.15

4.31

1.2

1.0

1.20

0.91

u/ml

—

Other obstetric conditions, not elsewhere classified

715

3831

1.18

4.30

1.1

0.92

0.99

u/ml

0.17

332

1603

Other systemic involvement of connective tissue

255

1950

1.31

4.26

1.1

0.51

1.01

u/ml

1.75

115

835

Psoas tendinitis

3.58

4.26

1.0

0.48

1.62

u/ml

—

Other and unspecified polyneuropathies, also in other diseases

127

865

1.48

4.26

1.1

0.93

0.91

u/ml

0.02

362

Mycoses

314

2468

1.28

4.26

1.1

0.61

1.14

u/ml

1.94

142

1099

Spondylosis

465

2972

1.23

4.24

1.1

0.88

1.02

u/ml

0.18

192

1217

Other otitis externa (chronic)

548

1.61

4.22

1.0

1.1

1.19

1.49

u/ml

0.19

251

Deforming dorsopathies

325

2567

1.27

4.22

1.1

0.58

1.13

u/ml

2.05

149

1144

Benign neoplasm: Liver/bile ducts

207

2.02

4.21

1.1

0.24

0.81

u/ml

2.20

Other diseases of anus and rectum

266

2041

1.30

4.20

1.1

0.69

0.94

u/ml

0.65

112

910

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

381

1.74

4.20

1.2

1.1

1.76

1.18

u/ml

0.29

174

Use of anticholinesterases

581

0.52

4.20

1.1

0.50

0.85

u/ml

0.57

255

N06DA Anticholinesterases

581

0.52

4.20

1.1

0.50

0.85

u/ml

0.57

255

All influenza (not pneumonia)

200

1482

1.36

4.18

1.2

1.1

1.14

1.06

u/ml

0.09

710

Chondrocostal junction syndrome [Tietze]

271

1.87

4.17

1.2

1.1

0.70

1.19

u/ml

0.45

112

Other viral diseases

495

4087

1.21

4.16

1.1

0.98

1.20

u/ml

0.59

246

1993

Other disorders of adrenal gland

427

1.69

4.16

1.1

0.56

1.23

u/ml

0.86

215

Uterine polyps

290

1309

1.30

4.16

1.1

0.49

0.78

u/ml

1.12

127

530

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

811

0.54

4.15

1.1

0.46

1.07

u/ml

1.21

341

Lateral epicondylitis

151

1070

1.42

4.14

1.2

1.1

1.34

1.08

u/ml

0.12

435

Ischaemic Stroke, excluding all haemorrhages

212

2075

0.75

4.13

1.0

1.1

0.50

1.01

u/ml

1.70

886

Benign neoplasm: Ascending colon

550

1.59

4.12

1.1

0.92

0.93

u/ml

0.01

228

Polyp of the female genital tract

319

1414

1.28

4.12

1.1

0.90

0.76

u/ml

0.19

135

582

Complications of procedures, not elsewhere classified

964

6777

1.15

4.11

1.1

0.90

0.98

u/ml

0.19

422

2899

Viral pneumonia

144

1014

1.43

4.09

1.1

0.98

0.93

u/ml

0.05

466

Mental retardation, excluding more controls

646

0.50

4.09

1.2

0.16

1.11

u/ml

4.17

402

Endometriosis of ovary

204

1431

1.35

4.09

1.1

0.72

0.87

u/ml

0.24

601

Other immunodeficiencies

111

2.43

4.08

1.1

0.51

0.82

u/ml

0.28

Complications predominantly related to the puerperium

399

3244

1.24

4.07

1.1

0.99

u/ml

0.01

175

1353

Colonic or urogenital fistula

283

2211

1.29

4.05

1.1

0.62

1.03

u/ml

1.33

114

962

Acute renal failure

1008

0.59

4.04

1.0

1.1

1.15

1.13

u/ml

0.01

455

Dipeptidyl peptidase 4 (DPP-4) inhibitors

239

2441

0.77

4.03

1.1

0.90

0.98

u/ml

0.09

1041

Transplanted organ and tissue status

901

0.57

4.00

1.1

0.14

1.49

u/ml

4.83

466

Benign neoplasm: Choroid

304

1.79

3.97

1.1

0.67

1.30

u/ml

0.52

125

Dysplasia of cervi uteri

345

1937

1.26

3.96

1.1

1.26

1.09

u/ml

0.16

138

829

Other and unspecified disorders of vitreous body

302

2330

1.27

3.96

1.0

1.1

0.73

0.84

u/ml

0.23

125

911

Alzheimer disease

481

0.50

3.95

1.0

1.1

0.54

0.94

u/ml

—

211

Stomatitis and related lesions

268

2088

1.29

3.95

1.1

1.47

1.14

u/ml

0.28

132

964

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

391

3186

1.24

3.94

1.1

1.87

1.15

u/ml

0.72

176

1421

STROKE

389

3215

0.81

3.92

1.0

1.1

0.58

0.90

u/ml

1.25

163

1361

Other and unspecified visual disturbances

113

767

1.48

3.92

1.1

0.80

1.13

u/ml

0.51

327

Primary hyperparathyroidism

495

1.61

3.91

1.1

0.32

1.01

u/ml

1.65

214

Secondary uncertain malignant neoplasm

625

0.49

3.91

1.1

0.57

1.13

u/ml

0.71

271

Other/unspecified enthesopathies of lower limb, excluding foot

624

1.54

3.87

1.1

1.03

1.16

u/ml

0.11

261

Disorders of ocular muscles, binocular movement, accommodation and refraction

720

6145

1.17

3.87

1.1

0.94

1.12

u/ml

0.35

334

2870

Other bacterial intestinal infections, including avohilmo

237

1822

1.31

3.86

1.1

0.67

1.22

u/ml

1.43

115

807

Primary_lymphoid and hematopoietic malignant neoplasms

1299

0.65

3.82

1.1

0.79

0.96

u/ml

0.18

603

Viral infections characterized by skin and mucous membrane lesions

523

4389

1.19

3.81

1.1

1.75

1.08

u/ml

0.74

264

2084

Persons encountering health services in circumstances related to reproduction

888

5191

1.15

3.81

1.1

1.16

1.11

u/ml

0.07

413

2435

Hypothyroidism (congenital or acquired)

503

2341

1.21

3.80

1.1

0.95

1.11

u/ml

0.26

220

1096

Infections with a predominantly sexual mode of transmission

517

4332

1.20

3.80

1.1

1.52

1.06

u/ml

0.57

232

1882

Other systemic involvement of connective tissue (FG)

252

1920

1.29

3.80

1.1

0.52

0.92

u/ml

1.31

112

796

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

621

5187

1.18

3.79

1.1

0.80

0.99

u/ml

0.41

291

2208

Other maternal disorders predominantly related to pregnancy

858

4670

1.15

3.78

1.1

1.00

1.04

u/ml

0.07

334

1949

Other spirochaetal diseases, including avohilmo

359

2910

1.24

3.77

1.1

0.59

1.05

u/ml

2.30

161

1288

Vulvovaginal ulceration/inflammation in other diseases

125

874

1.45

3.77

1.1

0.60

0.90

u/ml

0.63

371

Benign neoplasm of middle ear and respiratory system

392

1.67

3.77

1.1

0.32

1.25

u/ml

1.85

174

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

465

0.43

3.76

1.3

1.1

1.58

1.34

u/ml

—

216

Covid-19 confirmed case

369

2998

1.23

3.74

1.1

0.56

1.10

u/ml

2.64

172

1357

Inhalation and ingestion of food causing obstruction of respiratory tract

2.87

3.74

1.5

1.1

1.43

0.64

u/ml

0.75

Sulfonylureas

767

0.60

3.73

1.0

1.1

0.45

0.81

u/ml

0.60

332

Defects in the complement system

2.66

3.73

1.1

0.63

0.71

u/ml

0.05

Implicit viral Sepsis, including avohilmo

296

2348

1.26

3.70

1.1

0.84

1.03

u/ml

0.36

143

1068

malignant neoplasm of male genital organs

782

0.65

3.68

1.0

1.1

0.46

0.99

u/ml

0.93

326

Disorders of muscles

118

819

1.45

3.67

1.1

0.87

1.11

u/ml

0.29

347

malignant neoplasm of female genital organs, including Hilmo

994

0.62

3.67

1.1

0.56

0.82

u/ml

0.53

403

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

247

1.85

3.66

1.1

1.81

1.00

u/ml

0.31

107

Mental and behavioural disorders due to use of other stimulants, including caffeine

413

0.40

3.63

1.1

0.21

1.21

u/ml

2.19

186

Substance use, excluding alcohol

171

2284

0.74

3.61

1.1

1.13

1.17

u/ml

0.03

1024

Other specified/unspecified soft tissue disorders

233

1.86

3.61

1.1

1.0

0.14

0.84

u/ml

2.80

Nephropathy related operations

838

0.58

3.61

1.1

0.49

1.19

u/ml

1.42

408

Pain associated with micturition

130

922

1.42

3.60

1.1

0.77

1.26

u/ml

0.67

421

Malignant neoplasm of skin, including Hilmo

281

2370

0.79

3.60

1.1

0.70

0.93

u/ml

0.59

126

941

Benign lipomatous neoplasm

261

2052

1.28

3.60

1.0

1.1

0.48

0.99

u/ml

2.28

108

893

Deep bite

244

1671

1.30

3.60

1.1

1.33

1.31

u/ml

0.01

133

931

Single spontaneous delivery

375

2422

0.81

3.59

1.1

1.65

1.03

u/ml

0.63

159

1068

Hypothyroidism and >3 levothyroxin purchases

496

2323

1.20

3.58

1.1

0.96

1.12

u/ml

0.26

216

1083

Hypothyroidism, levothyroxine purchases

496

2323

1.20

3.58

1.1

0.96

1.12

u/ml

0.26

216

1083

Other local infections of skin and subcutaneous tissue

123

866

1.43

3.56

1.1

0.92

0.88

u/ml

0.03

392

Mental and behavioural disorders due to opioids

479

0.45

3.55

1.0

1.1

1.40

1.30

u/ml

0.03

215

Emotional disorders starting during childhood or adolecense, excluding more controls

138

965

1.41

3.54

1.1

1.28

1.38

u/ml

0.09

554

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1010

7671

0.88

3.52

1.1

0.79

1.06

u/ml

0.77

498

3412

Radiculopathy

124

876

1.42

3.51

1.2

1.1

1.76

1.14

u/ml

0.21

355

Gluteal tendinitis

265

1.79

3.49

1.1

1.08

1.40

u/ml

0.16

103

Diseases of arteries, arterioles and capillaries

337

3036

0.81

3.49

1.1

0.76

0.96

u/ml

0.48

145

1305

Urethritis and urethral syndrome

132

2.16

3.48

1.1

1.0

0.27

0.91

u/ml

1.55

Other spirochaetal diseases

350

2857

1.23

3.48

1.1

0.60

1.04

u/ml

2.10

156

1268

Benign neoplasm: Duodenum

2.50

3.48

1.4

1.1

0.28

0.98

u/ml

—

Drug-induced adrenocortical insufficiency

139

2.13

3.48

1.1

0.16

1.62

u/ml

1.09

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

208

1.90

3.46

1.1

0.36

1.61

u/ml

1.31

Oxycodone

179

2022

0.75

3.45

1.1

0.83

1.00

u/ml

0.29

839

Fibroblastic disorders

167

1243

1.35

3.44

1.1

1.0

0.79

1.00

u/ml

0.31

521

Retained placenta and membranes, without haemorrhage

153

1126

1.37

3.44

1.1

0.38

0.81

u/ml

1.71

460

Other sleep disorders

128

914

1.41

3.43

1.1

1.09

1.05

u/ml

0.03

390

Polyneuropathies and other disorders of the peripheral nervous system

154

1133

1.36

3.43

1.1

0.91

u/ml

0.00

491

Concussion

738

4973

1.15

3.43

1.1

1.08

1.24

u/ml

0.36

358

2333

Other predominantly sexually transmitted diseases, not elsewhere classified

294

2363

1.25

3.43

1.1

2.08

1.14

u/ml

0.74

134

1044

Otitis media, unspecified

246

1782

1.28

3.42

1.2

1.1

1.75

1.35

u/ml

0.25

146

931

Faecal incontinence

426

1.61

3.42

1.1

1.0

0.84

1.06

u/ml

0.14

175

L04AD Calcineurin inhibitors

1131

0.65

3.42

1.1

1.01

1.30

u/ml

0.18

580

Hypertrophy of tongue papillae

2.49

3.42

1.1

1.0

0.22

0.83

u/ml

—

Other and specified injuries of hip and thigh

120

2.20

3.41

1.1

0.61

1.55

u/ml

0.41

Ulcer of vagina/vulva

283

1.76

3.40

1.1

0.76

0.68

u/ml

0.10

122

Nausea and vomiting

313

2468

1.24

3.40

1.2

1.1

0.73

1.21

u/ml

1.61

155

1217

Flat foot [pes planus] (acquired)

104

717

1.46

3.39

1.1

1.01

1.20

u/ml

0.19

312

Other abnormal products of conception

610

3431

1.17

3.38

1.1

1.14

0.93

u/ml

0.43

255

1429

Unspecified fall

591

4975

1.17

3.38

1.1

0.92

1.12

u/ml

0.64

321

2348

Non-selective monoamine reuptake inhibitors

307

2377

1.24

3.38

1.1

0.42

0.90

u/ml

3.55

156

930

Polyarthropathies

642

4777

0.86

3.38

1.1

0.65

1.07

u/ml

2.23

277

2110

Occupational exposure to risk-factors

182

1.95

3.36

1.1

0.45

0.89

u/ml

0.73

Sub-endpoint used in defining T1D endpoints

246

3052

0.79

3.36

1.1

0.72

1.15

u/ml

0.98

111

1488

Contracture of joint

2.77

3.35

1.0

1.1

2.11

1.63

u/ml

—

Antihypertensive medication - note that there are other indications

1204

5631

1.12

3.35

1.1

1.37

1.11

u/ml

0.45

540

2699

Erysipelas

340

3574

0.82

3.34

1.1

2.26

0.86

u/ml

1.53

174

1510

Spinal osteochondrosis

2.53

3.34

1.1

0.32

3.30

u/ml

1.14

Toxic effect of contact with venomous animals

368

1.65

3.34

1.1

0.61

1.40

u/ml

0.87

171

ILD medications: immunosuppressive drugs

745

5888

1.15

3.33

1.1

1.57

0.98

u/ml

0.90

337

2492

Severe mental retardation

0.00

3.32

0.0

1.2

—

1.32

—

Budesonide

165

1235

1.34

3.32

1.1

1.82

1.08

u/ml

0.27

502

Disorders of refraction and accommodation

454

3806

1.19

3.32

1.1

0.82

1.17

u/ml

0.74

211

1843

Other and unspecified acute skin changes due to ultraviolet radiation

2.64

3.31

1.1

1.0

0.23

3.28

u/ml

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

346

1.67

3.31

1.1

0.22

1.43

u/ml

2.02

171

Chronic kidney disease

106

1449

0.70

3.31

1.1

0.98

1.07

u/ml

0.06

680

Hernia of abdominal wall

415

3465

1.20

3.29

1.1

1.64

0.93

u/ml

0.77

190

1498

Atherosclerosis, excluding cerebral and coronary sclerosis

1046

0.68

3.29

1.1

1.30

0.92

u/ml

0.31

448

Benign neoplasm: Small intestine

135

2.09

3.29

1.3

1.1

0.33

1.76

u/ml

0.98

Abnormal findings in secretions and smears from cervix uteri vagina vulva

761

4894

1.15

3.28

1.1

1.02

0.97

u/ml

0.09

289

2046

Gingivitis and periodontal diseases

1248

5785

1.12

3.27

1.1

0.85

1.09

u/ml

0.95

578

2558

Other acute skin changes due to ultraviolet radiation

163

1.99

3.26

1.1

1.0

0.17

1.60

u/ml

1.05

Benign paroxysmal vertigo

240

1894

1.27

3.25

1.1

0.75

0.90

u/ml

0.28

105

789

Injury of muscle and tendon at hip and thigh level

120

857

1.41

3.25

1.1

1.26

1.11

u/ml

0.07

356

Carpal tunnel syndrome

635

4756

1.16

3.24

1.1

0.36

0.95

u/ml

8.20

227

1972

Other and unspecified mental retardation

411

0.44

3.24

1.2

0.20

1.11

u/ml

—

301

Unspecified/other endometriosis

160

1174

1.35

3.23

1.1

1.00

1.09

u/ml

0.10

514

Implicit fungal Sepsis, including avohilmo

394

1.61

3.22

1.1

1.41

1.12

u/ml

0.19

166

Diseases of tongue

340

1.66

3.22

1.1

1.0

1.64

1.04

u/ml

0.21

133

Malignant neoplasm of respiratory system and intrathoracic organs

613

0.58

3.21

1.0

1.1

0.40

0.65

u/ml

0.73

251

Bruxism

193

1.91

3.21

1.1

0.18

1.49

u/ml

1.16

Persons encountering health services in other circumstances

541

4583

1.17

3.21

1.1

1.40

1.12

u/ml

0.31

228

2046

Coronary artery bypass grafting

530

0.57

3.21

1.0

1.04

1.16

u/ml

0.08

235

Systemic connective tissue disorders

316

2577

1.23

3.20

1.1

0.50

1.04

u/ml

2.39

146

1103

Benign lipomatous neoplasm of other sites/unspecified

364

1.63

3.18

1.1

0.54

1.09

u/ml

0.67

154

Meniscus derangement

543

3075

1.17

3.17

1.1

0.83

1.05

u/ml

0.37

219

1272

Heart failure, strict

207

1845

0.78

3.16

1.0

1.1

0.74

1.04

u/ml

0.55

821

Diabetic nephropathy, excluding more controls

659

0.60

3.15

1.1

2.34

0.78

u/ml

0.60

279

Thyroiditis

614

1.48

3.14

1.1

0.38

0.97

u/ml

1.55

264

All-cause Heart Failure

203

1812

0.78

3.12

1.0

1.1

0.75

1.05

u/ml

0.55

810

Female genital prolapse

265

1171

1.26

3.12

1.1

0.56

0.81

u/ml

0.66

107

475

Ehlers-Danlos syndrome, including avohilmo

160

2.00

3.11

1.1

0.85

0.77

u/ml

0.06

Post-traumatic stress disorder

172

1312

1.32

3.10

1.2

1.1

0.64

1.14

u/ml

1.23

579

Lyme disease, including avohilmo

341

2814

1.22

3.10

1.1

0.60

1.04

u/ml

2.07

154

1238

Lyme disease

341

2814

1.22

3.10

1.1

0.60

1.04

u/ml

2.07

154

1238

Other skin changes

169

1284

1.32

3.09

1.1

1.95

0.95

u/ml

0.42

560

Other and unspecified local infections of skin and subcutaneous tissue

116

832

1.40

3.08

1.1

0.93

0.90

u/ml

0.02

375

Disorders of vestibular function (Vertigo)

394

3209

1.20

3.08

1.1

0.76

0.91

u/ml

0.41

178

1315

malignant neoplasm of male genital organs, including Hilmo

813

0.69

3.07

1.0

1.1

0.42

0.96

u/ml

1.01

342

Universal erythroderma, KELA reimbursement

2.55

3.07

1.1

1.0

7.94

1.15

u/ml

0.45

Malignant neoplasm of brain, including Hilmo

343

0.40

3.06

1.3

1.1

1.68

1.45

u/ml

—

166

Other specified/unspecified bacterial intestinal infections

408

1.58

3.05

1.1

0.37

1.16

u/ml

1.52

183

Use of disulfiram, acamprosate or naltrexone

761

0.60

3.05

1.1

0.25

1.43

u/ml

2.68

317

Benign neoplasms

1413

6980

1.10

3.05

1.1

0.80

1.14

u/ml

2.04

622

3189

Testicular hypofunction

285

1.71

3.04

1.0

1.1

1.29

1.90

u/ml

0.22

128

Localized swelling, mass and lump of skin and subcutaneous tissue

342

2829

1.21

3.04

1.1

1.00

0.99

u/ml

0.02

163

1258

Acute nasopharyngitis (common cold)

143

1055

1.35

3.04

1.1

2.35

1.20

u/ml

0.47

492

Mild mental retardation

367

0.43

3.03

1.1

1.2

0.10

1.67

u/ml

—

210

Spirochaetal infections, other/unspecified, including avohilmo

343

2839

1.21

3.03

1.1

0.61

1.04

u/ml

2.05

156

1251

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

750

0.63

3.02

1.1

0.34

0.86

u/ml

1.61

316

Other shoulder lesions

115

827

1.40

3.02

1.1

0.21

1.02

u/ml

3.74

341

Autoimmune diseases excluding thyroid diseases, strict definition

1195

7198

0.90

3.02

1.1

0.99

1.11

u/ml

0.26

549

3340

Presence of other functional implants

291

2444

0.81

3.01

1.1

0.94

1.04

u/ml

0.11

1050

Artrosis, including avohilmo

963

4692

1.13

3.00

1.1

0.69

1.02

u/ml

1.29

394

2005

Complications associated with artificial fertilization

220

1.81

2.99

1.0

1.1

1.01

0.86

u/ml

0.06

Bacterial Sepsis

250

2568

0.80

2.99

1.1

1.05

1.03

u/ml

0.02

116

1174

Galactorrhea

2.34

2.99

1.1

5.79

0.95

u/ml

0.63

Delirium, not induced by alcohol and other psychoactive substances

381

0.44

2.98

1.1

1.31

1.53

u/ml

—

153

Premenstrual syndrome

177

1.91

2.96

1.1

0.86

0.84

u/ml

0.02

Sicca syndrome [Sjögren]

548

1.49

2.95

1.1

0.51

0.98

u/ml

0.63

228

Suppurative otitis media, unspecified

258

1.73

2.94

1.0

1.1

0.35

1.72

u/ml

1.58

127

Other disorders starting during childhood or adolecense, excluding more controls

144

1032

1.35

2.94

1.1

2.76

1.30

u/ml

0.61

609

Subacute thyroiditis

273

1.71

2.93

1.0

1.1

0.58

1.29

u/ml

0.72

119

Persistent mood disorders

217

1718

1.27

2.92

1.1

0.55

1.11

u/ml

2.36

721

Malignant neoplasm of skin

258

2161

0.81

2.92

1.1

0.65

0.96

u/ml

0.84

121

869

Other viral hepatitis, including avohilmo

763

0.61

2.92

1.1

0.37

0.96

u/ml

1.74

330

Implicit Sepsis

617

5210

0.87

2.91

1.1

0.78

0.98

u/ml

0.72

282

2338

L04AA Selective immunosuppressants

171

2208

0.77

2.90

1.0

1.1

0.28

1.16

u/ml

7.35

1009

Other noninflammatory disorders of vulva and perineum

122

893

1.38

2.90

1.1

0.62

1.28

u/ml

0.97

380

Adrenocortical insufficiency

282

1.69

2.88

1.1

0.72

1.51

u/ml

0.57

135

Haemangioma, any site

101

717

1.42

2.88

1.1

1.08

1.22

u/ml

0.09

331

Other/unspecified disorders of vestibular function

207

1.81

2.88

1.1

0.64

1.37

u/ml

0.59

Rheumatism, unspecified

115

834

1.39

2.88

1.1

1.0

0.67

0.84

u/ml

0.24

347

Hyperparathyroidism

109

774

1.40

2.87

1.1

0.55

1.20

u/ml

1.25

323

Pre-eclampsia or poor fetal growth

359

4255

0.84

2.86

1.1

1.10

1.02

u/ml

0.05

145

1772

Haemangioma and lymphangioma, any site

111

802

1.39

2.86

1.1

1.00

1.13

u/ml

0.08

370

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.39

2.85

1.4

1.0

1.06

0.95

u/ml

0.04

Autoimmune diseases excluding thyroid diseases

1227

7330

0.91

2.85

1.1

1.01

1.11

u/ml

0.21

567

3397

ILD-related respiratory insufficiency

2.31

2.85

1.1

0.82

1.14

u/ml

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.38

2.84

1.1

1.0

0.49

1.21

u/ml

—

Valvular heart disease excluding rheumatic fever

269

2357

0.81

2.84

1.1

0.99

u/ml

0.00

114

1106

Other puerperal infections

157

1200

1.32

2.84

1.1

1.02

1.07

u/ml

0.06

511

Poor fetal growth

152

1983

0.76

2.84

1.1

0.37

1.02

u/ml

4.38

845

Use of biperiden

331

0.42

2.83

1.0

1.1

1.79

1.15

u/ml

—

144

Pericarditis

179

1.86

2.83

1.2

1.1

0.71

0.84

u/ml

0.12

Kidney transplant status

478

0.52

2.82

1.2

1.1

0.08

1.45

u/ml

3.52

251

Heart failure,strict

203

1791

0.79

2.81

1.0

1.1

0.74

1.04

u/ml

0.56

805

Open wound of wrist and hand

585

4923

1.15

2.80

1.1

0.63

1.12

u/ml

2.98

266

2240

Pleural plaque without asbestos

2.66

2.80

1.0

1.1

0.98

1.13

u/ml

—

Inflammation of lacrimal passages (acute and unspecified)

2.20

2.79

1.1

0.44

1.94

u/ml

—

Benign neoplasm of eye and adnexa

605

1.45

2.77

1.1

0.60

1.01

u/ml

0.53

261

Delivery

392

2448

0.84

2.77

1.1

1.64

1.03

u/ml

0.64

166

1084

Any mental disorder

1398

6382

1.10

2.77

1.1

1.36

0.99

u/ml

0.84

661

2836

Presence of cardiac and vascular implants and grafts

150

1445

0.76

2.77

1.0

1.1

0.54

1.05

u/ml

1.29

650

Certain conditions originating in the perinatal period

236

1689

1.25

2.77

1.1

0.84

1.54

u/ml

1.84

136

950

Malignant neoplasm of bronchus and lung

497

0.57

2.76

1.0

1.1

0.44

0.68

u/ml

0.52

201

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

336

2805

1.20

2.76

1.1

0.54

1.16

u/ml

2.61

131

1274

Bacterial infection, other or unspecified

333

3361

0.83

2.75

1.1

0.93

0.89

u/ml

0.07

157

1518

Polyarthrosis

137

924

1.34

2.75

1.1

1.0

0.69

0.98

u/ml

0.31

365

Disorders of orbit

309

1.64

2.75

1.1

0.73

1.58

u/ml

0.77

135

Other neurological diseases

482

4337

0.86

2.73

1.1

0.71

1.00

u/ml

0.82

222

1876

Need for other prophylactic measures

502

1.49

2.71

1.1

0.74

1.39

u/ml

0.68

267

Benign neoplasm: Skin of ear and external auricular canal

146

1.93

2.71

1.0

0.56

0.82

u/ml

—

Implicit Sepsis, including avohilmo

752

6047

0.89

2.70

1.1

0.73

1.00

u/ml

1.32

342

2701

malignant neoplasm of female genital organs

852

0.65

2.69

1.1

0.61

0.77

u/ml

0.28

339

Other mycoses, not elsewhere classified/unspecified, including avohilmo

119

2.05

2.69

1.0

1.1

1.54

0.76

u/ml

0.29

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

205

1.77

2.67

1.1

1.0

0.78

1.36

u/ml

0.37

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

952

7132

0.90

2.65

1.1

0.80

1.03

u/ml

0.79

432

3203

Superficial injury of wrist and hand

327

2736

1.20

2.65

1.1

0.67

1.24

u/ml

2.34

158

1307

Contraceptive management

610

3732

1.15

2.65

1.1

0.94

1.07

u/ml

0.22

262

1582

Hypothyroidism, strict autoimmune, 3 medication purchases required

1032

6256

1.11

2.65

1.1

0.69

1.03

u/ml

1.70

390

2727

Idiopathic pulmonary fibrosis

183

1.81

2.65

1.1

1.47

0.93

u/ml

0.27

Fall on and from stairs and steps

276

2273

1.22

2.63

1.1

0.68

1.07

u/ml

0.78

138

1013

Bicipital tendinitis

251

1.69

2.63

1.1

0.14

0.96

u/ml

3.70

103

Sequelae of other external causes

400

1.54

2.62

1.1

0.48

1.17

u/ml

1.21

172

Mental and behavioural disorders due to cannabinoids

451

0.52

2.61

1.2

1.1

1.70

1.29

u/ml

0.16

209

Abrasion of teeth

388

3299

1.18

2.60

1.1

0.72

1.00

u/ml

0.90

171

1366

Otitis externa, unspecified

152

1172

1.31

2.58

1.1

2.15

1.14

u/ml

0.40

538

Achilles tendinitis

101

732

1.39

2.58

1.1

3.19

1.24

u/ml

0.57

290

Postmenopausal bleeding

168

677

1.30

2.58

1.1

1.03

0.77

u/ml

0.14

263

Other deformities of toe(s)

185

1.80

2.58

1.0

1.1

0.33

0.81

u/ml

0.97

Disorders of parathyroid gland

130

968

1.33

2.57

1.1

0.55

1.04

u/ml

1.15

414

Cardiovascular diseases

1232

5958

1.10

2.54

1.1

1.30

1.08

u/ml

0.45

566

2830

Other and unspecified trigeminal disorders

2.20

2.53

1.0

0.12

2.58

u/ml

—

Postpartum care and examination

210

1635

0.80

2.53

1.1

0.94

0.95

u/ml

0.01

687

Polycystic ovarian syndrome, consortium definition

1045

5423

1.11

2.52

1.1

0.86

1.02

u/ml

0.43

434

2292

Procedures for purposes other than remedying health state

172

1.83

2.52

1.1

0.27

1.50

u/ml

0.96

Cholecystectomy

687

5169

1.13

2.52

1.1

0.56

0.93

u/ml

2.32

289

2111

Alzheimer disease, excluding more controls

276

0.51

2.52

1.0

0.65

0.79

u/ml

—

124

Hard cardiovascular diseases

712

4735

0.89

2.52

1.1

0.92

0.96

u/ml

0.08

290

2140

Seborrhoeic keratosis

166

1298

1.28

2.52

1.1

0.87

1.00

u/ml

0.11

534

Viral hepatitis, including avohilmo

819

0.65

2.52

1.1

0.35

1.08

u/ml

2.15

357

Other diseases of stomach and duodenum

285

1.62

2.51

1.2

1.1

0.64

1.13

u/ml

0.66

119

Type 1 diabetes

247

2999

0.82

2.51

1.1

0.72

1.10

u/ml

0.89

113

1464

Ehlers-Danlos syndrome

130

1.98

2.51

1.1

1.0

0.82

0.73

u/ml

0.06

Other specified/unspecified hearing loss

428

1.50

2.51

1.1

0.31

1.43

u/ml

1.97

195

Sacrococcygeal disorders, not elsewhere classified

255

1.67

2.51

1.1

0.55

1.50

u/ml

0.93

106

MS-disease / Multiple Sclerosis

818

0.65

2.50

1.0

1.1

0.17

1.12

u/ml

3.52

356

Unspecified event, undetermined intent

225

1.72

2.50

1.3

1.1

0.98

1.40

u/ml

0.28

105

Melanocytic naevi

387

3304

1.18

2.49

1.1

0.69

1.13

u/ml

1.60

166

1470

Atypical facial pain

373

1.54

2.49

1.1

0.56

1.27

u/ml

0.92

161

Secondary and unspecified malignant neoplasm of lymph nodes

459

0.54

2.49

1.1

0.69

1.22

u/ml

—

206

Excessive vomiting in pregnancy

133

1014

1.32

2.49

1.1

0.25

1.29

u/ml

4.34

431

Fracture of femur

984

0.70

2.47

1.0

1.1

0.27

0.96

u/ml

3.22

448

Other disorders of penis

107

789

1.36

2.46

1.1

2.17

1.41

u/ml

0.28

433

Patellar tendinitis

174

1.82

2.45

1.1

1.38

1.77

u/ml

0.12

Nontoxic goitre/thyroid nodule

222

1802

1.24

2.45

1.1

0.84

0.87

u/ml

0.05

746

Other disorders of bone

248

2038

1.22

2.45

1.1

0.66

1.18

u/ml

1.72

116

903

Deficiency of other B group vitamins

2.11

2.44

1.2

1.0

0.08

0.98

u/ml

—

Dyshidrosis [pompholyx]

138

1.92

2.44

1.0

1.1

0.50

0.86

u/ml

—

Thyroiditis, ILD-related definition

154

1200

1.29

2.44

1.1

0.52

1.01

u/ml

1.56

524

Other factor of the environment

2.21

2.44

1.0

1.96

0.69

u/ml

—

Nonalcoholic fatty liver disease

117

878

1.34

2.43

1.1

1.00

1.08

u/ml

0.07

363

Urticaria due to cold and heat

2.27

2.42

1.1

0.81

0.54

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

173

1368

1.27

2.42

1.1

0.46

1.05

u/ml

2.55

646

Lichen ruber planus, wide definition including periferal and oral lichen planus

186

1484

1.26

2.41

1.0

1.1

1.16

0.98

u/ml

0.17

614

Noninfectious colitis NAS

163

1281

1.28

2.41

1.1

0.86

1.11

u/ml

0.37

585

Crushed, pushed or stepped on by crowd or human stampede

139

1072

1.31

2.41

1.1

0.55

1.38

u/ml

2.42

510

Dizziness and giddiness

811

5657

1.12

2.41

1.1

0.69

1.01

u/ml

1.99

366

2446

Bacterial pneumonia (organism specified)

378

2921

1.17

2.41

1.1

0.85

1.08

u/ml

0.47

193

1293

Acute alcohol intoxication

177

2218

0.80

2.40

1.1

1.41

1.20

u/ml

0.13

987

Diagnoses used for exclusion with ILD

189

1511

1.25

2.40

1.1

1.36

1.02

u/ml

0.14

654

Other disorders of Eustachian tube

220

1.70

2.40

1.1

0.59

2.21

u/ml

1.11

Disorders of iron metabolism

2.10

2.39

1.1

0.14

0.81

u/ml

—

Acute otitis externa, noninfective

2.09

2.39

1.1

1.0

6.56

0.96

u/ml

—

Major coronary heart disease event excluding revascularizations

273

2165

0.83

2.37

1.1

1.12

0.92

u/ml

0.20

104

951

Examination and encounter for administrative purposes

369

1.53

2.37

1.1

0.42

1.65

u/ml

1.02

132

Cerebrovascular diseases (FINNGEN)

254

2151

0.82

2.37

1.1

0.59

1.00

u/ml

1.02

924

Testicular dysfunction

330

1.56

2.37

1.0

1.1

1.29

1.77

u/ml

0.18

148

Amputation

320

0.47

2.36

1.1

2.79

1.30

u/ml

—

135

Exclusions for E4_PCOS_CONSORTIUM

917

6323

0.90

2.36

1.1

1.19

1.02

u/ml

0.39

372

2846

Respiratory insufficiency

153

1.83

2.36

1.0

0.43

2.44

u/ml

—

Acne

246

2022

1.22

2.35

1.1

0.87

1.43

u/ml

1.32

135

1001

Other viral hepatitis

708

0.64

2.33

1.1

0.37

0.94

u/ml

1.59

301

Viral hepatitis

768

0.66

2.32

1.1

0.36

1.05

u/ml

1.88

332

Impetigo

672

1.39

2.32

1.3

1.1

1.53

0.96

u/ml

0.31

355

Disorders of eyelid in diseases classified elsewhere

223

1.68

2.29

1.1

6.35

1.00

u/ml

0.83

Acute generalized exanthematous pustulosis

365

1.52

2.29

1.1

1.54

1.44

u/ml

0.04

170

Exposure to other and unspecified inanimate mechanical forces

110

827

1.34

2.29

1.2

1.1

0.44

1.14

u/ml

1.88

393

Other inflammation of vagina/vulva

456

1.47

2.28

1.1

0.39

0.85

u/ml

1.36

191

Nerve, nerve root and plexus disorders

1239

6825

1.09

2.27

1.1

0.59

1.06

u/ml

5.14

482

2947

Hordeolum and other deep inflammation of eyelid

606

1.40

2.27

1.1

0.46

1.23

u/ml

1.48

290

Insulin, fast-acting

293

3468

0.84

2.27

1.1

0.76

1.10

u/ml

0.76

123

1655

Other peripheral vertigo

480

1.45

2.26

1.1

0.53

1.12

u/ml

1.04

204

Insulin, fast-acting or short human

293

3467

0.84

2.26

1.1

0.76

1.10

u/ml

0.76

123

1655

Sexual dysfunction

135

1.88

2.24

1.1

6.11

1.70

u/ml

0.34

Drug-induced headache, not elsewhere classified

2.77

2.24

1.3

1.0

0.58

0.78

u/ml

—

Umbilical hernia

260

2168

1.20

2.24

1.1

1.28

1.03

u/ml

0.25

132

942

Other acquired deformities of musculoskeletal system and connective tissue

295

1.57

2.23

1.1

0.25

1.67

u/ml

1.64

126

Coronary atherosclerosis

329

2439

0.85

2.23

1.1

1.01

1.02

u/ml

0.00

129

1033

Other diseases of peritoneum

248

1.63

2.22

1.1

0.28

1.25

u/ml

—

106

Background retinopathy and retinal vascular changes

100

2.02

2.22

1.0

1.1

1.60

0.90

u/ml

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

200

1629

1.24

2.22

1.1

0.75

1.16

u/ml

0.97

728

Polyarthritis, unspecified

233

1.65

2.21

1.1

0.30

1.20

u/ml

1.88

101

Implicit bacterial Sepsis

196

2063

0.81

2.21

1.1

0.98

0.95

u/ml

0.04

920

False labour

574

3148

1.14

2.20

1.1

1.38

0.98

u/ml

0.49

243

1324

Type 1 diabetes, wide definition

226

2726

0.82

2.20

1.1

1.42

1.09

u/ml

0.17

106

1335

Impacted cerumen

677

1.37

2.19

1.1

1.10

1.41

u/ml

0.22

343

Injury of muscle and tendon at lower leg level

149

1174

1.27

2.19

1.1

0.70

0.89

u/ml

0.27

507

Exclusions for E4_PCOS_BROAD

242

2009

1.21

2.19

1.1

1.10

1.11

u/ml

0.01

1021

Ptosis of eyelid

492

1.43

2.18

1.1

0.69

1.25

u/ml

0.50

214

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

504

4387

1.14

2.18

1.1

0.90

1.15

u/ml

0.55

260

2067

Malignant neoplasm of bronchus and lung, including Hilmo

594

0.66

2.17

1.0

1.1

0.34

0.64

u/ml

1.02

242

Other and unspecified erythematous conditions

196

1.70

2.17

1.1

1.16

2.13

u/ml

0.45

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

877

6106

0.91

2.17

1.1

0.98

u/ml

0.00

374

2560

Zoster [herpes zoster], including avohilmo

455

3838

1.15

2.16

1.1

1.38

0.98

u/ml

0.37

202

1612

Chondropathies

192

1561

1.24

2.16

1.1

0.68

1.08

u/ml

1.12

685

Acute alcohol intoxication, ICD10

158

1976

0.80

2.16

1.1

1.52

1.10

u/ml

0.27

885

Coeliac disease

150

1186

1.27

2.16

1.1

1.31

1.19

u/ml

0.08

560

Spirochaetal infections, other/unspecified

569

1.40

2.16

1.1

0.71

1.41

u/ml

0.98

256

Stenosis and insufficiency of lacrimal passages

586

1.39

2.15

1.1

0.60

1.14

u/ml

0.85

261

Lifestyle-related condition

2.14

2.15

1.0

1.96

0.78

u/ml

—

Congenital malformations of trachea and bronchus

2.10

2.15

1.3

1.1

0.62

1.30

u/ml

0.36

Suicide or other Intentional self-harm

238

2853

0.83

2.15

1.1

1.10

1.19

u/ml

0.06

109

1263

Residual foreign body in soft tissue

453

1.45

2.14

1.1

0.27

1.01

u/ml

1.72

201

Horner syndrome

2.40

2.14

1.1

1.0

0.20

3.51

u/ml

—

Non-rheumatic valve diseases

267

2266

0.84

2.13

1.1

1.00

0.99

u/ml

0.02

113

1040

Other disorders of conjunctiva

672

1.36

2.13

1.0

1.1

2.29

1.24

u/ml

0.24

267

190

1546

1.24

2.13

1.1

1.03

1.28

u/ml

0.27

645

Other diseases of pleura

272

1985

1.19

2.13

1.1

0.55

1.03

u/ml

1.58

111

895

Melanocytic naevi of eyelid, including canthus

2.50

2.12

1.2

1.0

0.26

1.05

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

188

1527

1.24

2.12

1.1

0.46

1.16

u/ml

3.06

722

Other retinal disorders

387

3392

0.86

2.12

1.0

1.1

0.83

0.97

u/ml

0.33

166

1471

Varicose veins

365

3194

0.86

2.12

1.1

1.19

0.89

u/ml

0.28

123

1265

Type 1 diabetes, strict (exclude DM2)

129

1639

0.78

2.11

1.1

0.61

1.23

u/ml

1.22

867

Medicines for HER+ breast cancer

219

2461

0.83

2.10

1.1

1.02

0.82

u/ml

0.14

953

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

124

1.89

2.10

1.0

0.92

1.09

u/ml

0.14

Cardiomyopathy (excluding other)

620

0.64

2.10

1.1

1.52

1.00

u/ml

0.26

289

Use of pramipexole

154

1225

1.26

2.10

1.1

1.24

1.02

u/ml

0.17

519

Dental caries, including avohilmo

804

3712

1.11

2.09

1.1

1.11

1.02

u/ml

0.13

366

1615

Tongue abnormality

332

1.52

2.09

1.1

0.46

1.14

u/ml

0.99

139

Influenza and pneumonia

1455

8323

1.08

2.09

1.1

1.05

u/ml

0.02

738

3712

Early lumbar disc prolapse, operated

159

1272

1.26

2.09

1.1

0.82

1.18

u/ml

0.53

533

Chalazion

126

979

1.29

2.09

1.1

1.03

1.06

u/ml

0.02

427

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

300

1.54

2.08

1.0

0.37

1.20

u/ml

1.14

124

Generalized skin eruption due to drugs and medicaments

325

1.52

2.08

1.1

1.57

1.50

u/ml

0.02

151

Other erythematous conditions

214

1.65

2.08

1.1

1.10

2.05

u/ml

0.47

Other symptoms and signs involving the digestive system and abdomen

165

1326

1.25

2.07

1.1

1.05

1.10

u/ml

0.03

605

Sequelae of external causes of morbidity and mortality

222

1840

1.21

2.07

1.1

0.46

0.94

u/ml

2.59

110

809

Type1 diabetes, definitions combined, early onset

100

1305

0.75

2.06

1.1

2.06

1.17

u/ml

0.27

725

Caries of dentine, including avohilmo

922

4285

1.10

2.05

1.1

1.16

1.04

u/ml

0.19

434

1905

Other specified disorders of muscle

169

1.73

2.05

1.0

1.1

1.27

0.96

u/ml

0.17

Bleeding

659

5144

0.90

2.04

1.1

1.18

1.00

u/ml

0.24

299

2301

Speech and linguistic disorders, excluding more controls

179

1365

1.24

2.04

1.2

1.1

1.72

1.21

u/ml

0.41

105

777

KRA_PSY_EATING, excluding more controls

175

1407

1.24

2.04

1.1

0.87

1.13

u/ml

0.49

663

Trigger finger

133

1044

1.28

2.04

1.0

1.1

0.66

0.94

u/ml

0.42

423

Mixed conductive and sensorineural hearing loss

575

1.38

2.04

1.1

1.0

0.14

1.05

u/ml

3.48

255

Disorders of vitreous body

357

2932

1.16

2.03

1.0

1.1

0.84

0.93

u/ml

0.17

151

1177

Fracture at wrist and hand level

437

3820

1.14

2.03

1.1

1.54

1.15

u/ml

0.35

217

1785

Palmar fascial fibromatosis [Dupuytren]

474

1.42

2.03

1.1

0.64

0.83

u/ml

0.18

202

Diseases of inner ear

451

3789

1.14

2.02

1.1

0.72

0.90

u/ml

0.66

202

1562

Synovial cyst of popliteal space [Baker]

351

1.49

2.02

1.1

1.0

0.31

1.26

u/ml

1.56

144

Congenital malformations of the respiratory system, including avohilmo

248

1.60

2.02

1.2

0.68

0.90

u/ml

0.20

158

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

352

1.49

2.02

1.1

0.56

1.29

u/ml

0.82

148

Atrial septal defect

606

0.65

2.02

1.0

1.2

1.35

0.98

u/ml

0.18

389

Viral pneumonia (unknown virus, not influenza)

543

1.39

2.01

1.1

1.44

1.42

u/ml

0.01

236

Mental and behavioural disorders due to sedatives or hypnotics

696

0.67

2.01

1.1

0.64

1.08

u/ml

0.50

315

Chronic iridocyclitis

390

0.56

2.01

1.1

0.29

1.33

u/ml

—

182

Disorders of vitreous body and globe

366

2996

1.16

2.01

1.0

1.1

0.83

0.93

u/ml

0.20

154

1203

Scleritis and episcleritis

535

1.39

2.01

1.1

0.56

1.24

u/ml

0.77

220

Single ventricle heart

0.00

2.01

0.0

1.2

—

2.11

—

Superficial injury of hip and thigh

127

993

1.28

2.00

1.1

0.80

1.10

u/ml

0.42

430

Disorders of lacrimal system and orbit in diseases classified elsewhere

163

1.74

2.00

1.0

1.1

0.59

1.62

u/ml

0.67

Ischemic heart diseases

665

4403

0.90

1.99

1.1

1.00

0.98

u/ml

0.03

259

1989

Pediculosis, acariasis and other infestations, including avohilmo

285

2427

1.18

1.99

1.1

1.58

1.39

u/ml

0.14

141

1146

Type 1 diabetes, wide definition, subgroup 1

221

2642

0.83

1.99

1.1

0.70

1.11

u/ml

0.89

102

1292

Cluster headache, wide

353

1.49

1.99

1.1

0.42

1.21

u/ml

0.98

144

Other/unspecified enthesopathies, not elsewhere classified

494

1.40

1.97

1.3

1.1

0.41

1.07

u/ml

1.18

207

Monoamine oxidase A inhibitors

725

1.33

1.97

1.1

1.38

1.10

u/ml

0.18

296

Peripheral arterial reconstruction

426

0.59

1.96

1.2

1.0

0.23

1.09

u/ml

2.03

178

Type 1 diabetes, definitions combined

131

1644

0.79

1.96

1.1

1.73

1.14

u/ml

0.21

868

Sequelae of cerebrovascular disease

121

1318

0.78

1.95

1.1

0.48

0.78

u/ml

0.71

551

Implicit bacterial Sepsis, including avohilmo

236

2335

0.84

1.95

1.1

1.04

0.96

u/ml

0.11

109

1045

Benign mammary dysplasia

112

866

1.30

1.94

1.1

0.51

0.85

u/ml

0.74

364

Perforation of tympanic membrane

106

814

1.31

1.94

1.1

1.04

1.29

u/ml

0.10

369

Adhesive capsulitis of shoulder

126

989

1.28

1.94

1.1

1.00

0.86

u/ml

0.13

409

Bacterial infection, other or unspecified, including avohilmo

419

3906

0.88

1.93

1.1

0.88

0.92

u/ml

0.09

193

1755

Nontoxic multinodular goitre

134

1061

1.27

1.93

1.1

0.86

u/ml

0.01

425

Heart failure and coronary heart disease

131

1159

0.79

1.92

1.0

1.1

0.99

0.97

u/ml

0.01

526

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

128

1009

1.27

1.92

1.0

1.1

0.62

1.01

u/ml

0.81

415

Hypersomnia

1.99

1.92

1.2

1.0

0.25

1.04

u/ml

—

Chronic periodontitis, complicated

370

4130

0.87

1.91

1.1

1.42

0.92

u/ml

0.56

184

1694

Acute lymphadenitis

661

1.34

1.91

1.1

2.43

1.11

u/ml

0.26

305

Benign neoplasm: Rectum, anus and anal canal

113

877

1.29

1.90

1.1

0.31

0.99

u/ml

2.32

382

Pleural plaque with presence of asbestos

106

1.89

1.90

1.0

1.1

0.49

0.97

u/ml

—

Helminthiases

121

1.85

1.90

1.2

1.1

0.60

0.70

u/ml

0.14

Demyelinating diseases of the central nervous system

932

0.72

1.90

1.1

0.18

1.05

u/ml

3.94

406

Type 1 diabetes, strict definition

118

1492

0.78

1.90

1.1

1.86

1.14

u/ml

0.25

805

Bulimia nervosa (incl. atypical)

534

1.39

1.89

1.2

1.1

0.82

1.38

u/ml

0.60

240

Oral lichen planus

121

1.84

1.89

1.0

1.1

0.22

1.87

u/ml

0.89

Other abnormal uterine and vaginal bleeding

222

1330

1.20

1.89

1.1

1.07

0.96

u/ml

0.15

574

Other disorders of cornea

644

1.34

1.88

1.1

4.81

1.24

u/ml

0.72

262

Benign neoplasm: Stomach

423

1.42

1.88

1.1

0.60

1.21

u/ml

0.88

176

Emotional disorders and disorders of social functioning with onset specific to childhood

151

1195

1.25

1.88

1.1

1.21

1.20

u/ml

0.01

663

Intentional self-harm by jumping from a high place

0.00

1.88

0.0

1.1

—

2.82

—

Cardiomyopathies, Primary/intrinsic

591

0.66

1.88

1.1

1.51

1.02

u/ml

0.24

280

Diseases caused by chlamydiae, including avohilmo

167

1.71

1.87

1.1

1.0

0.35

0.59

u/ml

—

Open wound of lower leg

167

1362

1.23

1.87

1.1

0.66

1.14

u/ml

1.06

644

Benign neoplasm: Rectum

101

775

1.31

1.86

1.1

1.0

0.29

0.89

u/ml

2.32

338

Oral lichen planus, including avohilmo , including avohilmo

416

1.43

1.86

1.1

0.71

1.19

u/ml

0.42

176

Other diseases caused by chlamydiae, including avohilmo

175

1.69

1.86

1.1

1.0

0.35

0.58

u/ml

—

Iron deficiency

468

1.41

1.86

1.1

0.68

1.09

u/ml

0.49

208

Peripheral artery operations in Hilmo

381

0.58

1.86

1.2

1.1

1.75

1.20

u/ml

0.19

156

Impacted maxillary canine

192

1.67

1.85

1.0

1.1

1.34

1.28

u/ml

0.02

111

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.22

1.85

1.0

0.17

0.15

u/ml

—

Inflammatory disorders of breast

101

778

1.31

1.84

1.1

0.73

1.00

u/ml

0.30

339

Crowding of teeth, including avohilmo

243

1703

1.19

1.84

1.2

1.1

1.17

1.36

u/ml

0.18

153

933

Autonomic disorders

175

1.68

1.84

1.1

0.56

1.63

u/ml

0.72

Malignant neoplasm of prostate

642

0.75

1.84

1.0

1.1

0.46

0.86

u/ml

0.64

262

Intracranial injury

693

5851

1.11

1.84

1.1

1.10

1.05

u/ml

0.10

346

2698

Other sexually transmitted chlamydial diseases, including avohilmo

220

1850

1.20

1.83

1.1

0.76

1.27

u/ml

1.59

123

865

Viral pneumonia (known virus, not influenza)

183

1.66

1.83

1.2

1.1

0.46

1.76

u/ml

0.98

100

Ventral hernia

184

1519

1.21

1.83

1.1

2.03

1.06

u/ml

0.44

646

Atrial septal defect, secundum type

485

0.63

1.82

1.0

1.2

1.48

1.11

u/ml

0.15

322

Separation of retinal layers (serosa)

262

1.54

1.82

1.1

1.16

1.76

u/ml

0.28

106

Diabetic nephropathy

708

0.69

1.82

1.1

2.34

1.05

u/ml

0.46

302

Basal cell carcinoma

200

1637

0.83

1.82

1.1

0.55

0.83

u/ml

1.07

660

Aplastic and other anaemias

227

2459

0.84

1.81

1.1

0.51

1.01

u/ml

2.37

110

1093

Retinal breaks without detachment

115

902

1.28

1.81

1.1

0.58

1.03

u/ml

1.07

380

Effects of air pressure and water pressure

2.42

1.81

1.0

1.1

1.03

2.90

u/ml

—

Hypogonadotropic hypogonadism

263

1.54

1.80

1.1

1.78

1.17

u/ml

0.20

122

Female infertility, tubal origin

453

1.40

1.80

1.1

0.94

1.06

u/ml

0.05

189

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

175

2116

0.82

1.80

1.1

0.79

1.28

u/ml

0.91

944

Diverticular disease of intestine

561

3124

1.12

1.80

1.1

0.53

0.91

u/ml

2.55

214

1281

Other disorders of prostate

1.97

1.80

1.1

1.0

0.19

0.94

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

411

3571

1.14

1.80

1.1

0.98

1.12

u/ml

0.24

196

1611

Malignant neoplasm of breast, HER-negative

1193

0.77

1.79

1.1

1.17

0.76

u/ml

0.34

474

Neuralgia and neuritis, unspecified

353

1.45

1.79

1.1

2.59

0.78

u/ml

0.42

148

Personality disorders, excluding more controls

372

3254

1.14

1.79

1.1

0.81

1.02

u/ml

0.51

178

1407

Haemorrhage in early pregnancy

396

3386

1.14

1.78

1.1

0.65

1.06

u/ml

1.61

145

1424

Short Achilles tendon (acquired)

169

1.67

1.78

1.0

1.1

0.41

0.84

u/ml

0.61

Pulmonary embolism

185

1532

1.21

1.78

1.1

0.79

0.99

u/ml

0.30

642

Pedestrian injured in collision with pedal cycle

216

1.59

1.78

1.1

0.56

2.03

u/ml

1.11

Non-Hodgkin lymphoma, all, including Hilmo

559

0.66

1.77

1.0

1.1

1.30

1.24

u/ml

0.02

247

Cluster headache, strict

346

1.46

1.77

1.1

0.42

1.23

u/ml

1.00

141

Alcoholic liver disease

474

0.63

1.77

1.1

0.23

1.06

u/ml

2.32

204

Whooping cough, including avohilmo

233

1.57

1.77

1.2

1.1

0.17

0.78

u/ml

3.21

105

Pneumonia due to Streptococcus pneumoniae

256

1.53

1.77

1.0

1.1

0.46

1.44

u/ml

0.74

113

Other bursitis of hip

1.91

1.76

1.1

0.12

1.05

u/ml

—

Pulmonary heart disease

185

1534

1.21

1.76

1.1

0.79

0.98

u/ml

0.30

645

Other superficial mycoses, including avohilmo

166

1365

1.22

1.75

1.1

1.73

1.05

u/ml

0.40

607

Collagenous colitis

662

1.32

1.74

1.1

0.65

1.14

u/ml

0.77

291

Ulcerative colitis (strict definition, all Crohn cases excluded)

125

1558

0.80

1.74

1.1

0.50

1.31

u/ml

3.03

702

Other epidermal thickening

306

1.48

1.74

1.1

1.38

1.30

u/ml

0.03

135

Other bursopathies

767

1.30

1.73

1.0

1.1

0.53

1.02

u/ml

0.72

315

Malignant neoplasm of corpus uteri, including Hilmo

360

0.58

1.73

1.1

0.62

0.83

u/ml

—

147

Type 1 diabetes, strict definition, subgroup 1

113

1417

0.79

1.72

1.1

0.67

1.17

u/ml

0.79

764

L02BG Aromatase inhibitors

150

1810

0.82

1.72

1.1

1.33

0.84

u/ml

0.26

713

Use of donepezil

331

0.58

1.71

1.0

0.57

1.13

u/ml

—

134

Other noninflammatory disorders of vagina

629

1.33

1.71

1.0

1.1

0.32

0.95

u/ml

1.79

265

Overexertion and strenuous or repetitive movements

113

893

1.27

1.71

1.1

0.47

1.14

u/ml

1.72

388

Other diseases of liver

177

1468

1.21

1.71

1.1

0.75

1.20

u/ml

0.87

635

Otorrhagia

0.00

1.70

0.0

1.1

—

0.70

—

LeFortI or BSSO operation

476

1.38

1.70

1.0

1.1

0.28

1.39

u/ml

1.80

193

Cardiac murmurs and other cardiac sounds

130

1033

1.25

1.70

1.1

1.16

1.48

u/ml

0.34

510

Graves ophthalmopathy

164

1.67

1.69

1.0

1.1

0.59

1.70

u/ml

0.70

Chronic viral hepatitis

598

0.68

1.68

1.1

0.36

1.01

u/ml

1.58

254

Abnormal findings on diagnostic imaging of other body structures

118

939

1.26

1.68

1.1

0.19

1.13

u/ml

3.76

398

Oligomenorrhoea

384

1.42

1.67

1.0

1.1

0.40

1.12

u/ml

1.21

170

Other protozoal intestinal diseases, including avohilmo

228

1.56

1.67

1.1

1.62

1.25

u/ml

0.18

108

Polyarteritis nodosa and related conditions

1.92

1.67

1.5

1.1

0.45

1.87

u/ml

—

Erythema nodosum

196

1.60

1.67

1.1

0.19

0.79

u/ml

2.29

Endometriosis of rectovaginal septum and vagina

554

1.34

1.67

1.1

0.39

1.01

u/ml

1.01

226

Abnormal blood-pressure reading, without diagnosis

309

1.47

1.66

1.1

2.49

1.98

u/ml

0.12

147

Other specified and unspecified disorders of eye and adnexa

236

1.54

1.66

1.1

0.50

1.02

u/ml

0.77

Panniculitis affecting regions of neck and back

236

1.54

1.66

1.1

0.62

1.61

u/ml

0.87

Other neurotic disorders

236

1.54

1.65

1.3

1.1

0.74

1.75

u/ml

0.64

Other demyelinating diseases of the central nervous system

415

0.62

1.65

1.1

0.21

1.24

u/ml

2.15

176

Infections, IBD-co-morbidities

169

980

1.22

1.65

1.1

0.59

1.26

u/ml

1.83

474

Other infective otitis externa

461

1.38

1.65

1.0

1.1

1.69

1.16

u/ml

0.16

203

Insulin, fast-acting (human)

127

1569

0.81

1.64

1.0

1.1

0.41

1.26

u/ml

3.85

721

Cluster headache, wide,, including avohilmo

556

1.34

1.64

1.1

0.44

1.05

u/ml

1.21

226

Spinal instabilities

181

1.62

1.64

1.0

0.05

1.73

u/ml

1.81

Chronic apical periodontitis

1278

7668

0.93

1.63

1.1

0.99

1.03

u/ml

0.07

585

3317

Atrial fibrillation and flutter

232

1755

0.85

1.63

1.0

1.1

0.77

1.11

u/ml

0.81

104

743

Other and unspecified cicatricial alopecia

3.69

1.63

1.0

1.1

—

1.52

—

Alzheimer’s disease, strict definition

376

0.64

1.63

1.0

0.39

1.09

u/ml

—

157

Single delivery by forceps and vacuum extractor

249

1730

0.85

1.63

1.1

0.53

0.94

u/ml

1.64

102

784

Poisoning by drugs, medicaments and biological substances

259

2999

0.86

1.63

1.1

0.86

1.16

u/ml

0.65

128

1355

Disorder of lipoprotein metabolism, unspecified

470

1.37

1.62

1.0

1.1

0.43

0.74

u/ml

0.58

216

Benign neoplasm of other and unspecified female genital organs

262

1.50

1.61

1.1

1.12

1.14

u/ml

0.01

111

Metabolic disorders

976

6321

0.92

1.61

1.1

0.99

1.01

u/ml

0.04

461

2803

Drug-induced cataract

151

1.67

1.61

1.3

1.1

1.33

1.49

u/ml

0.05

Poisoning by medicine

233

2717

0.85

1.61

1.1

0.81

1.20

u/ml

0.88

115

1218

Abnormal results of function studies

741

1.29

1.61

1.1

0.28

1.25

u/ml

2.75

337

Dermatitis herpetiformis

1.93

1.61

1.1

1.0

1.90

0.95

u/ml

—

Abnormal findings on examination of blood, without diagnosis

373

2981

1.13

1.60

1.1

0.45

1.13

u/ml

4.63

148

1362

Malignant neoplasm of pancreas, including Hilmo

263

0.53

1.60

1.0

1.1

0.25

0.99

u/ml

—

105

Benign neoplasm: Oesophagus

2.36

1.59

1.3

1.1

0.05

1.37

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

107

848

1.27

1.59

1.1

0.97

1.07

u/ml

0.07

345

Medial epicondylitis

255

1.50

1.58

1.3

1.0

0.22

0.88

u/ml

2.73

105

Acute gastritis

354

1.42

1.58

1.1

0.58

1.18

u/ml

0.79

146

Fall on and from ladder

388

1.40

1.58

1.1

1.02

1.50

u/ml

0.38

169

Major anomalies of jaw size

264

1.50

1.58

1.1

0.61

1.26

u/ml

0.51

127

Cluster headache, strict, including avohilmo

543

1.34

1.57

1.1

0.44

1.07

u/ml

1.24

222

Biomechanical lesions, not elsewhere classified

280

1.47

1.57

1.2

1.1

1.12

1.80

u/ml

0.36

115

Heart failure and antihypertensive medication

135

1075

0.81

1.57

1.0

1.1

0.91

1.10

u/ml

0.21

490

Other and unspecified injuries of lower leg

104

824

1.27

1.57

1.1

1.07

1.06

u/ml

0.01

381

Congenital malformations of the respiratory system

224

1.54

1.57

1.2

0.75

0.87

u/ml

0.09

146

Carcinoma in situ of other and unspecified digestive organs

152

1.65

1.57

1.1

0.39

1.72

u/ml

0.80

Other viral diseases, not elsewhere classified

278

2409

1.15

1.56

1.1

0.87

1.27

u/ml

0.90

136

1216

Ulcerative colitis (strict definition, require KELA)

153

1843

0.83

1.56

1.1

0.46

1.27

u/ml

3.97

843

Care involving dialysis

482

0.66

1.55

1.1

0.40

1.41

u/ml

1.36

229

Myocardial infarction

203

1672

0.85

1.55

1.1

1.21

1.02

u/ml

0.14

724

Erythema intertrigo

107

1.79

1.55

1.1

0.33

0.88

u/ml

—

Ectropion of eyelid

2.11

1.55

1.1

0.38

1.19

u/ml

—

Agranulocytosis

785

0.74

1.55

1.2

1.1

0.70

1.16

u/ml

0.57

361

Calculus of kidney and ureter

226

1935

1.17

1.54

1.1

1.58

1.03

u/ml

0.33

108

844

Decubitus ulcer and pressure area

207

0.48

1.54

1.0

1.1

0.58

2.17

u/ml

—

Hernia of abdominal wall, postoperative

159

1311

1.21

1.54

1.1

0.93

0.90

u/ml

0.02

552

Cerebral cysts

572

1.32

1.52

1.1

0.64

1.29

u/ml

0.84

263

Other congenital malformations, including avohilmo

213

1819

1.18

1.52

1.1

1.05

1.21

u/ml

0.22

118

919

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

374

3322

1.13

1.52

1.1

1.00

u/ml

0.01

166

1517

Other female pelvic inflammatory diseases

157

1305

1.21

1.52

1.1

0.84

0.81

u/ml

0.04

529

Enlarged lymph nodes

167

1396

1.20

1.52

1.1

2.09

1.08

u/ml

0.47

640

Malignant neoplasm of prostate, including Hilmo

673

0.78

1.52

1.0

1.1

0.43

0.86

u/ml

0.79

275

Other prurigo

2.19

1.51

1.2

1.0

1.13

1.20

u/ml

—

Plantar fascial fibromatosis

739

1.28

1.51

1.1

0.91

0.90

u/ml

0.00

301

Endometriosis ASRM stages 1,2

239

2062

1.16

1.50

1.1

0.82

1.04

u/ml

0.38

871

Dilated cardiomyopathy

502

0.68

1.50

1.1

1.61

1.20

u/ml

0.17

227

Pneumonia due to other infectious organisms, not elsewhere classified

162

1.62

1.50

1.2

1.1

0.85

2.09

u/ml

0.53

Campylobacter enteritis

186

1.57

1.49

1.1

1.43

1.58

u/ml

0.05

Spondylopathies

746

4047

1.09

1.49

1.1

0.86

1.04

u/ml

0.40

301

1707

Dronedarone medication

2.08

1.49

1.1

0.35

0.84

u/ml

—

Event of undetermined intent

697

1.29

1.49

1.1

0.78

1.01

u/ml

0.35

304

Pacemaker

110

1268

0.80

1.49

1.0

1.1

0.61

0.88

u/ml

0.58

565

Colorectal cancer, including Hilmo

1106

0.79

1.49

1.1

1.36

0.90

u/ml

0.46

436

Contusion of toe(s) with damage to nail

109

1.77

1.49

1.2

1.1

0.31

0.98

u/ml

—

Congenital malformations of breast, including avohilmo

260

1.49

1.1

1.09

0.74

u/ml

0.32

106

COPD, hospital admissions 3, with asthma pneumonia sepsis

108

739

1.25

1.49

1.1

1.05

1.17

u/ml

0.10

327

Cholecystitis

661

1.29

1.48

1.1

0.59

0.98

u/ml

0.48

271

Diseases of arteries, arterioles and capillaries (FINNGEN)

152

1261

0.83

1.48

1.1

0.88

1.10

u/ml

0.27

550

Major coronary heart disease event

644

4214

0.91

1.48

1.1

1.04

0.98

u/ml

0.11

249

1908

179

1513

1.19

1.47

1.1

0.90

0.95

u/ml

0.05

114

622

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

479

1.34

1.47

1.1

0.73

1.26

u/ml

0.58

201

Peroneal tendinitis

132

1.69

1.47

1.0

1.1

2.07

3.18

u/ml

0.24

Osteopathies and chondropathies

548

4547

1.10

1.47

1.1

1.14

1.13

u/ml

0.02

256

2013

Other malignant neoplasms of skin (=non-melanoma skin cancer)

219

1732

0.86

1.47

1.1

0.68

0.84

u/ml

0.36

106

699

Lichen planus

698

1.28

1.46

1.0

1.1

1.61

1.28

u/ml

0.17

296

Other congenital malformations of skin, including avohilmo

113

913

1.25

1.46

1.1

0.86

1.13

u/ml

0.34

431

Lichen planus, including avohilmo

147

1219

1.21

1.46

1.0

1.1

1.22

1.02

u/ml

0.15

504

Superficial injury of shoulder and upper arm

134

1102

1.22

1.46

1.1

0.57

1.18

u/ml

1.27

486

Other diseases of gallbladder

203

1.54

1.46

1.2

1.1

0.21

1.45

u/ml

1.16

Excessive earwax

594

4907

1.10

1.46

1.1

1.03

1.09

u/ml

0.09

251

2251

Focal epilepsy

170

2013

0.84

1.46

1.1

0.73

1.16

u/ml

0.85

997

Other/unspecified synovitis and tenosynovitis

110

886

1.25

1.45

1.0

1.1

0.34

0.96

u/ml

2.23

367

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

245

1.49

1.45

1.1

0.76

0.77

u/ml

0.01

120

Pterygium

1.89

1.45

1.0

1.1

0.80

0.92

u/ml

—

Cleft lip, lip and palate or palate

226

0.52

1.44

1.1

6.00

1.28

u/ml

—

112

Bacterial pneumonia, not elsewhere classified

334

2593

1.13

1.44

1.0

1.1

0.91

1.03

u/ml

0.18

173

1153

Lymphoid leukaemia

291

0.58

1.44

1.2

0.68

1.43

u/ml

—

167

Muscle strain

278

1.45

1.43

1.1

0.60

1.22

u/ml

0.58

125

Viral meningitis, including avohilmo

405

1.37

1.43

1.1

0.76

1.42

u/ml

0.69

181

Myopia

206

1766

1.17

1.43

1.1

0.84

1.22

u/ml

0.45

797

Procreative management

533

3988

1.10

1.42

1.1

0.76

1.05

u/ml

1.02

271

1914

severe traumatic brain injury, does not include concussion

1100

0.79

1.42

1.1

1.18

1.21

u/ml

0.02

484

Basal cell carcinoma, including Hilmo

222

1744

0.86

1.42

1.1

0.60

0.84

u/ml

0.78

101

700

Contact with machinery

693

1.27

1.41

1.1

0.97

1.23

u/ml

0.27

308

Fatigue fracture of vertebra

2.14

1.41

1.2

1.1

0.13

0.73

u/ml

—

Emotional disorders starting during childhood or adolescence

139

1144

1.22

1.41

1.2

1.1

1.26

1.48

u/ml

0.20

633

Cicatricial alopecia [scarring hair loss]

2.29

1.41

1.0

—

1.33

—

Other orthopaedic follow-up care

363

1.39

1.41

1.1

0.30

1.84

u/ml

1.86

150

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

738

0.74

1.41

1.1

0.68

0.94

u/ml

0.30

329

Diseases of pulp and periapical tissues and dental caries

712

3352

1.09

1.41

1.1

1.23

1.05

u/ml

0.26

332

1454

Other endocrine disorders

119

932

1.24

1.40

1.2

1.85

1.09

u/ml

0.30

586

Benign neoplasm of mouth and pharynx

676

1.28

1.40

1.1

1.13

1.21

u/ml

0.05

283

Extracorporeal dialysis

338

0.62

1.40

1.1

0.49

1.28

u/ml

0.81

157

Tic and related disorders

281

1.46

1.40

1.1

1.2

1.17

1.28

u/ml

0.06

176

Convergence insufficiency and excess

150

1.63

1.40

1.2

1.1

0.20

1.60

u/ml

1.24

Pulmonary heart disease, diseases of pulmonary circulation

198

1693

1.17

1.40

1.1

0.77

1.08

u/ml

0.57

730

Disorders of gallbladder, biliary tract and pancreas

931

6222

0.93

1.39

1.1

0.51

1.04

u/ml

5.84

385

2654

Later onset COPD

428

1.31

1.39

1.0

0.52

1.04

u/ml

0.90

191

Injury of muscle and tendon at ankle and foot level

214

1.51

1.39

1.1

0.77

1.64

u/ml

0.58

Benign thyroid growths and nodules

255

2065

1.15

1.39

1.1

0.80

u/ml

0.00

111

836

Alcohol abuse, main dg

126

1526

0.82

1.39

1.1

1.60

1.14

u/ml

0.26

685

Autoimmune thyroiditis

190

1.55

1.39

1.1

0.13

1.36

u/ml

1.28

Delivery, wide proxy

349

2084

0.89

1.39

1.1

1.60

1.05

u/ml

0.49

143

929

Postpartum hemorraghe, parous women as controls

416

3127

1.12

1.39

1.1

1.43

0.97

u/ml

0.39

168

1283

Disorders of oesophagus in diseases classified elsewhere

1.96

1.39

1.1

0.47

0.99

u/ml

—

Malignant neoplasm of head and neck

300

0.60

1.38

1.0

1.1

0.25

0.88

u/ml

—

118

Rash and other nonspecific skin eruption

758

1.26

1.38

1.1

0.65

1.24

u/ml

0.89

355

Other arrhythmias

742

5112

1.08

1.37

1.1

0.96

0.97

u/ml

0.01

318

2195

Other disorders of male genital organs

306

1.42

1.37

1.1

0.47

1.44

u/ml

0.99

149

Disturbances of smell and taste

248

1.46

1.36

1.0

1.1

0.29

1.46

u/ml

1.41

Alzheimer’s disease (Late onset)

307

0.64

1.36

1.0

0.14

1.13

u/ml

—

130

Malignant neoplasm of breast, ER-negative, including Hilmo

117

1332

0.82

1.36

1.1

0.92

0.76

u/ml

0.16

525

Conotruncal defects

319

0.61

1.35

1.1

1.2

1.72

1.18

u/ml

0.15

219

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

238

1846

0.87

1.35

1.1

0.76

0.82

u/ml

0.12

110

738

Psychotic depression

478

1.32

1.35

1.1

0.35

1.29

u/ml

1.85

213

Hallux rigidus

662

1.27

1.35

1.1

0.40

1.03

u/ml

1.78

284

Inflammatory disease of cervix uteri

366

1.37

1.35

1.1

0.18

0.86

u/ml

2.32

146

Lesion of ulnar nerve

128

1058

1.21

1.35

1.1

0.28

1.43

u/ml

3.64

443

Mixed specific developmental disorders

629

0.73

1.35

1.1

1.2

0.21

1.06

u/ml

3.51

432

Hyperplasia of prostate

187

894

1.18

1.34

1.1

0.78

1.05

u/ml

0.36

394

Viral meningitis

367

1.37

1.34

1.0

1.1

0.86

1.25

u/ml

0.37

158

Benign neoplasm: Bones of skull and face

2.00

1.34

1.0

4.50

1.27

u/ml

—

Corneal degeneration

1.93

1.34

1.1

1.0

0.25

1.00

u/ml

—

Spontaneous abortion

630

3871

1.09

1.34

1.1

0.66

0.91

u/ml

1.02

243

1613

Unspecified kidney failure

358

0.64

1.33

1.2

1.1

1.08

1.80

u/ml

0.54

165

Degenerative macular diseases

375

1.36

1.33

1.0

1.1

1.18

1.10

u/ml

0.05

153

Anosmia

145

1.60

1.33

1.0

1.1

0.22

0.52

u/ml

—

Habitual aborter

275

1.44

1.33

1.1

1.32

0.95

u/ml

0.24

117

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

166

1951

0.85

1.33

1.1

0.58

1.24

u/ml

2.18

890

Myocardial infarction, strict

185

1530

0.85

1.32

1.1

1.18

1.06

u/ml

0.08

667

170

1297

1.18

1.32

1.1

1.49

0.93

u/ml

0.22

546

Episcleritis

463

1.33

1.32

1.1

0.64

1.39

u/ml

0.70

192

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

152

1798

0.84

1.32

1.1

0.46

1.29

u/ml

4.04

821

Abnormalities of forces of labour

142

1190

1.20

1.31

1.1

0.54

0.82

u/ml

0.78

473

Keratoconus

201

1.51

1.31

1.1

7.73

1.65

u/ml

0.58

Non-follicular lymphoma

368

0.65

1.31

1.0

1.1

1.98

1.83

u/ml

—

168

Amblyopia ex anopsia

552

1.30

1.1

0.60

1.53

u/ml

1.59

305

Astigmatism

104

845

1.24

1.30

1.1

0.94

1.21

u/ml

0.18

471

Gastric ulcer

648

1.27

1.30

1.1

0.58

0.94

u/ml

0.45

280

Coxarthrosis [arthrosis of hip](FG)

316

2445

0.89

1.29

1.1

0.69

1.02

u/ml

0.97

129

981

Benign neoplasm of other and unspecified endocrine glands

108

882

1.23

1.29

1.0

1.1

1.43

1.01

u/ml

0.22

377

Familial hypercholesterolemia

525

1.30

1.29

1.0

1.1

0.89

1.10

u/ml

0.11

247

Other and unspecified mood [affective] disorders

119

983

1.22

1.29

1.1

1.04

1.36

u/ml

0.30

435

Phobic anxiety disorders

235

2049

1.15

1.29

1.1

0.39

1.30

u/ml

6.29

116

930

Right ventricular outflow tract obstruction

215

0.54

1.29

1.0

1.2

3.17

1.34

u/ml

—

154

Other congenital malformations of the digestive system, including avohilmo

797

1.24

1.28

1.2

2.12

1.19

u/ml

0.24

485

Diffuse brain injury

268

0.59

1.28

1.1

0.71

1.17

u/ml

—

114

Reimbursement for rheumatic diseases

496

5398

0.91

1.28

1.1

0.53

1.03

u/ml

2.61

197

2374

Misadventures to patients during surgical and medical care

122

1010

1.21

1.28

1.1

0.67

0.83

u/ml

0.28

437

Other retinal artery occlusion

2.01

1.27

1.0

1.1

0.07

1.02

u/ml

—

Melanocytic naevi of other and unspecified parts of face

527

1.30

1.27

1.2

1.1

0.75

1.24

u/ml

0.42

224

Other and unspecified follicular disorders

362

1.36

1.27

1.1

0.23

1.49

u/ml

1.87

156

Bacterial pneumoniae

358

2817

1.12

1.27

1.0

1.1

0.88

1.07

u/ml

0.36

183

1260

Benign neoplasm: Larynx

130

1.63

1.27

1.1

0.19

1.06

u/ml

—

Glomerular diseases

110

1335

0.82

1.27

1.1

1.35

1.12

u/ml

0.15

631

Fever of other and unknown origin

658

5260

1.08

1.26

1.1

0.73

1.11

u/ml

1.72

328

2379

Other benign neoplasms of skin

303

2694

1.13

1.26

1.1

0.70

1.02

u/ml

0.79

116

1163

Retention of urine

143

1372

0.84

1.26

1.2

1.1

0.87

0.89

u/ml

0.03

596

Diabetic maculopathy, excluding more controls

814

0.77

1.26

1.0

1.1

1.07

1.11

u/ml

0.02

358

Lactose intolerance

303

1.40

1.26

1.0

1.1

0.48

1.42

u/ml

1.09

155

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

796

1.24

1.25

1.1

3.00

1.07

u/ml

0.44

362

Other and unspecified injuries of ankle and foot

529

1.30

1.25

1.1

0.89

1.10

u/ml

0.16

243

Maternal care for other conditions predominantly related to pregnancy

360

3155

1.12

1.25

1.1

0.74

1.18

u/ml

1.21

156

1341

Other and unspecified myopathies

423

0.68

1.25

1.0

1.1

1.13

1.06

u/ml

0.02

185

Sequelae of injuries of lower limb

796

1.24

1.25

1.1

0.86

1.08

u/ml

0.24

329

Diseases of the digestive system

387

3465

1.11

1.24

1.1

1.20

1.07

u/ml

0.18

185

1602

Infections of breast associated with childbirth

486

1.31

1.24

1.1

0.51

1.23

u/ml

1.32

195

Leiomyoma of uterus

595

3629

0.92

1.24

1.1

0.72

0.82

u/ml

0.28

214

1453

Congenital malformations of the musculoskeletal system, not elsewhere classified

196

1.50

1.24

1.1

0.72

u/ml

0.00

103

Complications of labour and delivery

809

4177

1.08

1.24

1.1

1.13

0.89

u/ml

0.46

336

1722

Dislocation, sprain and strain of joint and ligaments of hip

179

1.52

1.24

1.2

1.1

0.68

2.49

u/ml

0.96

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

526

3620

0.91

1.24

1.1

1.01

0.97

u/ml

0.04

217

1517

Scabies, including avohilmo

248

2183

1.14

1.24

1.1

1.37

1.35

u/ml

0.01

124

1026

Contact with and exposure to communicable diseases

483

5258

0.91

1.23

1.1

0.82

1.16

u/ml

0.98

210

2496

Other disorders of breast and lactation associated with childbirth

246

1.44

1.23

1.0

1.1

1.39

0.99

u/ml

0.25

101

Syncope and collapse

417

3151

1.11

1.23

1.1

0.77

1.06

u/ml

0.92

188

1409

Other sexually transmitted chlamydial diseases

130

1090

1.20

1.23

1.1

0.63

1.13

u/ml

1.39

502

Drug-induced osteoporosis

1.99

1.23

1.2

1.1

2.36

1.05

u/ml

—

Vascular disorders of the intestines

171

1.52

1.23

1.1

0.34

1.54

u/ml

0.92

Congenital malformations of breast

238

1.45

1.22

1.1

1.33

0.81

u/ml

0.44

Crohn disease (strict definition, all UC cases excluded)

575

1.28

1.22

1.0

1.1

3.91

1.22

u/ml

0.45

252

Meralgia paraesthetica

229

1.45

1.22

1.1

0.77

1.79

u/ml

0.74

Other bacterial intestinal infections

141

1189

1.19

1.22

1.1

0.57

0.81

u/ml

0.56

523

Osteoporosis

139

1074

1.19

1.22

1.1

1.86

1.09

u/ml

0.36

474

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

209

1810

1.15

1.22

1.1

0.70

1.34

u/ml

2.06

114

970

Special screening examination for neoplasms

330

1.37

1.22

1.1

1.0

0.42

1.03

u/ml

0.63

110

Myocarditis

382

1.34

1.22

1.1

1.28

1.16

u/ml

0.09

172

Cardiac arrest

245

0.62

1.20

1.0

1.1

1.03

1.25

u/ml

—

105

Spinal stenosis

295

1932

1.13

1.20

1.1

0.67

1.07

u/ml

0.95

124

762

Tic and related disorders

290

1.41

1.20

1.1

1.2

1.17

0.92

u/ml

0.14

179

Sequelae of injuries, of poisoning and of other consequences of external causes

245

2160

1.14

1.19

1.1

0.87

1.07

u/ml

0.37

121

948

Other and unspecified iridocyclitis

375

1.34

1.19

1.1

2.67

1.61

u/ml

0.27

175

Hypertensive diseases

874

5271

0.93

1.19

1.1

1.28

1.01

u/ml

0.42

389

2300

Tooth agenesis EXCLUDE clefts and syndromes

802

1.23

1.19

1.1

0.59

1.54

u/ml

1.85

427

699

0.76

1.19

1.1

1.2

0.39

1.30

u/ml

2.86

476

Delayed milestone in childhood

606

0.75

1.19

1.1

1.2

2.15

1.03

u/ml

0.35

448

Superficial injury of thorax

144

1221

1.18

1.1

1.59

1.12

u/ml

0.23

540

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

445

1.32

1.18

1.2

2.61

1.08

u/ml

0.29

296

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

498

1.29

1.18

1.1

0.83

1.37

u/ml

0.58

214

Pregnancy, childbirth and the puerperium

314

1834

0.89

1.18

1.1

1.67

1.00

u/ml

0.61

128

833

Supernumerary ureter

0.00

1.18

0.0

1.1

—

0.43

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

402

1.33

1.18

1.0

1.1

0.62

1.12

u/ml

0.40

173

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

166

1.54

1.18

1.0

1.2

3.45

0.89

u/ml

0.38

103

Focal epilepsy, strict definition

149

1745

0.85

1.18

1.1

0.75

1.12

u/ml

0.57

870

Heterophoria

115

957

1.21

1.18

1.1

0.84

0.97

u/ml

0.10

481

Benign neoplasm: Parotid gland

393

1.33

1.17

1.1

0.15

1.43

u/ml

2.19

170

Other disorders starting during childhood or adolescence

148

1249

1.18

1.17

1.1

1.2

2.63

1.15

u/ml

0.66

732

Macular cyst

1.71

1.17

1.0

1.1

0.34

2.10

u/ml

—

Congenital nasolacrimal duct obstruction or stenosis

103

1.72

1.17

1.0

1.2

1.05

0.45

u/ml

0.30

Family history of malignant neoplasm

1190

0.82

1.16

1.1

0.20

1.17

u/ml

5.09

498

Coronary revascularization (ANGIO or CABG)

617

4053

0.92

1.16

1.1

1.06

0.98

u/ml

0.15

233

1827

Obstructed labour due to maternal pelvic abnormality

135

1141

1.19

1.16

1.1

2.30

0.74

u/ml

0.91

443

Other papulosquamous disorders

1.83

1.16

1.3

1.1

0.55

1.81

u/ml

—

Localized skin eruption due to drugs and medicaments

1.83

1.16

1.1

0.86

1.06

u/ml

—

Chronic ulcer of skin, not elsewhere classified

297

0.64

1.16

1.1

0.90

1.79

u/ml

0.51

122

conjunctival haemorrhage

325

1.36

1.16

1.0

1.1

3.87

1.49

u/ml

0.29

137

Graves ophthalmopathy, strict

150

1.55

1.15

1.0

0.63

1.96

u/ml

0.74

Diplopia

107

886

1.21

1.15

1.1

1.00

1.06

u/ml

0.04

376

Burn and corrosion confined to eye and adnexa

191

1.48

1.15

1.1

0.70

0.97

u/ml

0.29

Ovarian hyperstimulation (induction)

267

1.41

1.15

1.0

1.1

1.01

0.75

u/ml

0.12

107

Melanoma in situ

158

1.53

1.15

1.0

0.59

1.80

u/ml

0.72

Benign neoplasm of bone and articular cartilage

769

1.23

1.14

1.0

1.1

1.70

1.15

u/ml

0.29

339

Acquired absence of limb

0.00

1.14

0.0

1.0

—

1.21

—

Malignant neoplasm of corpus uteri

308

0.65

1.14

1.2

1.1

0.62

0.69

u/ml

—

128

Benign intracranial hypertension

151

1.55

1.14

1.1

0.91

0.76

u/ml

—

Postpartum haemorrhage due to anatomy

187

1627

1.16

1.14

1.1

2.42

1.00

u/ml

0.61

683

Anogenital herpesviral [herpes simplex] infection

103

852

1.22

1.14

1.1

1.00

0.93

u/ml

0.06

377

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

149

1250

1.18

1.13

1.1

2.63

1.19

u/ml

0.64

703

Other hearing loss

149

1232

1.17

1.13

1.1

0.69

0.96

u/ml

0.39

529

Follicular cysts of skin and subcutaneous tissue

176

1524

1.16

1.13

1.1

0.96

1.22

u/ml

0.25

663

Colorectal adenocarcinoma

757

0.78

1.13

1.1

0.90

0.86

u/ml

0.04

307

Fall on same level

1589

8063

1.05

1.12

1.1

1.03

1.05

u/ml

0.04

766

3627

Sequelae with surgical and medical care as external cause

154

1320

1.17

1.12

1.0

1.1

0.45

1.00

u/ml

2.02

572

Malignant neoplasm of urinary organs, including Hilmo

425

0.70

1.12

1.1

0.55

1.06

u/ml

0.62

185

Androgenic alopecia

1.81

1.12

1.0

2.09

1.22

u/ml

—

Abnormal findings on diagnostic imaging of central nervous system

423

1.31

1.12

1.0

1.1

1.71

1.30

u/ml

0.16

188

Percutaneous Coronary Intervention

617

4050

0.92

1.12

1.1

1.06

0.98

u/ml

0.14

233

1826

Emergency coronary revascularization (for ACS)

637

4146

0.93

1.12

1.1

1.05

0.97

u/ml

0.16

235

1872

Infectious mononucleosis

165

1425

1.16

1.12

1.1

1.13

1.36

u/ml

0.27

670

Infectious mononucleosis, including avohilmo

165

1425

1.16

1.12

1.1

1.13

1.36

u/ml

0.27

670

Colorectal neuroendocrine tumor and carcinoma

1.80

1.11

1.0

3.28

0.93

u/ml

—

Other abnormal immunological findings in serum

201

1.46

1.11

1.1

0.31

0.77

u/ml

0.89

Maternal care for other known or suspected fetal problems

402

2768

0.91

1.11

1.1

0.68

0.92

u/ml

0.80

162

1189

Hypertension

875

5259

0.94

1.10

1.1

1.28

1.01

u/ml

0.42

389

2295

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

354

1.33

1.10

1.0

1.1

0.47

1.46

u/ml

1.55

147

Female infertility, associated with anovulation

141

1204

1.18

1.10

1.0

1.1

1.01

1.24

u/ml

0.20

539

Convergent concomitant strabismus

740

0.78

1.10

1.0

1.1

2.67

1.17

u/ml

0.34

361

Thyroiditis, unspecified

112

1.63

1.10

1.1

0.22

2.05

u/ml

—

Other protozoal intestinal diseases

136

1.56

1.10

1.0

1.1

1.52

1.44

u/ml

0.03

Pedestrian injured in other and unspecified transport accidents

1.84

1.10

1.3

1.1

0.05

2.43

u/ml

—

Puerperal sepsis

118

992

1.19

1.09

1.1

0.93

0.97

u/ml

0.04

411

Urolithiasis

232

2052

1.13

1.09

1.1

1.56

1.01

u/ml

0.33

110

891

Sarcoidosis

111

928

1.20

1.09

1.1

1.97

1.06

u/ml

0.24

380

Intestinal malabsorption

355

1.33

1.09

1.1

2.32

1.59

u/ml

0.27

168

Parkinson's disease, including avohilmo

434

0.71

1.09

1.0

1.1

0.55

0.97

u/ml

0.46

184

Intestinal adhesions without obstruction

372

1.32

1.09

1.0

1.1

5.68

1.08

u/ml

0.52

171

Heart failure and bmi 25plus

129

1015

0.85

1.09

1.0

1.07

0.97

u/ml

0.09

420

Car occupant injured in other and unspecified transport accidents

248

2205

1.13

1.09

1.1

2.02

1.36

u/ml

0.34

985

Mucosal proctocolitis

116

1375

0.84

1.08

1.1

0.53

1.23

u/ml

2.24

607

Benign neoplasm: Cerebral meninges

443

1.29

1.08

1.1

0.72

1.12

u/ml

0.36

186

Burns and corrosions confined to eye and internal organs

219

1.43

1.08

1.1

0.62

1.41

u/ml

0.64

Persons encountering health services for specific procedures, not carried out

103

857

1.21

1.08

1.1

0.30

1.05

u/ml

2.74

353

Viral infections of the central nervous system, including avohilmo

703

1.23

1.07

1.1

0.66

1.27

u/ml

1.06

317

Non-ischemic cardiomyopathy

116

1092

0.84

1.07

1.0

1.1

0.51

0.99

u/ml

1.40

506

Dislocation, sprain and strain of joints and ligaments of thorax

270

1.38

1.07

1.1

0.88

0.90

u/ml

0.02

114

Hydronephrosis

682

0.77

1.07

1.0

1.1

0.41

1.17

u/ml

1.76

299

IgA nephropathy (IgA glomerulonephritis)

153

1.52

1.07

1.1

0.52

1.45

u/ml

0.48

Exophthalmic conditions

1.95

1.07

1.0

0.26

1.18

u/ml

—

Cerebral palsy

265

0.63

1.07

1.2

0.30

1.41

u/ml

—

156

Abnormal serum enzyme levels

178

1495

1.15

1.06

1.1

0.47

1.03

u/ml

1.72

673

Other articular cartilage disorders

105

1.63

1.06

1.2

1.1

0.39

1.91

u/ml

—

Other specified/unspecified systemic involvement of connective tissue

418

1.30

1.06

1.1

0.71

1.16

u/ml

0.33

172

Other noninflammatory disorders of uterus, except cervix

136

771

1.18

1.06

1.1

0.35

0.86

u/ml

1.30

305

Sequelae of injuries of upper limb

822

1.21

1.06

1.1

0.47

1.14

u/ml

1.65

352

Crohn's disease of large intestine

534

1.26

1.05

1.1

3.32

1.10

u/ml

0.35

242

Congenital malformations of great arteries

520

0.74

1.05

1.0

1.2

1.46

1.10

u/ml

0.25

364

Acne vulgaris

179

1561

1.15

1.05

1.1

1.01

1.59

u/ml

0.93

101

763

Status post-ami

594

0.79

1.05

1.0

0.49

0.98

u/ml

0.55

255

Speech and linguistic disorders

197

1660

1.14

1.05

1.2

1.1

1.56

1.23

u/ml

0.27

117

946

Viral warts

126

1071

1.18

1.05

1.1

1.12

1.16

u/ml

0.03

503

Trigeminal neuralgia

410

1.30

1.05

1.1

1.01

1.29

u/ml

0.18

167

Entropion and trichiasis of eyelid

203

1.43

1.05

1.0

0.21

1.38

u/ml

1.29

Erectile dysfunction

241

0.62

1.05

1.0

1.1

0.39

1.22

u/ml

—

116

Drug-induced neutropenia

395

0.71

1.05

1.1

0.90

1.52

u/ml

0.40

167

Other congenital malformations

149

1284

1.17

1.04

1.1

1.16

1.10

u/ml

0.06

682

Early syphilis, including avohilmo

1.65

1.04

1.1

1.0

6.13

0.64

u/ml

—

Spermatocele

254

1.38

1.04

1.1

1.0

1.01

0.80

u/ml

0.15

111

Retinal haemorrhage

1.68

1.04

1.1

0.46

0.65

u/ml

—

262

1.37

1.04

1.1

1.46

1.58

u/ml

0.04

104

Focal epilepsy, mode (most common among epilepsy diagnosis)

146

1691

0.86

1.04

1.1

0.76

1.05

u/ml

0.42

825

Lung cancer and mesothelioma

310

1.31

1.03

1.0

0.33

1.64

u/ml

1.15

108

Bitten or struck by other mammals

162

1407

1.16

1.03

1.1

1.79

1.33

u/ml

0.20

615

Corneal ulcer

205

1809

1.14

1.03

1.1

1.71

1.11

u/ml

0.49

793

Parkinson's disease

417

0.72

1.03

1.0

1.1

0.55

1.00

u/ml

0.48

176

Benign neoplasm of major salivary glands

482

1.27

1.02

1.1

0.16

1.27

u/ml

2.48

213

Malignant neoplasm of ovary, including Hilmo

323

0.68

1.02

1.0

1.1

0.34

0.92

u/ml

—

135

Cellulitis

239

2130

1.12

1.02

1.1

1.31

1.13

u/ml

0.14

115

979

5-aminosalicylic acid

232

2064

1.13

1.02

1.1

0.87

1.06

u/ml

0.32

871

Hypertrichosis

299

1.35

1.02

1.0

1.1

1.35

0.70

u/ml

0.21

123

Other specified/unspecified disorders of bone/cartilage

163

1.48

1.02

1.1

1.12

0.86

u/ml

—

Hirsprung

0.00

1.02

0.0

1.1

—

0.73

—

Alcohol abuse, main dg, excluding more controls

126

1474

0.85

1.02

1.1

1.60

1.06

u/ml

0.32

664

Congenital ichthyosis

2.06

1.02

1.3

1.0

3.26

0.75

u/ml

—

Glucosamine medication

201

1412

1.14

1.01

1.1

0.40

0.81

u/ml

1.16

577

Anomalies of pupillary function

197

1.44

1.01

1.1

0.72

1.51

u/ml

—

Contact with other hot fluids

343

1.32

1.01

1.1

1.29

1.02

u/ml

0.20

169

Benign neoplasm: Spinal meninges

2.02

1.00

1.0

1.1

—

2.08

—

Benign neoplasm: Vulva

115

1.58

1.00

1.1

1.22

0.80

u/ml

—

Congenital malformations of the nervous system

378

0.71

1.00

1.1

1.2

0.84

1.03

u/ml

0.15

223

Bacterial intestinal infections, IBD co-morbidities

139

1196

1.16

1.00

1.1

0.61

0.93

u/ml

0.78

520

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

368

0.70

1.00

1.1

1.41

0.74

u/ml

0.58

145

Other disorders of veins

365

3277

1.10

1.00

1.1

0.84

0.91

u/ml

0.08

164

1310

Colorectal cancer

965

0.82

1.00

1.1

1.20

0.94

u/ml

0.22

379

Spina bifida

0.00

1.00

0.0

1.1

—

0.16

—

Noonan syndrome

0.00

0.99

0.0

1.0

—

2.77

—

Caries of dentine

211

1802

1.13

0.99

1.1

0.78

1.24

u/ml

1.04

120

784

Maternal care for known or suspected abnormality of pelvic organs

439

2723

1.09

0.99

1.1

1.08

0.99

u/ml

0.13

192

1160

Chromosomal abnormalities, not elsewhere classified

456

0.73

0.99

1.1

1.2

4.27

1.03

u/ml

0.90

294

Disorders of continuity of bone

111

939

1.19

0.99

1.1

1.06

1.13

u/ml

0.04

406

Foreign object accidentally left in body during surgical and medical care

0.00

0.99

0.0

1.0

—

1.16

—

Other specified/unspecified dorsopathies

206

1.42

0.99

1.2

1.1

1.10

1.67

u/ml

0.27

Injury of nerves and spinal cord at thorax level

2.20

0.98

1.0

0.88

0.23

u/ml

—

Malignant neoplasm of head and neck, including Hilmo

390

0.72

0.98

1.1

0.26

0.90

u/ml

—

155

Crohn's disease of small intestine

766

1.21

0.98

1.1

3.14

1.12

u/ml

0.42

334

Ulcer of oesophagus

223

1.39

0.98

1.2

1.1

0.73

0.97

u/ml

0.26

Use of levodopa decarboxylase inhibitor

355

0.70

0.98

1.0

1.1

0.63

1.03

u/ml

—

152

Acute epiglottitis

1.65

0.98

1.1

1.0

0.13

1.13

u/ml

—

Ulcer of lower limb, not elsewhere classified

583

0.77

0.97

1.1

1.29

1.28

u/ml

0.01

248

Ménière disease

459

1.27

0.97

1.0

1.1

0.77

1.14

u/ml

0.43

190

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.97

0.0

1.1

—

1.17

—

Neuromuscular dysfunction of bladder

522

1.25

0.97

1.1

1.0

0.77

0.78

u/ml

0.00

227

Other hammer toe(s) (acquired)

671

1.21

0.97

1.1

1.58

1.02

u/ml

0.20

274

Use of other anti-dementia drugs

397

0.75

0.97

1.0

0.56

0.99

u/ml

—

172

Use of memantine

397

0.75

0.97

1.0

0.56

0.99

u/ml

—

172

Oesophageal obstruction

108

1.58

0.96

1.2

1.1

0.73

0.90

u/ml

0.14

Symptoms and signs involving emotional state

337

1.32

0.96

1.3

1.1

1.33

1.40

u/ml

0.03

156

Venous complications and haemorrhoids in the puerperium

1.71

0.96

1.1

2.65

0.95

u/ml

—

Malignant melanoma of skin, including Hilmo

693

0.79

0.96

1.1

0.38

0.75

u/ml

1.01

274

Barrett oesophagus

182

1.43

0.96

1.0

0.25

1.10

u/ml

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.71

0.96

1.2

1.0

0.38

2.26

u/ml

—

Benign neoplasm: Caecum

407

1.28

0.96

1.0

1.1

0.50

1.10

u/ml

1.03

168

Other disorders of electrolyte and fluid balance, not elsewhere classified

0.00

0.95

0.0

1.1

—

1.11

—

DVT of lower extremities and pulmonary embolism

261

2338

1.11

0.95

1.0

1.1

0.72

0.99

u/ml

0.64

109

990

Rare circulating lymphoid malignancy, including Hilmo

222

0.63

0.95

1.1

1.2

0.07

1.58

u/ml

—

138

Complications of surgical and medical care, not elsewhere classified

1146

7263

1.05

0.95

1.1

0.88

1.04

u/ml

0.50

505

3138

Eustachian salpingitis and obstruction

124

1064

1.17

0.95

1.0

1.1

0.74

1.19

u/ml

0.68

493

Superficial injury of forearm

136

1175

1.16

0.95

1.1

0.63

1.24

u/ml

1.35

556

Fentanyl

375

0.72

0.95

1.1

1.0

0.49

0.75

u/ml

0.27

162

Mumps

166

1.46

0.95

1.1

1.43

0.99

u/ml

—

Scleritis

1.63

0.94

1.0

1.86

2.24

u/ml

—

Congenital malformations of pulmonary and tricuspid valves

195

0.60

0.94

1.0

1.2

3.17

1.30

u/ml

—

138

Bilateral sagittal split ramus osteotomy operation

391

1.29

0.94

1.0

1.1

0.34

1.61

u/ml

1.58

158

Calcific aortic valvular stenosis, diagnosis (helper)

783

1.19

0.94

1.0

1.1

0.65

1.13

u/ml

0.80

353

Operations 2 for CAVS

783

1.19

0.94

1.0

1.1

0.65

1.13

u/ml

0.80

353

Dialysis

293

0.68

0.94

1.2

1.1

0.09

1.52

u/ml

—

157

Valvular operations

702

0.80

0.94

1.1

0.56

1.11

u/ml

0.74

360

Right bundle-branch block

125

1.53

0.94

1.1

0.26

2.11

u/ml

—

Short stature, not elsewhere classified

683

1.21

0.94

1.1

1.2

1.89

1.11

u/ml

0.25

473

Other and/or unspecified nontoxic goitre

471

1.26

0.93

1.1

0.92

0.99

u/ml

0.05

194

Congenital malformations of eyelid, lacrimal apparatus and orbit

176

1.45

0.93

1.1

1.2

0.94

1.03

u/ml

0.04

105

Left bundle-branch block

277

1.34

0.93

1.1

0.63

1.18

u/ml

0.43

117

789

0.81

0.93

1.1

1.2

0.39

1.27

u/ml

3.19

535

Superficial injury of ankle and foot

197

1749

1.13

0.93

1.1

1.10

1.34

u/ml

0.20

100

839

Retinal detachment with retinal break

570

1.23

0.93

1.1

3.02

1.07

u/ml

0.34

242

Crohn disease (strict definition, require KELA, min 2 HDR)

753

1.20

0.93

1.1

3.12

1.11

u/ml

0.41

337

Juvenile arthritis (FINNGEN)

754

0.80

0.93

1.1

0.17

1.30

u/ml

5.03

379

Other disorders of pigmentation

295

1.33

0.93

1.3

1.1

0.37

2.08

u/ml

1.74

129

Hypoplasia of dental enamel

377

0.71

0.93

1.2

1.3

0.07

1.16

u/ml

3.73

296

Schistosomiasis [bilharziasis], including avohilmo

2.20

0.93

1.2

1.0

1.19

0.65

u/ml

—

Other and unspecified mononeuropathies, also in other diseases

142

1.49

0.92

1.1

1.0

0.32

1.99

u/ml

—

Thrombocytopenia, unspecified

476

0.75

0.92

1.1

0.81

1.44

u/ml

0.56

228

Alcohol-induced chronic pancreatitis

350

0.71

0.92

1.0

1.1

0.36

1.21

u/ml

1.22

146

Crohn disease (strict definition, require KELA)

763

1.20

0.92

1.1

3.12

1.10

u/ml

0.41

340

Other meningitis

126

1.52

0.92

1.0

3.05

0.77

u/ml

—

Fasciculation

1.65

0.92

1.1

0.70

0.76

u/ml

—

Benign neoplasm: Long bones of lower limb

296

1.33

0.91

1.0

1.1

0.81

1.59

u/ml

0.53

136

Other keratitis

129

1114

1.16

0.91

1.1

3.61

1.07

u/ml

1.02

477

Disorders of lipoprotein metabolism and other lipidaemias

681

4411

0.94

0.91

1.1

0.98

u/ml

0.01

323

1860

Abscess of external ear

1.61

0.91

1.0

1.1

2.56

2.30

u/ml

—

Dental caries

241

2043

1.11

0.91

1.2

1.1

0.86

1.19

u/ml

0.66

141

876

Radial styloid tenosynovitis [de Quervain]

527

1.24

0.91

1.1

0.32

0.96

u/ml

1.45

222

Benign neoplasm: salivary glands, exclude unknown (D119)

446

1.26

0.91

1.1

0.18

1.37

u/ml

2.43

195

Nontoxic single thyroid nodule

482

1.25

0.91

1.0

1.1

0.98

0.99

u/ml

0.01

206

Certain zoonotic bacterial diseases, including avohilmo

176

1.43

0.91

1.2

1.1

1.47

0.82

u/ml

0.22

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

278

0.68

0.91

1.0

1.1

0.65

0.89

u/ml

—

116

Tic disorders

289

1.34

0.91

1.1

1.2

1.21

0.95

u/ml

0.15

175

Struck by thrown, projected or falling objec

528

1.24

0.90

1.2

1.1

0.64

1.14

u/ml

0.50

239

Benign neoplasm: Scapula and long bones of upper limb

1.71

0.89

1.1

1.0

1.26

3.83

u/ml

—

Combinations of oral blood glucose lowering drugs

129

1488

0.87

0.89

1.0

1.1

1.01

1.10

u/ml

0.05

639

Calcific aortic valvular stenosis, including rheumatic fever

787

1.19

0.89

1.0

1.1

0.65

1.13

u/ml

0.79

354

Seronegative juvenile rheumatoid arthritis

300

0.69

0.89

1.0

1.1

0.16

1.40

u/ml

—

152

Generalized epilepsy, strict definition

307

1.32

0.88

1.1

0.24

1.47

u/ml

1.93

162

Juvenile osteochondrosis

431

1.26

0.88

1.1

0.63

1.12

u/ml

0.63

202

Malignant neoplasm of rectum

370

0.73

0.88

1.1

1.62

0.74

u/ml

0.71

147

Benign neoplasm of meninges

502

1.24

0.88

1.0

1.1

0.72

1.07

u/ml

0.33

210

Thyrotoxicosis

237

2135

1.11

0.88

1.1

0.59

0.92

u/ml

1.18

102

898

Chronic mastoiditis

1.59

0.87

1.0

1.1

0.47

0.92

u/ml

—

Non-small cell lung cancer

262

0.68

0.87

1.1

1.0

0.70

0.92

u/ml

—

104

Malignant neoplasm of urinary organs

358

0.72

0.87

1.1

0.63

0.77

u/ml

—

154

Cysts of oral region, not elsewhere classified

449

1.25

0.87

1.1

0.97

1.45

u/ml

0.29

202

Periapical abscess

435

4691

0.93

0.87

1.1

0.85

1.04

u/ml

0.47

213

2076

Thyrotoxicosis, other and/or unspecified

200

1786

1.12

0.87

1.1

0.48

0.90

u/ml

2.12

762

Carcinoma in situ of skin of other and unspecified parts of face

144

1.46

0.87

1.0

0.70

0.89

u/ml

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

684

3767

1.07

0.87

1.1

1.01

0.98

u/ml

0.03

274

1568

Other salmonella infections, including avohilmo

325

1.30

0.87

1.1

0.52

1.48

u/ml

0.91

137

Unstable angina pectoris

119

1083

0.86

0.87

1.1

1.0

0.93

0.88

u/ml

0.07

468

Other disorders of bone density and structure

216

0.64

0.86

1.1

0.96

2.15

u/ml

—

Sulfasalazine

253

2290

1.11

0.86

1.1

0.59

1.04

u/ml

0.90

914

Symptoms and signs involving the nervous and musculoskeletal systems

595

5577

1.07

0.86

1.1

0.58

1.00

u/ml

3.12

270

2533

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

120

1.51

0.86

1.1

0.89

2.07

u/ml

0.49

Atrial fibrillation and flutter with reimbursement

152

1091

0.88

0.85

1.1

0.92

1.22

u/ml

0.42

462

Early syphilis

1.64

0.85

1.2

1.0

8.24

0.70

u/ml

—

Lesion of plantar nerve

317

1.30

0.85

1.1

1.0

0.18

1.37

u/ml

1.98

128

Nonspecific lymphadenitis

523

1.23

0.85

1.1

1.00

1.12

u/ml

0.07

206

Dystonia

406

1.26

0.85

1.1

0.57

1.47

u/ml

1.10

180

Other congenital malformations of ear

231

1.36

0.85

1.1

1.38

0.61

u/ml

0.72

119

Other anaemias

218

2267

0.90

0.85

1.1

0.53

0.87

u/ml

1.57

106

1005

Diabetic retinopathy, excluding more controls

144

921

0.87

0.85

1.1

1.93

0.75

u/ml

0.45

374

Other and unspecified mononeuropathies of lower limb

162

1.43

0.84

1.0

0.14

1.85

u/ml

—

Hyperlipidaemia, other/unspecified

217

1751

1.11

0.84

1.1

0.61

0.98

u/ml

0.73

748

Disorders of psychological development

260

2189

1.11

0.84

1.1

1.33

u/ml

0.00

143

1222

Infective bursitis

137

1.47

0.84

1.0

1.1

1.91

0.99

u/ml

—

Arteriovenous malformation of cerebral vessels

1.77

0.84

1.0

1.1

2.92

0.92

u/ml

—

Other complications of labour and delivery, not elsewhere classified

199

1966

0.89

0.84

1.0

1.1

1.27

1.02

u/ml

0.17

837

Single delivery by caesarean section

303

1892

0.91

0.84

1.1

0.65

0.99

u/ml

1.01

122

842

Malignant melanoma, including Hilmo

855

0.83

0.84

1.1

0.43

0.88

u/ml

1.04

340

Glomerulonephritis

745

0.82

0.84

1.1

0.94

1.25

u/ml

0.24

361

Other osteochondrodysplasias, including avohilmo

121

1.51

0.84

1.1

1.2

0.45

0.71

u/ml

—

Hyperhidrosis

336

1.29

0.84

1.1

0.22

1.31

u/ml

1.83

138

Myocardial infarction, unclassifiable

459

0.78

0.84

1.0

1.1

1.77

1.11

u/ml

0.27

198

Contact with heat and hot substances

579

1.22

0.83

1.1

1.13

1.04

u/ml

0.07

286

Sudden idiopathic hearing loss

542

1.22

0.83

1.1

1.32

1.36

u/ml

0.02

223

Calcific aortic valvular stenosis

794

1.18

0.83

1.0

1.1

0.65

1.14

u/ml

0.82

359

Calcific aortic valvular stenosis, operated

794

1.18

0.83

1.0

1.1

0.65

1.14

u/ml

0.82

359

Mumps, including avohilmo

171

1.41

0.83

1.1

1.43

0.95

u/ml

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

390

1.27

0.83

1.1

0.46

1.29

u/ml

1.23

194

Other/unspecified rheumatoid arthritis

568

0.79

0.83

1.1

0.26

1.09

u/ml

2.26

231

Venous thromboembolism

375

3333

1.08

0.83

1.1

0.87

0.89

u/ml

0.03

167

1391

Shigellosis, including avohilmo

1.67

0.83

1.0

1.1

0.28

0.58

u/ml

—

Malignant neoplasm of bladder

129

1.47

0.83

1.2

1.1

0.81

0.96

u/ml

—

Prolonged pregnancy

250

2348

0.91

0.82

1.1

0.95

1.00

u/ml

0.07

106

1031

Early lumbar disc prolapse operation

162

1436

1.13

0.82

1.1

0.81

1.04

u/ml

0.32

607

Fall involving playground equipment

199

1.39

0.82

1.4

1.2

0.86

1.51

u/ml

0.41

148

Rheumatic fever incl heart disease

105

1.53

0.82

1.1

0.35

0.78

u/ml

—

Malignant neoplasm of colon, including Hilmo

707

0.82

0.81

1.1

1.0

1.10

0.71

u/ml

0.26

284

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

267

1.32

0.81

1.1

0.47

1.10

u/ml

0.71

132

Other disorders of the musculoskeletal system and connective tissue

107

921

1.16

0.81

1.1

0.87

1.03

u/ml

0.17

386

Congenital malformations and deformations of the musculoskeletal system

169

1495

1.13

0.81

1.1

0.70

1.24

u/ml

1.49

821

Transient ischemic attack

236

2075

0.90

0.81

1.1

0.57

0.99

u/ml

1.11

107

861

Alport

0.00

0.80

0.0

1.2

—

0.17

—

Cerebral oedema

0.00

0.80

0.0

1.0

—

5.80

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

352

0.74

0.80

1.1

1.41

0.76

u/ml

0.55

140

Other leukaemias of specified cell type

0.00

0.80

0.0

1.1

—

0.75

—

Vitamin deficiency

347

1.27

0.80

1.1

1.82

1.60

u/ml

0.07

160

Vitamin deficiency, wide

347

1.27

0.80

1.1

1.82

1.60

u/ml

0.07

160

Diabetic retinopathy

160

1121

0.88

0.80

1.1

1.79

0.81

u/ml

0.40

452

Neuromyelitis optica

0.00

0.80

0.0

1.0

—

0.70

—

Presbyopia

600

1.20

0.80

1.1

1.44

1.07

u/ml

0.15

233

Restrictive cardiomyopathy

0.00

0.80

0.0

1.1

—

0.61

—

Macular pucker

482

1.23

0.79

1.0

1.1

0.55

0.98

u/ml

0.56

199

Malignant neoplasm of gum, including Hilmo

0.00

0.78

0.0

1.0

—

1.49

—

Malignant neoplasm of kidney, except renal pelvis

339

0.74

0.78

1.1

0.63

0.79

u/ml

—

147

Labyrinthitis

0.00

0.78

0.0

1.0

—

0.80

—

Other and unspecified anaemias

217

2251

0.90

0.78

1.1

0.53

0.87

u/ml

1.57

106

1000

Pilonidal cyst

1105

0.86

0.78

1.1

0.54

0.94

u/ml

1.21

474

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

581

0.80

0.78

1.1

1.2

2.31

1.20

u/ml

0.50

346

Caught, crushed, jammed or pinched in or between objects

575

1.21

0.78

1.1

1.86

1.26

u/ml

0.38

260

Other symptoms and signs involving the nervous and musculoskeletal systems

442

4121

1.07

0.78

1.1

0.52

1.08

u/ml

3.35

189

1859

Hypoplasia of dental enamel, prenatal , including avohilmo

195

0.64

0.78

1.2

1.3

0.52

0.97

u/ml

0.48

146

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.78

0.0

1.0

—

1.72

—

Statin medication

912

4882

1.05

0.78

1.1

0.85

0.97

u/ml

0.28

408

2131

Other and unspecified diseases of blood and blood-forming organs

123

1.47

0.78

1.1

1.0

0.11

2.01

u/ml

0.91

Papulosquamous disorders

354

3274

1.08

0.77

1.1

0.75

1.02

u/ml

0.62

164

1407

Periodontal disease, other/unspecified

191

1.37

0.77

1.0

1.1

0.22

1.41

u/ml

1.08

Intracerebral haemorrhage

406

0.76

0.77

1.1

0.29

1.38

u/ml

1.79

175

Maternal care for known or suspected disproportion

521

1.22

0.77

1.0

1.1

1.17

0.81

u/ml

0.40

209

Non-small cell lung cancer, including Hilmo

423

0.78

0.77

1.0

1.1

0.34

0.72

u/ml

0.87

173

Constipation

954

6157

1.05

0.77

1.1

0.93

1.01

u/ml

0.12

414

2820

Atrophic disorders of skin

146

1292

1.13

0.77

1.1

0.73

1.14

u/ml

0.65

553

Blindness or visual impairment, binocular

0.00

0.76

0.0

1.0

—

0.57

—

Viral conjunctivitis, including avohilmo

458

1.23

0.76

1.1

0.95

1.20

u/ml

0.21

208

Unattended death

0.00

0.76

0.0

1.1

—

0.64

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.76

0.0

1.0

—

2.09

—

Sleep disorders, other/unspecified

413

1.24

0.76

1.2

1.1

1.05

1.91

u/ml

0.81

189

Tobacco use

449

1.23

0.76

1.1

0.62

1.44

u/ml

1.11

179

Prophylactic surgery

1.67

0.76

1.0

0.26

0.95

u/ml

—

Injuries to the thorax

387

3592

1.08

0.76

1.1

1.16

1.04

u/ml

0.13

174

1589

Other congenital malformations of the digestive system

701

1.18

0.76

1.2

0.55

1.26

u/ml

1.50

427

Autoimmune diseases related-to ILD

1017

8111

1.05

0.76

1.1

0.89

1.08

u/ml

0.38

430

3601

Glaucoma

286

2645

0.92

0.76

1.1

0.63

0.95

u/ml

0.80

116

1103

Arthrosis

724

3752

1.06

0.75

1.1

0.77

1.03

u/ml

0.65

305

1558

Viral Sepsis

170

1521

1.12

0.75

1.1

1.57

0.91

u/ml

0.33

701

Intracranial trauma

792

5078

1.05

0.75

1.1

1.10

1.23

u/ml

0.30

387

2381

Recurrent dislocation of patella

744

1.18

0.75

1.1

0.42

1.35

u/ml

2.50

321

Small fibre neuropathy

141

1.43

0.75

1.4

1.0

0.84

0.73

u/ml

0.10

Hodgkin lymphoma, hilmo

208

0.67

0.74

1.2

1.1

0.61

1.84

u/ml

—

100

Injuries to unspecified part of trunk, limb or body region

102

883

1.16

0.74

1.0

1.1

2.10

1.26

u/ml

0.32

407

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

380

0.76

0.73

1.1

0.55

1.12

u/ml

0.67

167

Diffuse large B-cell lymphoma, including Hilmo

172

0.64

0.73

1.0

1.1

2.68

1.08

u/ml

—

Diffuse large B-cell lymphoma, helper endpoint

172

0.64

0.73

1.0

1.1

2.68

1.08

u/ml

—

Diffuse large B-cell lymphoma

172

0.64

0.73

1.0

1.1

2.68

1.08

u/ml

—

Acute pancreatitis (for exclusion)

110

1259

0.87

0.73

1.1

0.62

1.07

u/ml

0.75

532

Other congenital malformations of tongue, mouth and pharynx

370

1.26

0.73

1.2

0.28

1.10

u/ml

1.93

250

Other disorders involving the immune mechanism, not elsewhere classified

281

1.29

0.73

1.1

0.46

1.17

u/ml

0.90

138

Invasive ventilation

535

0.80

0.73

1.1

0.21

1.35

u/ml

3.05

293

Other other unspecified disorders of the circulatory system

207

0.67

0.73

1.0

1.1

0.02

1.22

u/ml

—

Parkinson's disease, strict definition

368

0.76

0.72

1.0

1.1

0.60

1.05

u/ml

0.43

158

Other specified and unspecified strabismus

117

1.47

0.72

1.1

1.2

1.70

0.72

u/ml

—

Maxillary retrognathism

282

1.29

0.72

1.1

0.19

0.82

u/ml

3.44

155

Hirsutism in women

273

1.29

0.72

1.0

1.1

1.45

0.76

u/ml

0.21

112

Abnormal involuntary movements

120

1054

1.14

0.72

1.1

0.57

0.97

u/ml

1.06

473

Viral encephalitis, not elsewhere classified/unspecified

117

1.46

0.72

1.1

0.49

2.10

u/ml

—

Caries in Clefts patients

158

0.62

0.72

1.0

1.1

7.15

0.80

u/ml

—

Congenital malformations of cardiac septa

1081

0.86

0.72

1.1

1.2

1.19

1.14

u/ml

0.04

650

Other and unspecified mononeuropathies of upper limb

206

0.68

0.71

1.1

0.03

1.80

u/ml

—

Carcinoma in situ of breast, intraductal

456

0.79

0.71

1.0

1.1

1.15

1.05

u/ml

0.03

179

Chronic nephritic syndrome

206

0.68

0.71

1.0

1.1

1.45

1.55

u/ml

—

6-mercaptopurine

444

0.78

0.71

1.0

1.1

0.53

0.98

u/ml

0.74

203

Other symptoms and signs involving the urinary system

636

1.18

0.71

1.0

1.1

0.42

1.16

u/ml

1.66

279

Benign neoplasm: Pituitary gland, craniopharyngeal duct

417

1.23

0.71

1.0

1.1

1.77

1.49

u/ml

0.07

182

Implicit viral Sepsis

169

1518

1.12

0.71

1.1

0.71

0.91

u/ml

0.41

700

Blood alcohol or alcohol intoxication level

240

0.70

1.1

3.01

1.22

u/ml

0.31

110

Artificial opening status

343

0.76

0.70

1.1

0.71

1.34

u/ml

0.45

183

Sacroiliitis, not elsewhere classified

564

1.19

0.70

1.0

1.1

0.69

1.22

u/ml

0.81

247

Exposure to other and unspecified man-made environmental factors

169

1.37

0.70

1.1

0.55

1.55

u/ml

0.70

Superficial injury of abdomen, lower back and pelvis

179

1615

1.11

0.70

1.1

1.23

1.21

u/ml

0.01

735

Complications following abortion and ectopic and molar pregnancy

195

1.34

0.69

1.1

0.42

1.02

u/ml

—

Cerebral palsy and other paralytic syndromes

954

0.86

0.69

1.1

0.42

1.19

u/ml

2.00

446

Haemolytic anaemias

239

1.30

0.69

1.1

0.82

1.22

u/ml

0.27

128

Viral infections of the central nervous system

629

1.18

0.69

1.0

1.1

0.65

1.16

u/ml

0.84

285

Septal defects

1037

0.86

0.69

1.1

1.2

1.28

1.12

u/ml

0.12

636

Lactose intolerance, other/unspecified

257

1.29

0.69

1.0

1.1

0.57

1.62

u/ml

1.01

133

Visual impairment including blindness (binocular or monocular)

409

0.78

0.69

1.1

0.46

1.32

u/ml

1.20

203

Hyperkinetic disorders (excl. ADHD)

486

1.21

0.69

1.2

1.28

1.10

u/ml

0.14

319

Other bursal cyst

1.60

0.68

1.0

0.08

1.09

u/ml

—

Other specified/unspecified spondylopathies

1.57

0.68

1.1

1.0

0.67

3.07

u/ml

—

Cardiomyopathy

931

0.86

0.68

1.1

1.61

1.22

u/ml

0.31

431

Bullous disorders

266

1.28

0.68

1.1

1.44

1.27

u/ml

0.07

112

Benign neoplasm: Tongue

127

1.42

0.68

1.1

1.0

0.41

2.23

u/ml

—

Tooth eruption problems

318

2850

1.08

0.68

1.1

1.19

1.33

u/ml

0.12

180

1475

Additional codes for the location of defect, injury or illness

456

1.21

0.68

1.1

0.70

1.42

u/ml

0.88

215

Respiratory and cardiovascular disorders specific to the perinatal period

707

1.17

0.67

1.2

0.82

1.21

u/ml

0.45

493

Acute pancreatitis

110

1250

0.88

0.67

1.1

0.62

1.08

u/ml

0.77

536

412

1.23

0.67

1.1

1.2

1.37

1.46

u/ml

0.04

225

Chronic Coagulation defects

249

0.72

0.67

1.2

1.1

1.24

1.01

u/ml

—

120

Fracture of lower leg, including ankle

563

5225

1.06

0.67

1.1

1.06

1.03

u/ml

0.05

275

2309

Macular hole

153

1.38

0.67

1.0

1.1

0.49

1.69

u/ml

0.87

Scabies

503

1.20

0.66

1.1

0.55

0.97

u/ml

0.44

225

Benign neoplasm: Adrenal gland

375

1.23

0.66

1.0

1.1

1.28

1.13

u/ml

0.06

157

Actinic keratosis

127

1024

1.13

0.66

1.1

1.99

0.89

u/ml

0.34

432

Thoracic aortic aneurysm

604

1.18

0.66

1.1

0.46

1.13

u/ml

1.37

264

Other follicular disorders

800

1.15

0.66

1.1

1.33

1.15

u/ml

0.09

342

Chronic suppurative otitis media, including avohilmo

772

1.16

0.66

1.1

0.35

1.25

u/ml

2.41

390

Melanocytic naevi of lower limb, including hip

403

1.22

0.66

1.1

0.39

1.22

u/ml

1.47

173

Mandibular retrognathia AND surgery (BSSO)

286

1.27

0.66

1.0

1.1

0.45

1.24

u/ml

1.07

107

Burns and corrosions of multiple and unspecified body regions

190

0.68

0.65

1.2

1.1

1.29

1.87

u/ml

—

101

Streptococcal septicaemia

549

0.82

0.65

1.0

1.1

0.99

1.21

u/ml

0.16

267

Syphilis

154

1.37

0.65

1.1

5.89

0.95

u/ml

0.46

Syphilis, including avohilmo

154

1.37

0.65

1.1

5.89

0.95

u/ml

0.46

Prominent ears

172

1.36

0.65

1.0

1.1

1.77

0.58

u/ml

0.87

Exposure to other and unspecified animate mechanical forces

404

1.22

0.65

1.1

0.40

1.56

u/ml

1.74

190

Sequelae of injuries of head

394

0.78

0.65

1.1

1.89

1.24

u/ml

0.26

172

Other or ill-defined heart diseases

358

1.23

0.65

1.2

1.1

1.41

1.30

u/ml

0.05

163

Other symptoms and signs involving general sensations and perceptions

293

0.75

0.65

1.2

1.1

0.68

1.62

u/ml

0.77

138

Nonischemic cardiomyopathy

471

0.80

0.65

1.1

0.19

1.32

u/ml

2.46

208

Other metabolic disorders

142

1272

1.12

0.65

1.0

1.1

0.92

u/ml

0.00

559

Myositis

120

1.42

0.64

1.2

1.0

1.03

0.80

u/ml

—

Vitreous haemorrhage

548

0.82

0.64

1.0

1.1

1.48

0.97

u/ml

0.35

238

Guttate psoriasis

1.49

0.64

1.1

2.88

1.03

u/ml

—

Encephalitis

224

0.71

0.64

1.1

1.22

1.20

u/ml

—

100

Other and unspecified abdominal hernia

198

1.32

0.64

1.2

1.1

0.20

1.34

u/ml

—

Ingrowing nail

496

1.19

0.64

1.2

1.1

0.35

1.48

u/ml

2.10

238

Skin changes due to chronic exposure to nonionizing radiation

137

1108

1.12

0.64

1.1

1.88

0.87

u/ml

0.33

464

Habit and impulse disorders

200

0.69

0.63

1.1

0.27

1.53

u/ml

—

Loose body in joint

129

1.40

0.63

1.2

1.1

0.58

2.34

u/ml

—

Finngen Rheumatological endpoints

1211

7130

0.96

0.63

1.1

0.70

1.13

u/ml

2.52

534

3156

Autoimmune diseases

1409

7400

0.97

0.63

1.1

0.85

1.11

u/ml

1.27

641

3439

Other bullous disorders

155

1.36

0.63

1.0

1.1

1.90

0.88

u/ml

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

369

1.23

0.63

1.0

1.1

4.97

0.92

u/ml

0.41

152

Use of fingolimod

101

0.59

0.63

1.0

1.1

—

0.62

—

Retinoblastoma

0.00

0.63

0.0

1.0

—

4.97

—

Postpartum haemorrhage

416

3224

1.07

0.63

1.1

1.43

0.93

u/ml

0.44

168

1343

Other diseases of arteries and capillaries

506

1.19

0.63

1.0

1.1

0.85

1.35

u/ml

0.35

213

Unknown and unspecified causes of morbidity

497

1.19

0.63

1.1

0.53

1.03

u/ml

0.73

214

Retinoblastoma, including Hilmo

0.00

0.62

0.0

1.0

—

4.97

—

Symptoms and signs concerning food and fluid intake

100

877

1.14

0.62

1.1

0.92

0.99

u/ml

0.06

457

Hypertensive Renal Disease

1.55

0.62

1.0

1.1

0.83

1.48

u/ml

—

Carrier of infectious disease

226

1.29

0.62

1.2

1.1

3.34

1.50

u/ml

0.53

Hypertensive diseases (excluding secondary)

696

4247

0.95

0.62

1.1

1.37

1.04

u/ml

0.43

322

1884

Other conjunctival vascular disorders and cysts

1.47

0.61

1.1

0.13

1.30

u/ml

—

Crohn disease

160

1449

1.11

0.61

1.1

2.25

1.06

u/ml

0.43

652

Other diseases of spinal cord

187

0.69

0.61

1.0

1.1

0.54

2.30

u/ml

—

Congenital malformations of the urinary system

684

0.84

0.61

1.1

2.29

1.35

u/ml

0.36

362

Intentional self-harm by smoke, fire and flames

0.00

0.61

0.0

1.0

—

0.82

—

Other specified and unspecified personality disorders

111

985

1.13

0.61

1.1

1.36

1.15

u/ml

0.14

429

Exposure to sunlight

0.00

0.61

0.0

1.1

—

0.58

—

Non-seminoma of testis

0.00

0.61

0.0

1.1

—

6.92

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.60

0.0

1.3

—

1.01

—

Amenorrhoea

110

976

1.13

0.60

1.1

0.88

1.24

u/ml

0.38

448

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.60

0.0

1.0

—

1.07

—

Other congenital malformations of integument

0.00

0.60

0.0

1.0

—

3.27

—

Malignant neoplasm of rectum, including Hilmo

456

0.81

0.60

1.1

1.77

1.12

u/ml

0.38

186

Complications peculiar to reattachment and amputation

0.00

0.60

0.0

1.1

—

0.28

—

Benign neoplasm: Other and unspecified parts of mouth

165

1.34

0.60

1.0

1.1

3.18

1.00

u/ml

—

Malignant neoplasm of ureter, including Hilmo

0.00

0.60

0.0

1.1

—

0.37

—

Dextrocardia

0.00

0.60

0.0

1.3

—

0.45

—

Varicose veins of other sites

435

1.20

0.60

1.1

0.56

1.36

u/ml

1.28

191

Injuries to the head

1447

8302

1.03

0.60

1.1

1.10

1.03

u/ml

0.15

692

3722

Polyglandular dysfunction

0.00

0.60

0.0

1.0

—

0.63

—

Familial hypercholesterolemia, with ischemic heart disease

218

1.29

0.60

1.1

1.0

3.23

1.53

u/ml

—

Pre-eclampsia or eclampsia

226

2450

0.92

0.60

1.1

1.55

0.99

u/ml

0.25

1027

Arthropathic psoriasis

897

0.87

0.59

1.1

1.18

0.99

u/ml

0.07

377

Disorders of purine and pyrimidine metabolism

0.00

0.59

0.0

1.2

—

0.95

—

Retinal detachments and breaks

205

1881

1.09

0.59

1.1

1.63

0.87

u/ml

0.39

781

Eating disorder

177

1612

1.10

0.59

1.1

0.86

1.25

u/ml

0.78

770

Other congenital malformations of skin

464

1.19

0.59

1.2

1.1

0.84

1.49

u/ml

0.63

235

Explicit bacterial Sepsis

725

0.85

0.59

1.0

1.1

1.16

u/ml

0.00

339

Secondary polycythaemia

114

1.41

0.59

1.0

1.1

0.13

1.08

u/ml

—

Other superficial mycoses

219

1.29

0.59

1.2

1.1

0.25

1.39

u/ml

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.59

0.0

1.0

—

1.67

—

Internuclear ophthalmoplegia

0.00

0.59

0.0

1.0

—

1.04

—

Vascular diseases of the intestine

1.45

0.59

1.1

0.24

1.02

u/ml

—

Pre-eclampsia

215

2333

0.92

0.58

1.1

1.65

1.00

u/ml

0.27

984

Postprocedural musculoskeletal disorders, not elsewhere classified

310

0.77

0.58

1.0

1.33

1.37

u/ml

—

126

Pedal cyclist injured in transport accident

266

2471

1.08

0.58

1.1

1.07

1.24

u/ml

0.29

134

1157

Other diseases caused by chlamydiae

106

1.43

0.58

1.1

1.0

0.26

0.69

u/ml

—

Traumatic subdural haemorrhage

414

0.81

0.58

1.1

1.0

0.67

1.38

u/ml

0.58

190

Other abnormal auditory perceptions

1.44

0.57

1.2

1.1

0.67

2.03

u/ml

—

Other congenital malformations, not elsewhere classified

159

1.34

0.57

1.1

1.2

0.27

0.74

u/ml

1.40

107

Herpesviral keratitis and keratoconjunctivitis

256

1.25

0.57

1.0

1.1

3.59

1.39

u/ml

0.38

105

Congenital malformations of aortic and mitral valves

451

0.82

0.56

1.0

1.2

0.98

1.12

u/ml

0.08

257

Other specified and unspecified retinal disorders

176

1.31

0.56

1.0

1.1

0.37

2.42

u/ml

—

Wet age-related macular degeneration

299

1.23

0.56

1.0

1.1

0.85

1.07

u/ml

0.18

125

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

177

1.32

0.56

1.0

1.1

0.94

1.09

u/ml

0.07

Fracture of neck

263

0.76

0.56

1.2

1.1

1.23

0.97

u/ml

—

115

Alopecia areata

284

1.24

0.56

1.1

0.70

1.36

u/ml

0.64

128

Pedal cyclist injured in other and unspecified transport accidents

124

1115

1.11

0.56

1.1

0.97

1.13

u/ml

0.17

498

Congenital malformations of the urinary system, including avohilmo

720

0.86

0.56

1.1

2.23

1.30

u/ml

0.37

376

Impotence

229

0.74

0.56

1.0

1.1

0.34

1.24

u/ml

—

Ectopic pregnancy

191

1755

1.09

0.56

1.1

1.05

0.89

u/ml

0.18

725

Bipolar affective disorders

246

2285

1.08

0.55

1.1

0.44

1.25

u/ml

5.20

116

965

Ulcerative ileocolitis

373

0.80

0.55

1.1

0.90

1.42

u/ml

0.38

159

Ascites

318

0.78

0.55

1.0

1.1

0.96

1.21

u/ml

0.17

138

Autoimmune hyperthyroidism

570

1.16

0.55

1.1

0.44

1.16

u/ml

1.54

226

Anterior Iridocyclitis

153

1679

0.91

0.55

1.1

0.81

1.01

u/ml

0.21

735

Diseases caused by chlamydiae

1.43

0.55

1.1

1.0

0.26

0.70

u/ml

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

783

0.87

0.54

1.1

0.98

0.89

u/ml

0.07

328

Isolated growth hormone deficiency

248

0.75

0.54

1.2

1.3

1.30

0.85

u/ml

0.47

189

Coxarthrosis, primary, with hip surgery

181

1828

0.92

0.54

1.1

0.75

0.93

u/ml

0.36

758

Other appendicitis

673

1.15

0.54

1.1

0.82

0.96

u/ml

0.14

284

Varicella [chickenpox]

515

1.17

0.54

1.1

1.03

1.20

u/ml

0.15

263

Torsion of ovary, ovarian pedicle and fallopian tube

222

1.27

0.54

1.1

1.74

1.10

u/ml

0.18

Lesion of radial nerve

204

1.28

0.54

1.1

1.0

0.74

1.59

u/ml

0.53

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

205

0.73

0.54

1.0

1.1

0.03

1.48

u/ml

—

Vitiligo

108

1.40

0.53

1.0

1.1

1.27

0.90

u/ml

—

Benign neoplasm of breast

100

891

1.12

0.53

1.1

0.65

0.90

u/ml

0.28

367

Venous complications and haemorrhoids in pregnancy

260

0.76

0.53

1.1

0.12

0.83

u/ml

—

106

Elevated blood glucose level

656

1.15

0.53

1.1

0.55

1.26

u/ml

1.29

314

Other and unspecified epidermal thickening

187

1.29

0.53

1.2

1.1

1.00

1.18

u/ml

0.09

Acute peritonitis

316

0.79

0.53

1.1

0.08

1.59

u/ml

2.20

142

Viral agents as the cause of diseases classified to other chapters, including avohilmo

241

1.25

0.53

1.1

0.69

1.27

u/ml

0.51

119

Subarachnoid haemorrhage

433

1.18

0.52

1.0

1.1

0.48

1.00

u/ml

0.82

189

Parkinson's disease, excluding more controls

341

0.81

0.52

1.0

0.55

1.06

u/ml

0.50

152

Chorioretinal inflammation

169

0.71

0.52

1.1

2.04

1.53

u/ml

—

Viral and other specified intestinal infections

363

3344

1.06

0.52

1.1

0.74

1.32

u/ml

1.82

163

1708

SLE, strict definition

248

0.76

0.52

1.1

1.48

1.35

u/ml

—

110

SLE, ICD10

248

0.76

0.52

1.1

1.48

1.35

u/ml

—

110

Left ventricular outflow tract obstruction (LVOTO), broad definition

959

0.88

0.52

1.0

1.1

0.40

1.19

u/ml

2.65

493

Chronic suppurative otitis media

592

1.15

0.51

1.1

0.36

1.52

u/ml

2.25

285

Intestinal stricture

163

1777

0.92

0.51

1.1

0.64

1.10

u/ml

1.07

775

Congenital malformations of ovaries, fallopian tubes and broad ligaments

677

1.14

0.51

1.1

1.70

0.93

u/ml

0.44

289

Pure hypercholesterolaemia

573

3809

0.95

0.51

1.1

1.05

0.98

u/ml

0.10

275

1593

Melanocytic naevi of scalp and neck

214

0.74

0.51

1.1

0.12

1.39

u/ml

—

Other pleural conditions

305

1.21

0.51

1.1

0.37

1.62

u/ml

1.55

133

Pediculosis and phthiriasis, including avohilmo

1.49

0.51

1.0

1.2

8.81

0.64

u/ml

—

Cramp and spasm

388

1.19

0.51

1.1

0.42

1.18

u/ml

1.33

174

Psoriasis (vulgaris), strict definition

260

1.24

0.51

1.1

0.47

1.38

u/ml

0.97

112

All dysplastic lesions of the vagina

225

0.75

0.51

1.0

1.1

0.78

1.25

u/ml

—

Delayed puberty

180

1.30

0.51

1.1

3.53

1.05

u/ml

0.80

111

Other heart diseases

665

4508

0.96

0.51

1.1

1.03

1.08

u/ml

0.12

306

2108

Streptococcal septicaemia, including avohilmo

564

0.85

0.51

1.0

1.1

0.94

1.19

u/ml

0.21

275

Seropositive rheumatoid arthritis, strict definition

979

0.89

0.50

1.0

1.1

0.43

0.99

u/ml

1.64

406

Other juvenile arthritis

638

0.86

0.50

1.1

0.17

1.16

u/ml

3.87

332

Open wound of ankle and foot

114

1028

1.11

0.50

1.0

1.1

1.67

1.27

u/ml

0.17

483

Tumor necrosis factor alpha inhibitors

187

2023

0.92

0.50

1.1

0.71

1.13

u/ml

1.04

910

Other localized connective tissue disorders

118

1.36

0.50

1.0

0.11

1.88

u/ml

0.93

Monoarthritis, not elsewhere classified

297

1.22

0.50

1.1

1.13

1.08

u/ml

0.03

130

Injury of unspecified body region

631

1.14

0.50

1.0

1.1

2.77

1.30

u/ml

0.43

290

Vitamin D deficiency

171

1.29

0.50

1.1

3.13

1.39

u/ml

0.41

Contusion of other and unspecified parts of foot

707

1.14

0.50

1.2

1.1

1.80

1.60

u/ml

0.06

337

Disorder of the sleep-wake schedule

225

1.25

0.50

1.1

4.19

1.60

u/ml

—

121

Helminthiases, including avohilmo

557

1.15

0.50

1.1

0.84

1.21

u/ml

0.46

282

Other and unspecified injuries of shoulder and upper arm

252

1.24

0.50

1.2

1.1

0.86

1.52

u/ml

0.32

108

Glomerular disorders in diseases classified elsewhere

755

0.87

0.50

1.0

1.1

1.48

1.21

u/ml

0.12

332

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

375

3960

0.95

0.50

1.1

0.88

1.15

u/ml

0.34

159

1738

Acute alcohol intoxication ICD-9

127

1.34

0.49

1.1

0.16

1.41

u/ml

—

Aortic aneurysm

804

1.12

0.49

1.1

0.43

1.03

u/ml

1.64

345

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

128

1.36

0.49

1.0

1.2

1.05

1.13

u/ml

0.03

SLE (Finngen)

268

0.78

0.49

1.1

1.48

1.37

u/ml

—

117

Postprocedural disorders of nervous system

891

0.88

0.49

1.1

0.33

1.07

u/ml

1.98

396

Other, unspecified and serous retinal detachments

145

1.32

0.49

1.1

10.91

2.33

u/ml

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

226

1.25

0.49

1.1

1.2

0.44

1.56

u/ml

0.97

135

Other disorders of fluid, electrolyte and acid-base balance

164

1677

0.92

0.48

1.1

1.31

0.77

u/ml

0.32

752

Assault by sharp object

166

0.72

0.48

1.0

1.1

0.30

1.57

u/ml

—

Personal history of other diseases and conditions

206

1906

1.08

0.48

1.1

0.77

1.34

u/ml

1.62

108

994

Other salmonella infections

217

1.25

0.48

1.1

0.12

2.01

u/ml

1.58

Acquired haemolytic anaemia

128

1.33

0.48

1.2

1.1

1.49

1.80

u/ml

—

Anaemias

382

2318

1.06

0.48

1.1

0.67

1.08

u/ml

1.17

192

1129

Intermittent heterotropia

929

0.89

0.47

1.1

1.2

0.55

1.20

u/ml

1.73

526

Shoulder region

102

1.38

0.47

1.1

0.29

1.13

u/ml

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

200

1.27

0.47

1.1

1.2

0.94

0.97

u/ml

0.01

122

Malignant melanoma of skin

560

0.86

0.47

1.1

0.36

0.81

u/ml

1.14

225

Lung diseases due to external agents

559

1.15

0.47

1.1

0.43

1.15

u/ml

1.17

250

AV-block

588

0.87

0.47

1.1

1.99

0.87

u/ml

0.71

280

Pedestrian injured in transport accident

569

1.15

0.47

1.1

0.80

1.27

u/ml

0.46

249

Exposure to other specified electric current

266

0.78

0.47

1.0

1.1

1.40

1.27

u/ml

0.04

118

Endometriosis ASRM stages 3,4

245

2294

1.07

0.47

1.1

0.77

0.94

u/ml

0.30

103

960

Pectus excavatum, including avohilmo

1.41

0.47

1.2

1.1

1.09

1.78

u/ml

—

Congenital deformities of hip, including avohilmo

355

1.19

0.47

1.2

0.41

1.46

u/ml

1.66

195

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

782

0.88

0.47

1.2

1.1

1.10

1.36

u/ml

0.24

352

Congenital malformations of eye, ear, face and neck

107

968

1.11

0.46

1.1

1.55

1.18

u/ml

0.33

501

Other and unspecified glaucoma

199

0.75

0.46

1.0

2.49

1.40

u/ml

—

Burns and corrosions

166

1533

1.08

0.46

1.1

0.83

1.22

u/ml

0.89

730

Other aneurysm

182

1.27

0.46

1.1

1.29

1.01

u/ml

—

Specific personality disorders

329

3112

1.06

0.46

1.1

0.81

1.15

u/ml

0.84

159

1363

Other misadventures during surgical and medical care

120

1.34

0.46

1.3

1.1

0.07

0.93

u/ml

—

Isolated patent ductus arteriosus

282

0.79

0.46

1.0

1.3

2.25

0.70

u/ml

0.94

198

L02BA Anti-estrogens

105

1160

0.90

0.46

1.1

0.33

0.87

u/ml

2.03

460

Other abnormal findings of blood chemistry

319

1.19

0.46

1.0

1.1

0.29

1.35

u/ml

1.83

143

Injury of eye and orbit

168

1553

1.08

0.46

1.1

0.96

1.22

u/ml

0.27

708

Anorexia (incl.atypical)

822

0.88

0.46

1.1

1.02

1.61

u/ml

0.64

394

Iron deficiency anaemia secondary to blood loss (chronic)

873

1.11

0.46

1.1

0.67

1.00

u/ml

0.55

372

Superficial injury of head

248

2323

1.07

0.46

1.1

1.48

1.19

u/ml

0.18

128

1099

Mandibular prognathia

219

1.24

0.46

1.0

1.2

3.07

0.86

u/ml

0.37

133

Hydrocephalus

342

0.82

0.46

1.0

1.1

1.18

1.63

u/ml

0.22

173

Primary biliary cholangitis, wide definition

153

0.72

0.46

1.0

1.1

0.03

1.34

u/ml

—

Failed attempted abortion

174

1.28

0.45

1.0

1.1

0.27

1.03

u/ml

—

Biological medication for rheuma

208

2229

0.93

0.45

1.1

0.63

1.27

u/ml

2.14

1011

Colectomy operation

802

0.88

0.45

1.1

0.29

1.07

u/ml

2.60

347

Other Crohn's disease

798

1.12

0.45

1.0

1.1

0.86

1.08

u/ml

0.20

350

Other specified/unspecified arthritis

256

2404

1.07

0.45

1.1

0.83

1.17

u/ml

0.60

110

1062

Abscess of anal and rectal regions

751

1.12

0.45

1.1

1.41

1.09

u/ml

0.25

335

Benign neoplasm of other and unspecified sites

183

1.26

0.45

1.0

0.14

2.37

u/ml

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

330

0.82

0.45

1.0

0.55

1.15

u/ml

—

138

Personality disorders

372

3535

1.05

0.45

1.1

0.81

1.12

u/ml

0.85

178

1550

Diabetic maculopathy

646

0.88

0.45

1.1

0.91

u/ml

0.00

278

Pyoderma

112

1.35

0.45

1.1

1.0

0.55

0.44

u/ml

—

Unspecified urinary incontinence

506

1.15

0.45

1.0

1.1

0.99

1.22

u/ml

0.14

219

Prepatellar bursitis

274

1.21

0.45

1.0

1.1

1.04

0.86

u/ml

—

108

Systemic lupus erythematosus

264

0.79

0.44

1.1

1.48

1.30

u/ml

—

118

Disorders of lens

457

2969

0.95

0.44

1.1

1.34

0.92

u/ml

0.48

208

1208

Benign neoplasm: other/unspecified salivary gland

1.40

0.44

1.2

1.0

0.19

2.76

u/ml

—

Hypertrophic disorders of skin

648

1.13

0.44

1.1

0.36

1.29

u/ml

2.36

284

Pathological resorption of teeth

302

1.20

0.44

1.1

0.23

1.27

u/ml

1.73

129

Benign neoplasm: Brain, supratentorial

130

1.32

0.44

1.0

1.1

0.25

0.96

u/ml

—

Other/unspecified reactive arthropathies

535

1.14

0.44

1.0

1.1

0.66

1.28

u/ml

0.94

233

Eating disorders

187

1738

1.08

0.44

1.1

0.83

1.27

u/ml

1.00

102

822

Pedestrian injured in collision with car, pick-up truck or van

163

0.73

0.44

1.0

1.1

2.24

1.84

u/ml

—

Ischaemic heart disease, wide definition

494

3177

0.96

0.44

1.1

1.02

0.93

u/ml

0.13

191

1330

Hereditary corneal dystrophies

139

1.30

0.43

1.1

1.0

0.31

1.71

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

103

1135

0.91

0.43

1.1

0.26

1.10

u/ml

3.80

478

Other problems related to primary support group, including family circumstances

210

1910

1.07

0.43

1.1

1.02

1.20

u/ml

0.21

1016

Other congenital malformations of circulatory system

175

1.26

0.43

1.1

1.32

1.58

u/ml

0.07

Autism spe, excluding more controls

517

1.15

0.43

1.1

0.75

0.88

u/ml

0.14

269

Other eating disorders

877

1.11

0.43

1.2

1.1

0.92

1.56

u/ml

0.79

442

Implicit fungal Sepsis

184

1.25

0.43

1.1

1.44

0.88

u/ml

0.20

Other and unspecified coagulation defects

527

1.14

0.43

1.2

1.1

0.98

1.19

u/ml

0.15

239

Ulcerative colitis

241

2563

0.94

0.43

1.1

0.56

1.21

u/ml

2.96

105

1166

Other and unspecified iron deficiency

290

2735

1.06

0.43

1.1

0.82

1.00

u/ml

0.29

138

1239

Benign neoplasm: Descending colon

257

1.21

0.43

1.1

0.71

1.38

u/ml

0.55

104

Gestational [pregnancy-induced] hypertension

374

3553

1.05

0.43

1.1

0.62

1.05

u/ml

1.66

149

1489

Disorders of mineral metabolism

546

1.14

0.42

1.1

0.98

1.14

u/ml

0.10

263

Necrosis of pulp, including avohilmo

686

7022

0.96

0.42

1.1

1.19

1.03

u/ml

0.20

307

3020

Unspecified maternal hypertension

176

1.26

0.42

1.1

0.31

1.18

u/ml

—

Mandibular hypoplasia

1.45

0.42

1.2

1.1

0.02

0.74

u/ml

—

Molar incisor enamel hypoplasia, with caries

354

0.82

0.42

1.2

1.3

0.07

1.34

u/ml

4.09

272

Reactive arthropathies

698

1.12

0.42

1.1

1.04

1.10

u/ml

0.04

307

Secondary hypertension

649

0.88

0.42

1.0

1.1

0.71

1.29

u/ml

0.69

323

Volume depletion

446

0.85

0.42

1.1

2.17

1.17

u/ml

0.42

233

Benign neoplasm: Conjunctiva

194

1.24

0.42

1.1

0.56

1.60

u/ml

0.69

Scissor bite

636

1.13

0.42

1.1

1.2

0.61

1.67

u/ml

2.39

385

Autoimmune polyglandular failure

0.00

0.42

0.0

1.0

—

0.14

—

Nontraumatic intracranial haemmorrhage

796

0.89

0.42

1.1

0.42

1.05

u/ml

1.71

354

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.42

0.0

1.0

—

0.32

—

599

1.12

0.41

1.1

0.76

0.79

u/ml

0.03

258

Other parasitologically confirmed or unspecified malaria

0.00

0.41

0.0

1.0

—

1.42

—

Squamous cell neoplasms and carcinomas of the skin

203

1.23

0.41

1.0

1.34

0.89

u/ml

0.16

Lumbosacral spina bifida and hydrocephalus

0.00

0.41

0.0

1.1

—

0.25

—

Other and unspecified pemphigus

0.00

0.41

0.0

1.0

—

1.32

—

Congenital retinoschisis

0.00

0.41

0.0

1.1

—

0.74

—

Use of riluzole

0.00

0.41

0.0

1.1

—

1.13

—

Thromboangiitis obliterans

0.00

0.41

0.0

1.1

—

0.18

—

Foreign body in alimentary tract

435

1.15

0.41

1.2

1.1

0.36

1.51

u/ml

1.96

221

Benign neoplasm: Scrotum

0.00

0.41

0.0

1.1

—

1.24

—

Benign neoplasm: Eye, unspecified

0.00

0.41

0.0

1.1

—

0.21

—

Assault by drugs, medicaments and biological substances

0.00

0.41

0.0

1.1

—

0.86

—

Postinflammatory hyperpigmentation

0.00

0.41

0.0

1.1

—

1.22

—

Burkitt lymphoma, helper endpoint

0.00

0.41

0.0

1.1

—

5.48

—

Burkitt lymphoma

0.00

0.41

0.0

1.1

—

5.48

—

Burkitt lymphoma, including Hilmo

0.00

0.41

0.0

1.1

—

5.48

—

Hypertension, essential

832

4856

0.97

0.41

1.1

1.35

0.98

u/ml

0.58

368

2030

Corns and callosities

391

0.84

0.41

1.1

0.54

1.20

u/ml

0.75

163

Fitting and adjustment of external prosthetic device

0.00

0.41

0.0

1.1

—

2.59

—

Injuries to the hip and thigh

381

3256

1.05

0.41

1.1

1.31

1.14

u/ml

0.12

185

1462

Cerebral amyloid angiopathy

0.00

0.41

0.0

1.1

—

1.20

—

Other and unspecified injuries of abdomen, lower back and pelvis

123

1.31

0.41

1.2

1.1

0.39

0.89

u/ml

—

Neoplasms

1257

6419

1.03

0.40

1.1

0.95

1.18

u/ml

0.70

572

3022

Hypotension

567

1.13

0.40

1.1

1.06

0.94

u/ml

0.09

244

Hyposplenism

0.00

0.40

0.0

1.0

—

1.40

—

Eccrine sweat disorders

0.00

0.40

0.0

1.1

—

0.75

—

Polymyalgia rheumatica

358

0.84

0.40

1.0

1.1

0.45

1.16

u/ml

0.95

153

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.40

0.0

1.1

—

2.17

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.40

0.0

1.0

—

1.85

—

Progressive systemic sclerosis

0.00

0.40

0.0

1.0

—

2.01

—

Ankyloglossia

455

1.15

0.40

1.2

2.75

1.08

u/ml

0.31

292

Other adrenocortical overactivity

115

1.33

0.40

1.1

0.23

0.62

u/ml

—

Qualitative platelet defects

1.44

0.39

1.2

1.1

0.16

0.23

u/ml

—

Congenital hydrocephalus

1.44

0.39

1.0

1.1

—

0.15

—

Congenital deformities of hip

334

1.17

0.39

1.3

1.2

0.41

1.42

u/ml

1.54

192

Male infertility

475

1.14

0.39

1.1

0.63

1.77

u/ml

1.38

226

Endometroid carcinoma of ovary

0.00

0.39

0.0

1.0

—

1.64

—

Contact with sharp glass

442

0.86

0.39

1.1

0.20

0.97

u/ml

1.83

195

Carcinoma in situ of cervix uteri, endocervix

133

1.29

0.39

1.0

1.1

0.31

1.22

u/ml

—

Malignant neoplasm of ovary

237

0.80

0.39

1.0

0.29

0.95

u/ml

—

102

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

475

1.14

0.39

1.1

0.36

1.10

u/ml

1.42

207

Toxic effects of substances chiefly nonmedicinal as to source

129

1191

1.09

0.39

1.1

0.53

1.15

u/ml

1.64

549

Peripheral retinal degeneration

178

1.24

0.39

1.0

1.1

0.16

1.58

u/ml

—

Diseases of peritoneum

579

1.12

0.39

1.1

0.17

1.29

u/ml

2.89

246

Intentional self-harm by unspecified means

170

0.76

0.38

1.2

1.1

0.64

1.03

u/ml

—

Inguinal hernia, bilateral

447

1.14

0.38

1.1

0.19

1.01

u/ml

2.37

198

Bacterial, viral and other infectious agents, including avohilmo

101

923

1.10

0.38

1.1

0.77

1.38

u/ml

0.86

416

Adjustment and management of implanted device

664

0.89

0.38

1.1

0.88

1.01

u/ml

0.08

301

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

108

991

1.09

0.38

1.1

0.98

1.14

u/ml

0.12

403

LSIL lesion of the vagina

136

0.73

0.38

1.0

1.1

0.48

0.85

u/ml

—

435

1.14

0.38

1.1

0.53

0.90

u/ml

0.59

186

Gestational diabetes (for exclusion)

654

4346

1.04

0.38

1.1

0.86

1.06

u/ml

0.41

278

1832

Melanocytic naevi of upper limb, including shoulder

188

1.23

0.37

1.1

0.77

1.39

u/ml

—

Asymmetry of jaw

170

1.24

0.37

1.0

1.1

0.25

1.67

u/ml

—

Malignant melanoma

747

0.90

0.37

1.1

0.45

0.95

u/ml

1.02

296

Tularaemia, including avohilmo

116

1.30

0.37

1.2

1.1

2.47

0.97

u/ml

—

Impacted maxillary molar

105

1142

0.92

0.37

1.1

0.69

1.34

u/ml

1.14

535

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

662

0.89

0.37

1.1

0.61

1.20

u/ml

0.64

276

Rheumatoid arthritis

217

2036

0.94

0.37

1.1

0.43

1.10

u/ml

2.84

824

Injuries to the shoulder and upper arm

934

7003

1.03

0.37

1.1

0.70

1.14

u/ml

3.05

395

3171

Long labour

370

2999

1.05

0.36

1.1

1.22

0.94

u/ml

0.21

164

1232

Undescended testicle

276

0.82

0.36

1.2

2.67

1.46

u/ml

0.29

207

Supervision of high-risk pregnancy

315

1987

0.95

0.36

1.1

0.71

0.98

u/ml

0.72

120

808

Arthropathies in other diseases classified elsewhere

207

1.21

0.36

1.1

1.60

1.42

u/ml

0.07

Abdominal aortic aneurysm (AAA)

142

1.26

0.36

1.1

0.30

1.13

u/ml

1.57

Pyogenic arthritis

384

1.15

0.36

1.2

1.1

1.35

1.20

u/ml

0.07

181

Gonarthrosis,primary

626

3903

0.97

0.36

1.1

0.84

0.88

u/ml

0.06

242

1556

Maternal care for cervical incompetence

347

1.16

0.36

1.0

1.1

1.38

1.20

u/ml

0.05

138

Vitamin B12 deficiency anaemia

385

0.86

0.35

1.1

0.18

1.23

u/ml

2.13

155

Other encephalitis

201

0.79

0.35

1.1

1.22

1.23

u/ml

—

Other specified disorders of kidney and ureter

168

0.77

0.35

1.1

0.89

1.57

u/ml

—

Other diseases of pancreas

394

1.14

0.35

1.1

0.42

1.06

u/ml

1.01

176

Gastroduodenal ulcer

110

1011

1.09

0.35

1.1

1.0

0.75

0.82

u/ml

0.08

429

Explicit bacterial Sepsis, including avohilmo

743

0.90

0.35

1.0

1.1

1.08

1.19

u/ml

0.09

347

Chronic pancreatitis

659

0.89

0.35

1.1

0.33

1.05

u/ml

1.77

291

Other and unspecified injuries of wrist and hand

433

1.14

0.34

1.2

1.1

1.66

1.40

u/ml

0.10

209

Whooping cough

1.36

0.34

1.2

1.0

0.09

0.65

u/ml

—

Burn and corrosion of head and neck

189

0.79

0.34

1.0

1.1

0.51

0.82

u/ml

—

100

Other obstetric trauma

757

1.10

0.34

1.0

1.1

1.30

0.97

u/ml

0.16

313

Other and unspecified corneal deformities and disorders

218

1.20

0.34

1.0

1.1

5.79

1.47

u/ml

0.34

Wide developmental disorders, excluding more controls

749

1.10

0.34

1.1

1.2

0.80

1.13

u/ml

0.41

439

Other ulcerative colitis

584

0.89

0.34

1.1

0.44

1.36

u/ml

1.43

255

Laparoscopic right hemicolectomy

163

1.23

0.34

1.0

1.1

0.29

1.87

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

200

1889

1.06

0.34

1.1

0.63

0.97

u/ml

0.95

783

Diseases of liver

275

2620

1.05

0.34

1.1

0.73

1.11

u/ml

1.00

128

1135

Erythema multiforme

145

1.25

0.34

1.2

1.1

3.25

0.84

u/ml

—

Social disorders starting during childhood or adolecense, excluding more controls

173

1.23

0.34

1.0

1.1

0.42

0.66

u/ml

0.36

108

Myocardial infarction, with ST-elevation

510

0.88

0.33

1.0

1.1

0.51

1.05

u/ml

0.60

218

Vertical strabismus

265

1.17

0.33

1.1

0.44

0.76

u/ml

0.70

126

Nephrotic syndrome

275

0.83

0.33

1.2

0.12

1.09

u/ml

—

166

Lichen sclerosus et atrophicus

768

1.10

0.33

1.1

0.54

1.15

u/ml

1.27

325

Use of hypnotics and sedatives

1159

6776

0.98

0.33

1.1

0.92

1.00

u/ml

0.17

505

2953

Malignant neoplasm of mesothelium and soft tissue

166

0.78

0.33

1.2

1.0

0.24

1.08

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

101

932

1.09

0.33

1.1

1.03

1.19

u/ml

0.10

376

Injuries to the elbow and forearm

876

7309

1.03

0.33

1.1

1.12

1.06

u/ml

0.13

419

3317

Pneumonitis due to solids and liquids

307

0.85

0.33

1.2

1.1

0.67

1.54

u/ml

0.66

146

Superficial injuries involving multiple body regions

231

0.82

0.32

1.1

1.50

1.36

u/ml

0.05

Hypoplasia of dental enamel , including avohilmo

929

0.92

0.32

1.2

0.78

1.16

u/ml

0.59

587

Other congenital malformations of kidney

1.29

0.32

1.0

1.1

0.10

1.92

u/ml

—

Other benign neoplasms of uterus

164

1.22

0.32

1.2

1.0

0.28

1.59

u/ml

—

Inguinal or femoral hernia, bilateral

454

1.12

0.32

1.1

0.19

1.00

u/ml

2.36

200

Diabetes mellitus in pregnancy

597

3673

1.03

0.32

1.1

0.92

1.13

u/ml

0.39

253

1563

Car occupant injured in noncollision transport accident

370

0.86

0.32

1.1

2.44

1.28

u/ml

0.29

147

Hypertrophic scar

607

1.11

0.32

1.1

0.39

1.34

u/ml

2.21

265

Contusion of toe(s) without damage to nail

332

1.15

0.32

1.2

1.1

0.44

1.46

u/ml

1.27

150

Bursitis of shoulder

146

1.24

0.32

1.2

1.0

0.37

1.22

u/ml

—

Specific development disorders of scholastic skills

108

981

1.08

0.32

1.2

1.57

1.29

u/ml

0.21

585

Hallux valgus (acquired)

262

1784

1.05

0.32

1.1

1.27

0.96

u/ml

0.24

106

696

Other and unspecified disorders of skin and subcutaneous tissue

398

1.13

0.32

1.2

1.1

0.24

1.32

u/ml

1.70

171

Iron deficiency anaemia

351

3304

1.04

0.32

1.1

0.83

1.00

u/ml

0.30

163

1467

Enterocolitis due to Clostridium difficile

518

0.89

0.32

1.1

0.81

1.33

u/ml

0.52

227

Burn and corrosion of trunk

248

1.17

0.32

1.1

0.49

1.18

u/ml

0.85

126

Agoraphobia

475

0.88

0.32

1.0

1.1

0.07

1.14

u/ml

2.97

203

LSIL lesion of the cervix uteri, vagina or vulva

169

1792

0.94

0.31

1.1

0.41

0.98

u/ml

1.98

735

Parkinson's disease, strict definition, excluding more controls

305

0.86

0.31

1.0

0.60

0.89

u/ml

0.24

135

UC patients in KELA-register (code 208), prior to 1994

219

0.82

0.31

1.0

1.1

0.35

1.59

u/ml

—

Rheumatoid arthritis, including avohilmo

259

2714

0.95

0.31

1.1

0.42

1.02

u/ml

3.26

113

1129

Cystic kidney disease

262

0.84

0.31

1.0

1.1

4.35

1.08

u/ml

0.50

137

Distal bite

862

1.09

0.31

1.1

1.2

2.21

1.51

u/ml

0.23

515

Hyperkalaemia

165

1.21

0.31

1.0

0.71

0.81

u/ml

—

All pneumoniae

1300

8265

1.02

0.31

1.1

1.05

1.04

u/ml

0.04

671

3675

Missing teeth due to accident, extraction or parodontitis

431

3987

0.96

0.31

1.1

0.87

0.92

u/ml

0.05

204

1650

Diabetic neuropathy

451

0.88

0.31

1.1

1.30

1.27

u/ml

0.01

194

All dysplastic lesions of the vulva

347

0.86

0.31

1.0

1.1

0.11

1.18

u/ml

—

149

Clear cell adenocarcinoma of kidney

164

0.79

0.30

1.1

0.85

1.18

u/ml

—

Gonococcal infection

249

1.17

0.30

1.1

0.87

1.25

u/ml

0.24

107

Other cataract

256

1993

0.95

0.30

1.1

1.63

0.99

u/ml

0.39

108

842

Congenital malformations of heart and great arteries

165

1695

0.94

0.30

1.0

1.1

1.03

1.20

u/ml

0.21

941

Reactive arthropathies, FINNGEN

619

1.10

0.30

1.0

1.1

1.06

1.02

u/ml

0.03

261

Viral conjunctivitis

212

1.18

0.30

1.0

1.1

1.23

1.30

u/ml

—

Synovial hypertrophy, not elsewhere classified

1.34

0.30

1.1

0.21

0.85

u/ml

—

Hypertensive heart and/or renal disease

743

0.92

0.30

1.0

1.1

0.43

0.97

u/ml

1.47

325

Supplementary factors related to causes of morbidity and mortality classified elsewhere

337

3238

1.04

0.30

1.1

1.69

1.14

u/ml

0.48

164

1496

Other and unspecified vasculitis limited to skin

129

1.24

0.30

1.1

0.30

1.03

u/ml

—

Disorders in reading

344

1.14

0.30

1.2

1.33

1.20

u/ml

0.06

206

Viral agents as the cause of diseases classified to other chapters

203

1.19

0.30

1.0

1.1

0.69

1.25

u/ml

0.44

101

Burn and corrosion of wrist and hand

448

1.12

0.30

1.1

1.15

1.23

u/ml

0.06

217

Mandibular retrognathia

1001

0.92

0.30

1.1

0.75

1.35

u/ml

0.79

497

Other congenital malformations of peripheral vascular system

157

1.22

0.30

1.1

0.07

1.14

u/ml

0.94

Gonarthrosis

540

2954

1.03

0.29

1.1

0.86

1.03

u/ml

0.27

220

1186

Premature rupture of membranes

352

2602

0.96

0.29

1.1

0.97

u/ml

0.01

136

1131

Fracture of shoulder and upper arm

297

3091

0.96

0.29

1.1

1.09

1.28

u/ml

0.32

136

1477

Mixed disorders of conduct and emotions

503

0.89

0.29

1.0

1.1

0.77

1.08

u/ml

0.30

261

Central nervous system disorder causing precocious puberty

1.35

0.29

1.1

1.2

1.10

0.61

u/ml

—

Multiple delivery

910

0.92

0.29

1.1

0.79

0.69

u/ml

0.09

384

Vasculitis limited to skin, not elsewhere classified

148

1.22

0.29

1.2

1.1

0.31

1.19

u/ml

—

Motorcycle rider injured in other and unspecified transport accidents

702

0.91

0.29

1.2

1.1

0.47

1.29

u/ml

1.85

314

Unspecified misadventure during surgical and medical care

335

1.14

0.29

1.1

0.82

1.76

u/ml

0.77

141

Disorder of external ear, unspecified

206

0.82

0.29

1.2

1.0

0.74

1.00

u/ml

0.20

Accidental poisoning by and exposure to alcohol

195

0.82

0.29

1.0

1.1

0.16

1.40

u/ml

—

Other disorders of skin and subcutaneous tissue

672

5516

1.03

0.29

1.1

0.76

1.03

u/ml

1.08

303

2370

Dissociative [conversion] disorders

478

1.11

0.29

1.1

1.12

1.38

u/ml

0.11

199

Disorders of calcium metabolism

366

0.87

0.29

1.1

0.80

1.42

u/ml

0.37

174

Fitting and adjustment of other devices

193

1613

1.05

0.29

1.1

0.69

0.87

u/ml

0.35

676

Lack of expected normal physiological development

567

0.90

0.28

1.1

1.2

2.12

0.80

u/ml

0.45

389

Seropositive rheumatoid arthritis

155

1632

0.94

0.28

1.0

1.1

0.49

0.95

u/ml

1.30

657

Embedded teeth, including avohilmo

159

1503

1.06

0.28

1.0

1.1

0.75

1.29

u/ml

1.42

712

Spontaneous rupture of synovium and tendon

402

1.12

0.28

1.1

1.27

0.83

u/ml

0.19

161

L04AC Interleukin inhibitors

690

0.91

0.28

1.0

1.1

0.29

1.10

u/ml

2.22

298

Unspecified nephritic syndrome

103

1.27

0.28

1.0

0.13

0.97

u/ml

—

Contusion of ankle

498

1.11

0.28

1.2

1.1

0.85

1.12

u/ml

0.25

229

Disorders of globe

1.28

0.28

1.0

0.24

0.92

u/ml

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

312

0.86

0.28

1.1

0.17

0.91

u/ml

—

139

Hyperprolactinaemia

403

1.12

0.28

1.1

1.85

1.33

u/ml

0.13

168

Assault

169

1782

0.95

0.28

1.1

0.83

1.25

u/ml

0.65

100

815

Pneumonias (Asthma/COPD co-morbidities)

1288

8246

1.02

0.28

1.1

1.06

1.04

u/ml

0.05

665

3665

Burn and corrosion of shoulder and upper limb, except wrist and hand

183

0.82

0.27

1.0

1.1

1.38

1.87

u/ml

—

101

Contact with other sharp object(s)

855

0.92

0.27

1.0

1.1

0.57

1.23

u/ml

1.49

384

Other diseases of blood and blood-forming organs

384

1.12

0.27

1.0

1.1

0.09

1.56

u/ml

2.50

166

HSIL lesion of the cervix uteri

274

2630

1.04

0.27

1.0

1.1

1.35

0.90

u/ml

0.43

109

1119

Open wound of abdomen, lower back and pelvis

299

1.14

0.27

1.1

1.24

1.16

u/ml

0.04

144

Other pulmonary heart/vessel disease

177

1.19

0.27

1.0

1.1

0.44

1.72

u/ml

—

Suppurative and necrotic conditions of lower respiratory tract

258

0.85

0.27

1.0

1.1

4.74

2.15

u/ml

—

120

Disorders of adult personality and behaviour

400

3869

1.03

0.27

1.1

0.83

1.19

u/ml

1.03

196

1705

Other osteochondrodysplasias

113

1.25

0.27

1.1

1.2

0.53

0.72

u/ml

—

Viral hepatitis, IBD co-morbidity

521

0.90

0.27

1.1

0.36

1.33

u/ml

2.46

254

Other strabismus

288

2758

1.04

0.27

1.1

0.99

1.17

u/ml

0.20

144

1358

Psoriatic arthropathies, ICD10

802

0.92

0.27

1.1

1.16

1.09

u/ml

0.03

331

Cystic kidney disease, including avohilmo

289

0.86

0.26

1.0

1.1

4.04

1.15

u/ml

0.47

146

Gonarthrosis, primary, with knee surgery

280

2267

0.96

0.26

1.0

1.1

1.00

0.81

u/ml

0.14

102

888

Cholelithiasis

763

5330

0.98

0.26

1.1

0.52

0.95

u/ml

3.84

321

2214

Other nonscarring hair loss

1.27

0.26

1.0

1.1

0.53

1.08

u/ml

—

Acute and subacute iridocyclitis

150

1584

0.95

0.26

1.1

0.82

0.98

u/ml

0.16

686

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

597

5038

1.03

0.26

1.1

0.89

0.99

u/ml

0.09

238

2063

Carcinoma in situ of colon

1.27

0.26

1.0

1.1

0.51

2.19

u/ml

—

Other arthritis (FG)

303

2918

1.04

0.26

1.1

0.82

1.14

u/ml

0.67

134

1270

Motor disorders, excluding more controls

452

1.11

0.26

1.1

1.2

1.38

1.07

u/ml

0.18

316

Molar incisor enamel hypoplasia

971

0.93

0.26

1.1

1.2

0.77

1.11

u/ml

0.56

613

Bell's palsy

915

1.07

0.26

1.1

1.57

1.20

u/ml

0.25

397

Pneumococcal septicemia

246

0.85

0.26

1.0

1.1

0.72

1.26

u/ml

0.47

126

Congenital deformities of feet, including avohilmo

520

1.10

0.26

1.1

0.28

1.30

u/ml

2.44

252

DVT of lower extremities

1059

0.93

0.26

1.1

0.43

1.03

u/ml

1.71

432

Neonatal jaundice from other and unspecified causes

514

1.10

0.26

1.2

1.11

1.16

u/ml

0.03

372

Disorders of puberty, all

425

1.11

0.26

1.1

1.2

2.16

1.15

u/ml

0.62

256

Chondromalacia

197

1.17

0.26

1.2

1.1

0.18

1.53

u/ml

—

Other symptoms and signs involving cognitive functions and awareness

288

2651

0.96

0.25

1.1

0.64

1.02

u/ml

1.26

130

1165

Other disorders of kidney and ureter

717

0.92

0.25

1.1

0.54

1.25

u/ml

1.20

317

Seropositive rheumatoid arthritis, wide

154

1623

0.95

0.25

1.0

1.1

0.49

0.97

u/ml

1.30

678

Postprocedural endocrine and metabolic disorders, not elsewhere classified

123

1159

1.06

0.25

1.0

1.1

0.90

0.96

u/ml

0.03

503

Arthropod-borne viral fevers and viral haemorrhagic fevers

644

0.91

0.25

1.1

0.48

1.24

u/ml

1.31

266

Cyst of kidney

282

1.14

0.25

1.2

1.1

0.31

1.51

u/ml

1.48

109

Burns and corrosions of external body surface, specified by site

128

1208

1.06

0.25

1.1

0.89

1.18

u/ml

0.51

571

Oral leukoplakia, including avohilmo

123

1.22

0.25

1.1

0.29

1.90

u/ml

—

Pregnancy hypertension

561

4880

1.03

0.25

1.1

0.93

0.99

u/ml

0.06

225

1995

Gout, strict definition

592

0.91

0.25

1.1

0.61

1.00

u/ml

0.68

244

Striae atrophicae

114

1.24

0.25

1.1

1.0

0.19

0.98

u/ml

—

Other facial nerve disorders

179

1.18

0.25

1.3

1.1

0.12

2.29

u/ml

—

Congenital malformations of genital organs

159

1502

1.05

0.25

1.1

1.36

1.18

u/ml

0.14

768

Foreign body in ear

198

1.17

0.25

1.0

1.1

1.11

1.10

u/ml

—

109

Fracture of rib(s), sternum and thoracic spine

187

1958

0.95

0.24

1.1

0.47

0.98

u/ml

2.54

846

Gonococcal infection, including avohilmo

302

1.13

0.24

1.1

0.77

1.25

u/ml

0.40

135

Coxarthrosis

308

2060

0.96

0.24

1.1

0.70

1.09

u/ml

1.08

126

830

Polycystic kidney disease

191

0.84

0.24

1.1

2.11

0.76

u/ml

—

Other fall from one level to another

256

2659

0.96

0.24

1.1

0.95

1.25

u/ml

0.52

117

1332

Social disorders starting during childhood or adolescence

180

1.18

0.24

1.0

1.2

0.42

0.62

u/ml

0.30

114

Generalized epilepsy

561

1.09

0.24

1.1

0.37

1.18

u/ml

1.94

284

Constitutional tall stature

143

1.21

0.24

1.3

1.2

0.38

1.05

u/ml

0.68

Glaucoma-related operations

161

1.18

0.24

1.1

0.34

1.66

u/ml

—

Chronic respiratory disease originating in the perinatal period

0.74

0.24

1.1

1.2

0.12

1.13

u/ml

—

Fibrosis and cirrhosis of liver

381

0.89

0.24

1.0

0.89

1.12

u/ml

0.13

172

Other benign neoplasms of connective and other soft tissue

714

0.92

0.24

1.0

1.1

0.39

1.11

u/ml

1.76

302

Left ventricular outflow tract obstruction, narrow definition

558

0.91

0.24

1.0

1.2

0.76

1.06

u/ml

0.28

316

Problems related to lifestyle

105

1116

0.94

0.24

1.1

1.77

1.49

u/ml

0.13

468

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

271

1.13

0.24

1.0

1.80

1.08

u/ml

0.26

110

Overjet

607

1.09

0.24

1.2

2.91

1.27

u/ml

0.56

377

Benzodiazepine use

1143

7847

0.98

0.24

1.1

0.73

1.05

u/ml

1.83

481

3432

Ulcerative rectosigmoiditis

755

0.93

0.24

1.1

0.69

1.26

u/ml

0.88

316

Disorders of optic nerve and visual pathways

951

0.93

0.24

1.1

1.34

1.07

u/ml

0.11

453

Haemorrhagic and haematological disorders of fetus and newborn

639

1.08

0.23

1.2

0.99

1.30

u/ml

0.27

450

Hypertrophic cardiomyopathy

201

0.84

0.23

1.1

1.22

1.44

u/ml

—

Open bite

106

998

1.06

0.23

1.1

0.56

1.14

u/ml

1.53

538

Follow-up care involving plastic surgery

246

1.14

0.23

1.1

0.32

1.24

u/ml

1.07

100

Haemorrhage, not elsewhere classified

152

1.19

0.23

1.1

0.54

1.54

u/ml

—

Postpartum hemorraghe, all women as controls

416

3940

1.03

0.23

1.1

1.43

0.99

u/ml

0.38

168

1666

Ventricular septal defect, a heart condition

493

0.91

0.23

1.1

1.2

1.75

1.24

u/ml

0.28

315

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

143

1.19

0.23

1.1

1.42

1.76

u/ml

0.10

Pediculosis, acariasis and other infestations

591

1.08

0.23

1.1

0.53

1.15

u/ml

0.71

261

Osteoporosis with pathological fracture (FG)

199

1.16

0.23

1.1

0.47

0.74

u/ml

—

Other disorders of ear

961

6088

1.02

0.23

1.1

0.76

1.05

u/ml

1.69

413

2713

Cholelithiasis, broad definition with cholecystitis

801

5440

0.98

0.23

1.1

0.50

0.98

u/ml

4.64

335

2257

Other peripheral vascular diseases

601

1.08

0.23

1.1

0.66

1.01

u/ml

0.53

247

Intentional self-harm by sharp object

369

0.89

0.23

1.1

0.16

1.61

u/ml

2.41

170

Contact with other hot metals

134

1.20

0.23

1.1

1.00

0.85

u/ml

—

Embolic stroke

106

1.23

0.23

1.0

0.32

1.90

u/ml

—

Autism spe

544

1.09

0.23

1.1

0.75

1.12

u/ml

0.42

288

Malignant neoplasm of thyroid gland, including Hilmo

534

1.09

0.23

1.0

1.1

0.62

0.84

u/ml

0.25

224

Allergic purpura

285

1.13

0.22

1.1

1.90

1.53

u/ml

0.08

130

Placental disorders

125

1.21

0.22

1.1

1.0

0.60

1.76

u/ml

—

Melanocytic naevi of trunk

119

1126

1.06

0.22

1.1

0.63

1.09

u/ml

0.78

497

Cardiomyopathy, other and unspecified

379

0.90

0.22

1.2

1.1

1.67

1.57

u/ml

0.04

173

Other assisted single delivery

263

0.87

0.22

1.0

1.1

0.42

0.45

u/ml

0.07

115

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

375

3594

1.03

0.22

1.1

0.88

1.01

u/ml

0.14

159

1557

Varicella [chickenpox], including avohilmo

718

1.07

0.22

1.1

0.98

1.19

u/ml

0.22

395

Other CVD (FINNGEN)

464

0.92

0.22

1.1

1.18

0.95

u/ml

0.18

203

Other/unspecified seropositive rheumatoid arthritis

152

1594

0.95

0.22

1.0

1.1

0.49

0.99

u/ml

1.31

667

Abnormal findings on examination of urine, without diagnosis

295

1.12

0.22

1.1

0.34

1.13

u/ml

1.28

138

Albinism

0.00

0.22

0.0

1.1

—

0.14

—

Disorders of visual cortex

0.00

0.22

0.0

1.2

—

0.85

—

Medullary carcinoma of thyroid gland

0.00

0.22

0.0

1.0

—

1.67

—

Ulcerative colitis, NAS

137

1439

0.95

0.22

1.1

0.56

1.11

u/ml

1.53

640

Contact with nonpowered hand tool

305

1.12

0.22

1.1

1.0

1.50

1.61

u/ml

0.03

129

Deep endometriosis

904

1.06

0.21

1.1

0.57

0.94

u/ml

0.61

402

Disorders of copper metabolism

0.00

0.21

0.0

1.0

—

1.39

—

Hydrocele

545

1.08

0.21

1.1

0.66

1.20

u/ml

0.76

263

Protozoal diseases, including avohilmo

167

0.84

0.21

1.1

0.18

2.75

u/ml

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

199

0.85

0.21

1.1

0.22

1.13

u/ml

—

Abnormal spermatozoa

378

0.90

0.21

1.0

1.1

0.40

0.72

u/ml

—

170

Dengue fever [classical dengue]

0.00

0.21

0.0

1.1

—

0.15

—

Presbycusis

226

1.14

0.21

1.1

1.0

0.18

1.45

u/ml

1.55

Benign neoplasm of brain and other parts of central nervous system

449

1.09

0.21

1.1

0.39

1.20

u/ml

1.32

207

Congenital retinoschisis

0.00

0.21

0.0

1.1

—

0.12

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.0

—

1.44

—

Localized hypertrichosis

0.00

0.21

0.0

1.1

—

1.32

—

Alkalosis

0.00

0.21

0.0

1.0

—

1.53

—

Cardiovascular diseases (excluding rheumatic etc)

1137

6394

1.02

0.21

1.1

1.25

1.09

u/ml

0.28

522

2997

Other acantholytic disorders

0.00

0.21

0.0

1.0

—

1.64

—

Malignant neoplasm of palate

0.00

0.21

0.0

1.1

—

1.56

—

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.2

—

0.25

—

Malignant neoplasm of hypopharynx

0.00

0.21

0.0

1.2

—

1.49

—

Brain mixed glioma, helper endpoint

0.00

0.21

0.0

1.0

—

1.18

—

Malignant neoplasm of renal pelvis

0.00

0.21

0.0

1.1

—

2.11

—

Reduction defects of unspecified limb, including avohilmo

0.00

0.21

0.0

1.0

—

0.26

—

Diffuse (eosinophilic) fasciitis

0.00

0.21

0.0

1.0

—

1.37

—

Adalimumab

112

1182

0.95

0.21

1.1

0.58

1.01

u/ml

0.92

529

Sequelae of injuries of neck and trunk

188

0.85

0.21

1.1

0.76

1.69

u/ml

—

Other sideroblastic anaemias

0.00

0.21

0.0

1.0

—

1.42

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.21

0.0

1.1

—

2.10

—

Malignant neoplasm of gum

0.00

0.21

0.0

1.1

—

3.04

—

Induced delusional disorder

0.00

0.21

0.0

1.0

—

1.22

—

Primary Sclerosing Cholangitis, IBD and UDCA required

209

0.86

0.21

1.1

0.35

1.48

u/ml

—

107

Other and unspecified vascular occlusions

262

0.88

0.21

1.0

1.1

1.33

1.42

u/ml

0.03

106

Thyrotoxicosis with diffuse goitre

138

1315

1.05

0.21

1.1

0.46

1.04

u/ml

2.22

551

Disorders resulting from impaired renal tubular function

209

0.86

0.21

1.0

1.1

0.68

1.83

u/ml

—

105

Brain mixed glioma

0.00

0.21

0.0

1.0

—

1.04

—

Other disorders of amniotic fluid and membranes

216

2164

0.96

0.21

1.1

0.85

1.01

u/ml

0.24

928

Acute necrotizing ulcerative gingivitis, including avohilmo

0.00

0.21

0.0

1.0

—

1.54

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

533

0.92

0.21

1.1

0.50

1.31

u/ml

1.09

225

Postprocedural disorders of digestive system, not elsewhere classified

177

0.85

0.21

1.0

1.1

0.36

1.42

u/ml

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.21

0.0

1.0

—

1.46

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

0.21

0.0

1.0

—

1.49

—

Dengue fever [classical dengue], including avohilmo

0.00

0.21

0.0

1.1

—

0.15

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.0

—

1.30

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

151

1580

0.96

0.21

1.0

1.1

0.49

0.99

u/ml

1.33

661

Failure of sterile precautions during surgical operation

0.00

0.21

0.0

1.0

—

1.08

—

Other fibroblastic disorders

0.00

0.21

0.0

1.0

—

2.13

—

Bicuspidal aortic valve syndrome

314

0.89

0.21

1.0

1.1

0.93

1.01

u/ml

0.03

161

Enteropathic arthropathies

192

1.15

0.21

1.0

1.1

0.33

1.26

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

108

1023

1.06

0.21

1.1

0.98

0.95

u/ml

0.02

424

Manic episode

268

1.12

0.21

1.0

1.1

0.36

1.63

u/ml

—

113

Benign neoplasm: Skin of upper limb, including shoulder

117

1.20

0.20

1.1

1.0

0.23

0.74

u/ml

—

Other noninflammatory disorders of cervix uteri

230

1.13

0.20

1.1

1.0

0.11

0.98

u/ml

0.99

Linear scleroderma

0.00

0.20

0.0

1.1

—

0.47

—

Precocious puberty

115

0.77

0.20

1.1

1.23

0.70

u/ml

—

Bacterial meningitis

240

0.87

0.20

1.0

1.1

2.33

0.81

u/ml

0.48

105

Acute disseminated encephalitis/encephalomyelitis

0.00

0.20

0.0

1.1

—

0.08

—

Intentional self-harm by drowning and submersion

0.00

0.20

0.0

1.0

—

1.11

—

Hip and thigh

0.00

0.20

0.0

1.1

—

1.56

—

Mononeuritis multiplex

0.00

0.20

0.0

1.1

—

1.51

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.20

0.0

1.0

—

3.00

—

Other necrotizing vasculopathies (FG)

240

0.87

0.20

1.0

1.1

0.02

0.89

u/ml

—

106

Malignant neoplasm of meninges, including Hilmo

0.00

0.20

0.0

1.0

—

1.20

—

Social phobias

141

1346

1.05

0.20

1.1

0.33

1.23

u/ml

5.01

617

In situ neoplasms

293

2840

1.03

0.20

1.0

1.1

1.34

0.89

u/ml

0.47

117

1197

Malignant neoplasm of lip

0.00

0.20

0.0

1.1

—

1.29

—

Effects of other external causes

326

1.11

0.20

1.0

1.1

0.82

1.50

u/ml

0.39

141

Hyperfunction of pituitary gland

567

1.08

0.20

1.1

1.70

1.29

u/ml

0.13

260

Benign neoplasm: Skin, unspecified

259

1.12

0.20

1.0

1.1

0.24

1.61

u/ml

1.52

117

Colon adenocarcinoma

386

0.91

0.20

1.1

0.41

0.81

u/ml

1.21

153

Primary open-angle glaucoma

956

0.95

0.19

1.0

1.1

0.40

0.91

u/ml

1.65

416

Injury of muscle and tendon at wrist and hand level

108

1137

0.95

0.19

1.1

0.82

1.24

u/ml

0.46

502

LSIL lesion of the cervix uteri

147

1535

0.96

0.19

1.1

0.40

0.96

u/ml

1.74

639

Lesion of lateral popliteal nerve

302

0.89

0.19

1.1

0.60

1.73

u/ml

1.09

132

Other disorders of optic [2nd] nerve and visual pathways

582

0.93

0.19

1.1

2.24

1.18

u/ml

0.27

298

Dislocation, sprain and strain of joints and ligaments of head

520

1.08

0.19

1.1

0.93

1.19

u/ml

0.14

239

Convalescence

375

1.10

0.19

1.2

1.1

0.47

1.46

u/ml

1.19

155

!Aliquae complicationes praecoces traumatis

312

0.90

0.19

1.1

3.08

1.17

u/ml

0.36

136

Early complications of trauma

312

0.90

0.19

1.1

3.08

1.17

u/ml

0.36

136

Fracture of foot, except ankle

295

2864

1.03

0.19

1.1

0.75

1.14

u/ml

0.60

143

1301

Transient global amnesia

312

0.90

0.19

1.1

0.76

1.10

u/ml

—

129

Raynaud syndrome

841

1.06

0.19

1.1

0.67

1.23

u/ml

1.13

349

Primary open-angle glaucoma, strict

806

0.94

0.19

1.0

1.1

0.41

0.83

u/ml

1.18

347

Brain meningioma, including Hilmo

249

0.88

0.19

1.1

0.08

1.01

u/ml

—

106

Fetus and newborn affected by maternal complications of pregnancy

223

1.14

0.19

1.1

1.3

0.39

0.84

u/ml

0.63

164

Algoneurodystrophy

318

1.10

0.19

1.1

0.35

1.39

u/ml

1.60

137

Guillain-Barre syndrome

1.24

0.19

1.3

1.0

1.06

0.61

u/ml

—

Pyothorax

175

0.86

0.19

1.0

1.1

4.48

2.46

u/ml

—

Secondary right heart disease

137

1.17

0.18

1.1

0.20

0.78

u/ml

—

Use of interferon beta-1a

238

0.88

0.18

1.1

0.17

1.15

u/ml

—

Pneumothorax

328

1.10

0.18

1.1

0.23

1.66

u/ml

1.95

149

Congenital malformations of the circulatory system

199

1865

1.04

0.18

1.1

0.97

1.12

u/ml

0.19

113

1010

Duodenal ulcer

328

1.10

0.18

1.1

1.35

0.79

u/ml

0.41

139

Disorders of speech understanding and production

770

0.94

0.18

1.2

1.75

1.07

u/ml

0.28

481

Other and unspecified injuries of head

611

0.93

0.18

1.1

0.63

1.26

u/ml

0.92

277

Amiodarone users

311

0.90

0.18

1.1

0.37

1.27

u/ml

1.31

130

Assault by bodily force

100

1052

0.95

0.18

1.1

0.93

1.40

u/ml

0.45

471

Meningitis

386

1.09

0.18

1.0

1.1

1.93

1.38

u/ml

0.22

173

Arthropathy in ulcerative colitis

100

1.20

0.18

1.1

1.0

0.33

1.01

u/ml

—

Other maltreatment syndromes

321

0.90

0.18

1.0

1.1

0.28

1.54

u/ml

1.54

143

Fungal Sepsis

204

1.13

0.18

1.1

1.44

1.35

u/ml

0.02

Other disorders of skin and subcutaneous tissue, not elsewhere classified

939

0.95

0.18

1.1

0.67

0.98

u/ml

0.39

400

Hypoparathyroidism

185

1.14

0.18

1.1

0.52

1.99

u/ml

—

Chronic tubulo-interstitial nephritis

185

1.14

0.18

1.2

1.1

0.35

1.84

u/ml

—

Pneumonia, organism unspecified

1095

7397

1.01

0.17

1.1

1.05

u/ml

0.00

562

3294

Maternal care for known or suspected fetal abnormality and damage

276

2271

1.03

0.17

1.1

0.47

0.92

u/ml

2.41

119

973

Gout

107

963

0.95

0.17

1.1

0.48

1.14

u/ml

1.74

414

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

489

1.08

0.17

1.1

1.3

0.61

0.95

u/ml

0.40

357

Other secondary gonarthrosis

262

1.11

0.17

1.0

1.1

0.18

0.89

u/ml

2.73

105

Superficial injury of neck

226

0.88

0.17

1.3

1.1

0.95

0.80

u/ml

—

104

Glaucoma suspect

203

1962

1.03

0.17

1.1

0.82

0.99

u/ml

0.22

834

CR(E)ST syndrome

1.22

0.17

1.0

1.60

1.18

u/ml

—

Scarlet fever, including avohilmo

148

1.16

0.17

1.0

1.1

6.51

0.76

u/ml

—

Other infectious diseases

436

1.08

0.17

1.0

1.1

0.73

1.37

u/ml

0.70

195

Dementia in other diseases classified elsewhere

131

0.84

0.17

1.0

0.13

1.63

u/ml

—

Pregnancy examination and test

293

1766

1.03

0.17

1.1

1.33

0.95

u/ml

0.39

126

741

Other vitreous opacities

205

1.12

0.17

1.0

1.1

0.28

1.33

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

301

1.10

0.17

1.0

1.1

0.40

1.82

u/ml

1.52

129

Outcome of delivery

288

1719

1.03

0.17

1.1

1.25

0.89

u/ml

0.54

158

716

Pustular psoriasis

309

0.90

0.17

1.1

0.30

1.41

u/ml

1.71

130

Psoriasis

246

2389

1.03

0.16

1.1

0.64

1.07

u/ml

0.92

110

1035

Symptoms and signs involving the urinary system

690

5113

1.02

0.16

1.1

1.02

1.01

u/ml

0.01

328

2269

Bacterial, viral and other infectious agents

827

1.05

0.16

1.0

1.1

0.79

1.42

u/ml

0.82

369

Benign neoplasm: Skin of scalp and neck

162

0.86

0.16

1.1

0.49

1.16

u/ml

—

Congenital deformities of feet

331

1.09

0.16

1.1

0.40

1.20

u/ml

1.26

163

Coarctation of the aorta

172

0.87

0.16

1.0

1.2

0.73

1.09

u/ml

—

111

Etanercept

720

0.94

0.16

1.0

1.1

0.32

1.04

u/ml

1.86

320

Anisometropia and aniseikonia

302

1.09

0.16

1.0

1.1

0.16

1.16

u/ml

2.09

147

Other infectious diseases, including avohilmo

593

1.06

0.16

1.0

1.1

1.29

1.37

u/ml

0.04

258

111

1.18

0.16

1.1

1.11

1.78

u/ml

—

Other embolism and thrombosis

769

1.05

0.16

1.1

1.17

0.91

u/ml

0.19

318

Conductive and sensorineural hearing loss

616

4159

0.98

0.16

1.1

0.69

1.07

u/ml

1.82

257

1779

Optic neuritis

442

0.93

0.16

1.0

1.1

0.19

1.13

u/ml

2.15

190

Causalgia

130

1.16

0.15

1.0

0.29

0.78

u/ml

—

Type of accident

303

2956

1.03

0.15

1.1

1.57

1.16

u/ml

0.29

145

1371

Calculus of lower urinary tract

172

0.87

0.15

1.0

0.87

1.83

u/ml

—

Brain meningioma

245

0.90

0.15

1.1

0.08

1.04

u/ml

—

103

Inguinal hernia

515

3486

0.98

0.15

1.1

0.78

1.10

u/ml

1.01

235

1600

Preparatory care for dialysis

203

0.89

0.15

1.0

1.1

0.71

1.56

u/ml

—

Birth asphyxia

169

1.14

0.15

1.3

1.2

0.34

0.93

u/ml

0.75

119

Endovascular or surgical operations to intracerebral aneurysms

307

0.91

0.15

1.1

0.81

1.39

u/ml

0.52

125

Osteonecrosis

307

0.91

0.15

1.0

1.1

0.22

1.29

u/ml

1.63

126

Benign leiomyoma with endometriosis

984

0.95

0.15

1.1

0.68

0.92

u/ml

0.36

407

Other and unspecified haemorrhagic conditions

102

1.18

0.15

1.0

1.1

0.02

0.90

u/ml

—

Myocardial infarction, without ST-elevation

144

1252

1.04

0.15

1.1

1.0

1.48

0.81

u/ml

0.54

520

Perioral dermatitis

255

1.10

0.15

1.1

0.86

1.65

u/ml

0.56

103

Cyst of Bartholin Gland

379

0.92

0.15

1.1

0.42

0.80

u/ml

0.84

161

Mental and behavioural disorders due to tobacco

677

0.94

0.15

1.1

1.59

1.17

u/ml

0.11

285

Other surgical follow-up care

313

1.09

0.15

1.1

0.79

1.53

u/ml

0.56

138

Special screening examination for other diseases and disorders

105

1005

1.04

0.15

1.1

0.93

1.57

u/ml

0.57

422

Other psoriatic arthropathies

779

0.95

0.15

1.1

1.16

1.11

u/ml

0.02

322

Other heart diseases, wide

1209

7397

0.99

0.15

1.1

1.08

u/ml

0.01

545

3338

Complications of the puerperium, not elsewhere classified

576

1.06

0.14

1.0

1.1

0.50

0.79

u/ml

0.65

249

Gout, idiopatic and unspecified

932

0.95

0.14

1.1

0.50

0.97

u/ml

1.25

395

Systemic sclerosis

150

0.86

0.14

1.0

1.35

1.63

u/ml

—

Inflammatory bowel disease, strict (require KELA)

263

2697

0.97

0.14

1.1

1.48

1.20

u/ml

0.14

112

1239

Malignant neoplasm of bladder, including Hilmo

290

1.09

0.14

1.1

0.65

0.70

u/ml

0.06

116

Donors of organs and tissues

131

1.15

0.14

1.0

1.1

0.29

1.88

u/ml

—

Hidradenitis suppurativa

450

0.93

0.14

1.1

2.77

1.53

u/ml

0.33

184

Patent foramen ovale

314

1.09

0.14

1.1

1.2

0.82

1.02

u/ml

0.16

192

Infections specific to the perinatal period

377

0.92

0.14

1.2

0.46

1.39

u/ml

1.65

264

Dislocation, sprain and strain of joints and ligaments of elbow

792

1.05

0.14

1.2

1.1

1.34

1.27

u/ml

0.04

383

Other and unspecified disorders of psychological development

375

0.92

0.14

1.3

1.2

0.47

0.81

u/ml

0.66

269

Other disorders of glucose regulation and pancreatic internal secretion

743

1.05

0.14

1.1

0.89

1.29

u/ml

0.44

367

Protozoal diseases

160

0.87

0.14

1.1

0.18

2.89

u/ml

—

Carcinoma in situ of cervix uteri

144

1392

1.04

0.14

1.0

1.1

1.91

1.06

u/ml

0.44

606

Sixth [abducent] nerve palsy

160

1.13

0.14

1.1

0.29

1.01

u/ml

—

HSIL lesion of the cervix uteri, vagina or vulva

283

2765

1.02

0.14

1.0

1.1

1.33

0.89

u/ml

0.45

113

1165

Open wound of shoulder and upper arm

170

0.88

0.13

1.1

0.08

1.85

u/ml

—

Other specified congenital malformation syndromes affecting multiple systems

325

0.92

0.13

1.1

1.2

1.18

1.05

u/ml

0.04

209

Other disorders of binocular movement

276

1.09

0.13

1.2

1.1

0.52

1.65

u/ml

1.03

127

Systemic sclerosis, icd10

149

0.87

0.13

1.0

1.35

1.64

u/ml

—

Colon adenocarcinoma, helper endpoint

377

0.93

0.13

1.1

0.42

1.19

u/ml

1.35

155

Essential (haemorrhagic) thrombocythaemia

170

1.12

0.13

1.2

1.0

0.21

0.96

u/ml

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

294

0.92

0.13

1.1

1.2

1.49

1.34

u/ml

0.07

172

Other disorders of bladder

541

0.94

0.13

1.1

0.34

0.80

u/ml

1.49

229

Psoriatic and enteropathic arthropathies

1000

0.96

0.13

1.1

0.97

1.20

u/ml

0.12

415

Pedal cyclist injured in noncollision transport accidents

116

1203

0.96

0.13

1.1

1.03

1.11

u/ml

0.08

552

Enterobiasis, including avohilmo

407

0.93

0.13

1.1

0.93

1.19

u/ml

0.23

219

Scar conditions and fibrosis of skin

393

1.07

0.13

1.1

0.56

1.60

u/ml

1.21

167

Normotensive glaucoma

232

0.90

0.13

1.0

1.1

0.04

1.26

u/ml

—

100

Other specific arthropathies, wide

132

1.14

0.13

1.1

1.06

1.23

u/ml

—

Erosion and ectropion of cervix uteri

132

1.14

0.13

1.1

0.66

1.37

u/ml

—

Smoking dependency

673

0.95

0.13

1.1

1.59

1.17

u/ml

0.11

282

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

687

1.05

0.13

1.2

1.1

0.63

1.27

u/ml

0.73

380

Medical abortion

792

4230

1.01

0.13

1.1

0.97

0.90

u/ml

0.09

341

1779

Other and unspecified acne

190

1.11

0.13

1.1

0.32

0.83

u/ml

1.04

Torsion of testis

248

1.09

0.13

1.2

1.1

0.79

1.33

u/ml

0.43

127

Glucagon-like peptide-1 (GLP-1) analogues

265

2591

1.02

0.13

1.1

0.68

0.99

u/ml

0.62

1081

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

265

2591

1.02

0.13

1.1

0.68

0.99

u/ml

0.62

1081

Labour and delivery complicated by umbilical cord complications

550

1.06

0.12

1.0

1.1

0.73

1.02

u/ml

0.32

222

Congenital ovarian cysts

560

1.06

0.12

1.1

1.77

0.99

u/ml

0.32

235

Epilepsy

283

2761

1.02

0.12

1.1

0.70

1.13

u/ml

1.24

126

1376

Non-invasive ventilation

258

2176

1.02

0.12

1.1

0.31

1.06

u/ml

5.55

115

952

Senile cataract

369

2200

1.02

0.12

1.1

1.09

0.83

u/ml

0.55

174

862

Foreign body or object entering through skin

580

1.05

0.12

1.1

0.55

1.30

u/ml

1.24

255

Fracture of skull and facial bones

205

2102

0.97

0.12

1.1

1.31

1.13

u/ml

0.17

107

969

Intrahepatic Cholestasis of Pregnancy (ICP)

101

973

1.04

0.12

1.1

1.03

0.99

u/ml

0.03

401

Fracture of forearm

602

5330

1.01

0.12

1.1

1.22

1.14

u/ml

0.12

299

2405

Endocarditis

158

0.89

0.12

1.1

1.63

1.57

u/ml

—

Other obstructive and reflux uropathy

385

1.07

0.12

1.0

1.1

0.77

1.57

u/ml

0.54

161

Other condition

134

1382

0.97

0.12

1.1

1.49

1.08

u/ml

0.32

597

Other disorders of nervous system

354

0.93

0.12

1.1

0.18

1.46

u/ml

1.82

151

Malignant neoplasm of thyroid gland

483

1.06

0.12

1.0

1.1

0.73

0.86

u/ml

0.11

209

Measles

1.16

0.11

1.2

1.1

14.99

1.68

u/ml

—

Measles, including avohilmo

1.16

0.11

1.2

1.1

14.99

1.68

u/ml

—

Personal history of malignant neoplasm

701

0.95

0.11

1.1

0.96

1.35

u/ml

0.32

309

Assault by unspecified means

230

0.91

0.11

1.0

1.1

1.05

1.38

u/ml

—

105

Hydatidiform mole

143

1.12

0.11

1.0

2.39

1.34

u/ml

—

Fracture of lumbar spine and pelvis

124

1198

1.03

0.11

1.1

0.72

0.93

u/ml

0.35

521

Nail disorders

768

1.04

0.11

1.2

1.1

0.32

1.27

u/ml

2.69

350

Obstructed labour due to malposition and malpresentation of fetus

337

3064

1.02

0.11

1.1

1.65

0.91

u/ml

0.61

150

1240

Sequelae of infectious and parasitic diseases, including avohilmo

513

1.05

0.11

1.1

0.59

1.13

u/ml

0.69

207

Convulsions, not elsewhere classified

273

2642

1.02

0.11

1.1

1.11

1.25

u/ml

0.18

143

1317

Systemic lupus erythematosus, unspecified

209

0.91

0.11

1.1

1.48

1.54

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

572

1.05

0.11

1.2

1.1

0.63

1.31

u/ml

0.86

242

Open wound of head

510

4856

0.99

0.11

1.1

0.88

1.09

u/ml

0.61

257

2276

Inflammatory bowel disease

350

3440

1.02

0.11

1.1

1.34

1.15

u/ml

0.12

151

1588

Anxious personality disorder

250

0.92

0.11

1.1

1.00

1.34

u/ml

—

110

Unspecified abortion

455

1.06

0.11

1.0

1.1

0.57

1.02

u/ml

0.92

191

Paralytic strabismus

373

0.94

0.11

1.1

0.23

1.48

u/ml

2.27

170

Other disorders of binocular vision

134

1.12

0.11

1.1

1.0

0.45

1.77

u/ml

—

Pregnancy with abortive outcome

837

4311

1.01

0.11

1.1

1.10

0.95

u/ml

0.25

344

1819

L04AX Other immunosuppressants

605

5970

1.01

0.10

1.1

1.75

1.00

u/ml

0.99

274

2699

Polycystic ovarian syndrome, broad definition

193

1886

1.02

0.10

1.1

0.74

1.17

u/ml

0.65

825

Other disorders originating in the perinatal period

329

1.07

0.10

1.3

0.97

0.86

u/ml

0.05

247

Dermatophytosis

973

0.97

0.10

1.1

0.71

1.11

u/ml

0.51

437

Malignant neoplasm of colon

556

0.95

0.10

1.1

1.10

0.80

u/ml

0.17

229

Unspecified jaundice

218

0.92

0.10

1.0

1.1

0.58

1.32

u/ml

—

105

Ankylosing spondylitis

712

1.04

0.10

1.0

1.1

0.51

1.42

u/ml

1.62

307

Multiple gestation

128

1245

1.03

0.10

1.1

0.72

0.85

u/ml

0.17

523

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mugwort IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS